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Dulcolax
clearly offers 
a clean bowel 
when you need it!
also,
less trauma to 
the patient's 
dignity.
Which would you rather have?
Adm inistration
Tablets
Adults  —  two to three tablets taken at 
bedtim e or before breakfast. Children  
under 10 years —  one to two tablets 
depending on age and severity of 
constipa tion.
Suppositories
Infants and ch ild ren  under 2 years — 
one 5 mg suppository at the time a 
bowel m ovem ent is required.
Children over 2 years and adults— one 
10 mg suppository taken as above. 
Note: Dulcolax tablets should be 
swallowed whole —  not chewed or 
crushed.
They should not be taken in conjunc­
tion w ith antacids.
Side Effects
As w ith any laxative abdominal cramps 
are occasionally noted, particu larly  
in severely constipated individuals.
Precautions
Caution should be observed in treat­
ing cases of co litis , carcinoma of the 
colon and d iverticu litis . 
Contraindications 
Acute surg ica l abdomen.
Availability
Enteric coated tablets o f 5 mg. 
Suppositories of 5 mg and 10 mg.
Full prescrib ing inform ation is avail­
able on request.
(dlnh Boehringer Ingelheim Products
\BOIHRINGER /  ______ _  _  _
Montreal 308, P.Q.
DULCOLAX
(bisacodyl) B-5332S.70
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QUILL ON SCALPEL This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
FLAMMABLE FABRICS AND 
HUMAN BURNS*
Each year approximately 180,000 Cana­
dians burn themselves;1 about 600 of them 
die from their bums.2 Between 30% and 
40% of bums are caused by direct con­
tact with flames,3' 4 and these “flame” 
burns are responsible for the greatest num­
ber of burn deaths.3'3 The ignition of cloth­
ing, the single most significant feature of 
flame burns,5 is most common in the very 
young and the elderly6 and produces the 
most severe burns.7
Flame burns are responsible for 31% 
of the burn admissions to the Hospital for 
Sick Children, Toronto. A review of 100 
flame burns, five of which were fatal, re­
vealed that clothing was ignited in 90%. 
In 17% of these, flammable fluids were in­
volved, and so the flammability of clothing 
was not the primary factor ifl the burn 
injury. However, in 25% of these cases 
the small flame of a match or cigarette 
lighter ignited clothing and produced a 
major, and sometimes fatal, burn. Of these 
25 children, 12 were burned by flaming 
nightgowns and pyjamas, five by shirts, 
four by dresses, two by pants, one by a 
blouse and one by a towel tied around 
the neck. In each case the child would not 
have been burned if the clothing had been 
non-flammable. In most flame burns only 
exposed areas of the body would bo 
burned, or there might be no injury at all 
if the clothing did not ignite. Non-flam­
mable clothing would prevent burns due 
to clothing ignition and also protect the 
wearer against flame and radiant heat 
burns. Flammable fabrics are also re-
“This review, which was suggested by the Com­mittee on Public Health of the Ontario Medical Association, was made possible by a grant from the Ontario Medical Foundation.
sponsible for fires in bedding, draperies, 
and tents, all of which may cause human 
burns.8
Experience at the Hospital for Sick Chil­
dren confirms the reports of others that 
most clothing burns are due to fabrics of 
normal flammability—85% of clothing worn 
in North America, chiefly cotton, falls into 
this category.6' 10 The elimination of highly 
flammable clothing therefore has little 
effect on the overall incidence of clothing 
burns.9 Cotton is responsible for clothing 
burns in 87%  of cases, nylon in 7% , “syn­
thetic” fibres in 3% , wool in 2%  and 
cotton-Dacron combinations in 2% .8 
Fabrics with normal flammability can be 
made more flammable by changing the 
weight, weave and finish. Clothing that 
is loose and flaring or fabrics that are 
napped or piled bum faster. Synthetics 
may melt to form a burning syrup.11 The 
afterglow of many fabrics produces more 
heat than the flame itself.12 Thus it is diffi­
cult to produce entirely safe fabrics.
Flame-proof clothing can be produced 
from fabric made from non-flammable 
fibres or by processing normally flammable 
fabric to render it flame-proof. Many types 
of synthetic fibres are non-flammable or 
can be made non-flammable by introduc­
ing fire-resistant chemicals into the “melt” 
from which the fibres will be made.9 
Normally flammable fabrics can also be 
flame-proofed by weaving non-flammable 
synthetics into them. Cotton with 40% 
Modacrylic is flame-retardant.13 However, 
because non-flammable synthetics have a 
less desirable texture and are more ex­
pensive they have not replaced normally 
flammable fabrics.
Normally flammable fabrics, mainly 
cotton, can be flame-proofed by the addi­
tion of various fire-resistant chemicals, the 
simplest of which is boracic acid.14 Phos-
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phorus-nitrogen resin and antimony oxide 
chlorinated paraffin finish9 give more per­
manent flame-resistant finishes. However, 
many of these chemicals, such as boracic 
acid, wash out or dust out, and those that 
do not are expensive or damage the 
texture of the fabric.1' 9
Prevention of clothing burns can be 
approached from two directions: education 
of the public and legislation to force the 
industry to produce flame-proof clothing.
In Britain, flame-proof clothing has been 
marketed with appropriate labelling, yet, 
in spite of an education campaign to in­
crease public awareness of the hazard of 
clothing burns, the public has refused to 
buy the slightly more expensive flame- 
proofed clothing and prefers to take a 
chance with cheaper flammable garments. 
To date no fully successful public educa­
tion campaign has been mounted.9- 15’ 16
Legislation prohibiting the sale of ex­
ceptionally flammable fabric has eliminated 
the almost explosive “torch sweaters” and 
the highly flammable cowboy chaps once 
sold in the United States,9- 12 and, in 
Britain, flame-proofing has been made 
compulsory in children’s nightdresses.9- 17 
This legislation has been a step in the 
right direction, but the normally flam­
mable fabrics responsible for most clothing 
burns remain on the market. In addition, 
we do not have yet a laboratory test that 
will determine accurately which fabrics 
are “dangerous” and which are not.9 Most 
fabrics now in use are dangerous not be­
cause of excessive flammability, but be­
cause of the wearer’s carelessness. Finally, 
these fabrics play such a large part in our 
economy that legislation against them—to 
force the maker to produce more expen­
sive, less attractive, flame-proofed fabrics- 
is probably not warranted at present.
The only Canadian law limiting the sale 
of flammable fabrics is the Hazardous 
Products Act, and it deals only vaguely 
with this subject. It states that “No person 
shall advertise, sell, or import into Canada 
a hazardous product . . . any product that 
is or contains a poisonous, toxic, inflam­
mable, explosive, or corrosive product 
likely to be a danger to the health or safety 
of the public.”9 This law will prevent the
sale of exceptionally flammable fabrics but 
will not control the use of normally flam­
mable fabrics—the main offenders. Canada 
does not have any particularly common 
type of clothing burn such as the severe 
bums frequently suffered by little girls in 
Britain when their nightdresses are ignited 
by unguarded electrical fires.17 Thus it is 
difficult to frame effective legislation, as 
Britain has been able to do, to reduce 
significantly clothing burns by controlling 
a specific type of clothing fire. It seems 
impractical legally to force all clothing to 
be flame-proofed.
The National Besearch Council of Can­
ada continues ( I ) to collect data on burns 
to define better the flammable-fabric prob­
lem in the hope of finding some area 
where control will be possible, (2) to do 
research into better ways of testing the 
flammability of textiles, and (3) to survey 
the literature and new products to dis­
cover methods and products that might be 
used to lessen our fabric-burn problem.18
However, in the face of this negative 
survey, we still need much more public- 
education regarding flammable-fabric 
burns. Individual citizens, if they were 
made sufficiently aware of the burn prob­
lem, might reduce fabric burns by avoid­
ing situations where clothing may be 
ignited and by creating a demand for 
flame-proof fabric. This demand would 
encourage an already willing textile in­
dustry to produce better and cheaper non­
flammable fabrics.
J o hn  R. B irc h
The Hospital for Sick Children,
Toronto, Ont.
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LECTURE: RITUAL OR REALITY?
“No lecturer can be sufficiently acquainted 
with the nature and causes of the transient 
hesitations and perplexities which beset the 
intellectual progress of any individual 
mind . . . (that he can) adapt his exposition 
closely to the intellectual needs of any indi­
vidual. Besides, the one thing that the lecturer 
cannot allow is the pause for reflection; he 
must go on talking.”1
According to Henry Sidgwick’s “A Lec­
ture Against Lecturing”,1 the expository 
lecture has limited usefulness. Sidgwick 
summarized his reservations at that time 
by saying “(if) the lecturer’s function is 
merely to impart instruction by reading or 
saying a series of words that might be
written and printed . . . this species of 
lecture is an unsuitable and uneconomical 
employment of the time of the teacher 
and the class”. Yet, 80 years later, in most 
of our “scientific” meetings, we rely on this 
technique and thus demonstrate how little 
we have learned from earlier teachers. Men 
of international repute, acknowledged 
masters of content, rise before us often to 
read or disclaim haltingly; “It is — um — um 
— my intention to — ah — ah — speak to 
you today — about — um — um — the con­
nection — er-ah — or I should say the 
relation between the pancreas and — ah — 
pineal — homeostasis.”
To the critical listener such lectures as 
these seem not to have been prepared but 
to have been accumulated. The speaker’s 
text has no (apparent) logical order and 
his slides (few or none of which were pre­
pared professionally) cannot be read ex­
cept from the first few rows. The resent­
ment his listeners feel is almost palpable 
and, despite his eminence and their com­
pulsion to hear the famous, many will 
leave before he is through.
Masters of content are not always (or 
not often) masters of form. Hence, these 
spectacular failures (and the waste of pro­
fessional time and money they represent) 
will cease only when organizers of scien­
tific meetings become tough-minded. Under 
our mythology, the program committee 
chairman feels unable to ask intended 
faculty for their credentials. However, if he 
is to do his full duty to the sponsors and to 
the consumer, he must consider not only 
the visitor’s eminence as a scientist but his 
ability to present his material. In summary, 
unless we are prepared to abandon the 
lecture altogether, we must institute some 
sort of “quality control”. At the recent 40th 
Annual Meeting of the Royal College of 
Physicians and Surgeons of Canada held in 
Ottawa, Dr. Helen E. Reid and her col­
leagues from the Hospital for Sick Children 
in Toronto showed, in their “Preview and 
Rehearsal Service”, how this might be 
done.
J. O. G odden
R e f e r e n c e
1. S idgw ick  H: Miscellaneous Essays and A d­
dresses, London, Macmillan, 1904, p 340
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R E V I E W  A R T I C L E
INTRAVENOUS HYPERALIMENTATION: A REVIEW ”
JOEL B. FREEMAN, M.D. and LLOYD D. MacLEAN, M.D., F.R.C.S.fC], Montreal, Que.
Protein hydrolysates have been used for 
at least 70 years as a source of intravenous 
nitrogen.1' 2 General application of this 
technique has awaited the development of 
safer methods of cannulation of central 
veins, and the clinical and experimental 
demonstration that the technique can be 
life-saving. In 1967, Dudrick3' 4 adminis­
tered a 30% glucose-hydrolysate solution 
to four 12-week-old Beagle puppies, while 
four litter-mates were fed a standard diet. 
Over the following 255 days, all the 
puppies maintained exclusively on intra­
venous feedings outstripped the controls in 
weight gain and matched them in skeletal 
growth.
In 1968, Wilmore and Dudrick5 described 
normal growth and development in an 
infant who had received all nutrients by 
vein for 44 days. Wilmore et al.n published 
a cumulative report of 18 infants similarly 
treated in 1969. Since that time, many 
other workers have demonstrated weight 
gain and positive nitrogen balance with­
out oral intake in adults,711 in patients 
with acute renal failure12 and in in­
fants13-16 receiving this therapy.
This communication will review the 
theoretical and practical aspects of intra­
venous alimentation based on our experi­
ence over the past eight months at the 
Royal Victoria Hospital, Montreal, with 60 
critically ill adult patients. W e will pre­
sent a summary of nitrogen balance and 
the rationale underlying the protein- 
hydrolysate-hypertonic glucose mixture. 
The mixing technique for both large and 
small hospitals will be discussed in detail, 
as well as the indications for treatment and 
the methods for avoiding complications. 
W e will also describe our methods for 
managing patients with complications and 
those with special medical problems.
“ From the Department of Surgery, Royal Victoria 
Hospital and McGill University, Montreal, Que.
Supported by a grant from the Medical Research 
Council of Canada.
Indications for Intravenous 
H yperalim entation
“The most destructive processes seen in the 
study of body composition are those that 
combine severe injury with starvation and 
invasive sepsis.” 17
In planning metabolic and nutritional 
care during acute illness, one must be 
aware of the caloric intake as well as the 
daily electrolyte balance. Any patient who 
consumes 2000 to 3000 cal./day in health 
should receive at least that much when he 
is attempting to heal a wound and/or ward 
off infection. It now appears that positive 
nitrogen balance with weight gain can be 
attained with parenteral nutrition alone.7-11 
Controlled studies have also shown that 
nutrients are as efficiently utilized when 
given by vein as when given by mouth.18' 85 
Therefore, intravenous alimentation is indi­
cated in any patient who has a consistently 
demonstrable reduction in his caloric in­
take, especially when tube or oral feedings 
produce undesirable side effects.
An absolute indication for intravenous 
alimentation is found in patients who are 
unable to eat or in whom a malfunctioning 
gastrointestinal tract prevents adequate ab­
sorption of nutrients; e.g. those with coma, 
cerebrovascular accident, severe burns, 
sepsis or trauma, oral or pharyngeal can­
cer, gastrointestinal obstruction, severe 
enteritis, short-bowel syndrome, congenital 
abnormalities of the gastrointestinal tract, 
peritonitis, and anorexia nervosa.
A relative indication is provided by pa­
tients who can eat but who would benefit 
from temporary reduction of oral intake; 
e.g. those with any of the following: carci­
nomatosis; anorexia secondary to radiation 
or cancer chemotherapy; intestinal fistulas, 
especially those located in the small in­
testine; non-healing sacral decubiti; and 
preoperative malnutrition.
The necessity for preoperative prepara­
tion should be emphasized. Normal sub­
jects maintained on a protein diet of 10
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g./day and subsequently fed intravenously 
require 33% more protein to attain nitrogen 
balance than control subjects who are fed 
normally before intravenous feeding begins. 
Clinically, a patient may present in nega­
tive nitrogen balance with weight loss be­
cause of preoperative anxiety, pain, nausea, 
vomiting, anorexia or diarrhea. In addi­
tion, patients seldom eat adequately during 
the investigational period and their post­
operative intake is seldom greater than 
700 cal./day. If the patient develops some 
complication after operation, his poor 
nutrition will continue and the total period 
of inadequate intake may easily reach 
three weeks, with an approximate deficit 
of 20,000 calories. Even if the patient does 
have reserve fat, this cannot be converted 
to protein.
Practical M a n a g em en t
Subclavian venipuncture is performed as 
described by Dudrick and Wilmore8 and 
Borja and Hinshaw.10 Catheters placed 
through the brachial or axillary veins are 
dangerous for prolonged intravenous ali­
mentation because there is little or no 
circulation between the peripheral vein 
wall and the catheter, and constant arm 
movement predisposes to phlebitis. Further­
more, the position of the catheter must be 
verified by radiograph because if it enters 
the external jugular vein or is accidentally 
pulled back, venous thrombosis may occur. 
The internal jugular approach assures that 
the catheter will lodge in a large-calibre 
vein,20 but occlusive dressings are very 
difficult to maintain on the neck and re­
strict head movement, which is uncomfort­
able for prolonged periods.
The care and placement of the catheters 
must be meticulous. Dudrick’s recom­
mendations must be followed closely in 
order to prevent complications. We assign 
dressing changes to a specially trained 
nurse so that proper care is assured.
The most common complication, clotting 
of the catheter, is easily treated by adding 
heparin ( one unit of heparin per milli­
litre of solution). Local infection is com­
mon but usually occurs in patients where 
this risk can be predicted. The factors pre­
disposing to infection include the presence 
of other catheters, concomitant liver dis­
ease, the administration of broad-spectrum 
antibiotics, and prolonged illness or sepsis 
during which technique is often violated 
and resistance is low. While the incidence 
of bacterial sepsis has long been recog­
nized,21-23 Candida sepsis is an increasing 
hazard when catheters have been in place 
for more than 15 days.24 In our experience, 
candidiasis seems to occur only in patients 
who are on broad-spectrum antibiotics 
during hyperalimentation.
Catheter sepsis can be prevented by 
substituting Teflon for polyvinylchloride 
catheters; by using millipore filters in the 
intravenous line;25 by meticulous attention 
to mixing techniques and catheter care; 
and possibly by giving intravenous fats 
through a peripheral vein, when the risks 
of central catheterization are excessively 
high. Routine blood cultures and urinaly­
sis should be done every seven days, with 
a special search for Candida.24
Other complications, while rare, are 
equally hazardous; these include pneumo­
thorax, catheter embolism, air embolism 
and injury to the subclavian artery or 
brachial plexus. Hydrothorax results when 
the catheter is not properly placed in the 
lumen of the vein. Phlebitis of the upper 
thorax or neck can occur when the catheter 
lies in the cephalic or external jugular 
vein. Catheters that lie in the internal 
jugular vein are well tolerated, but pa­
tients must be carefully observed for neck 
pain or swelling. One must be thoroughly 
aware of all of these possibilities in order 
to avoid the serious sequels of unrecog­
nized complications.26-29 Catheter embolus 
can be prevented by using a plain catheter 
or a standard intercath from which the 
female adapter has been removed. After 
venipuncture, the needle is withdrawn over 
the catheter, which is then fitted with a 
blunt needle.
W a ter  and  E lec tr o ly tes
Routine Tests
The following orders should be written 
routinely at the beginning of therapy:
(1) Serum sodium, chloride, potassium, 
carbon dioxide combining power, blood 
urea nitrogen ( BUN) and glucose—every 
Monday, Wednesday and Friday.
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(2 ) Calcium, phosphorus, magnesium, 
protein electrophoresis, hemogram, pro­
thrombin time and creatinine—every Mon­
day.
(3 ) Daily weights; fractional urines (or 
Dextrostix) and temperature—every six 
hours.
(4 ) Serum osmolarities and urinary 
electrolytes—as indicated.
(5 ) Blood cultures for bacteria and 
fungi—every Monday. This blood must be 
drawn from a peripheral vein and not 
from the subclavian catheter. We believe 
that the accumulation of fibrin on the 
catheter tip may predispose to infection. 
Accordingly, the catheter is adjusted 
weekly and failure of blood to return 
promptly suggests that clot is present, and 
removal of the catheter should be seriously 
considered.
Rate and Infusion
Patients who do not have renal, cardiac 
or liver disease will tolerate 3000 to 4000 
ml. of nutritional fluid a day. It is best to 
begin with a rate of 90 ml./hr. and gradu­
ally increase the flow to 140 ml./hr. over 
several days. This schedule will avoid 
hyperosmolarity and give the pancreas time 
to increase its output of insulin. The nurs­
ing staff should be provided with tables 
clearly showing the conversion of drops 
per minute into ml./hr., and 100-ml. drip 
chambers must be interposed between 
bottle and tubing. Above all, the nurses 
must understand that constant infusion is 
the primary objective and that, if the in­
put should fall behind, the deficit is not to 
be corrected by rapid infusions over the 
last hour or two of the shift. Bather, errors 
in the rate should be recorded and the 
prescribed rate resumed.
Complications
H yperglycem ia— Blood glucose levels of 
under 200 mg./100 ml. or glycosuria of less 
than 1% is not treated. When the infusion 
is constant and nursing care is good, hyper­
glycemia is uncommon. Glycosuria usually 
occurs only during the first 10 days of 
treatment and need arouse no concern un­
less it is accompanied by prerenal dehy­
dration secondary to water diuresis. Two 
per cent ( 4 + )  glycosuria should be treated 
vigorously (12 to 20 units of crystalline zinc 
insulin subcutaneously) because one does 
not know how much greater than 2% the 
actual “spillage” is. A 2% spillage occur­
ring twice in succession is sufficient evi­
dence of significant glycosuria, if the phy­
sician is certain that the previously ordered 
insulin was given. Because of the variance 
in renal thresholds for glucose, blood Dex­
trostix determination may prove more ac­
curate than fractional urines in the prob­
lem patient. Increasing the potassium con­
centration is another valuable way of in­
creasing glucose utilization.8 Because the 
normal pancreas can increase its output, 
do not give insulin routinely unless the pa­
tient has diabetes or is severely cachectic.
Hypoglycemia.—'Circulating levels of in­
sulin are continually elevated during 
intravenous alimentation because of pan­
creatic stimulation. Sudden cessation of the 
nutritional solution will result in hypo­
glycemia with a wide range of symp­
toms — from sweating and palpitation to 
central nervous system signs. Herein lies 
one of the principal reasons for administer­
ing routine plasma infusions through an 
alternative route, because if the plasma is 
given into the subclavian catheter, the 
nutritional solution will be temporarily 
omitted. When it is time to discontinue 
nutritional fluids, the bottle is replaced 
with 10% glucose which is run at 50 ml./ 
hr. for a minimum of five hours. A similar 
procedure is followed when a patient on 
nutritional solutions is to have an opera­
tion.
Hyponatremia. — Hyponatremia is very 
common during hyperalimentation, and 
levels of 130 mEq./l. are frequently seen 
and require no treatment. When the level 
is below 130 mEq./l., the serum glucose 
should be checked because when it is 
elevated, it tends to increase intravascular 
water.30 Thus, hyponatremia may effec­
tively be treated by insulin and/or potas­
sium.
When not due to hyperglycemia, hypo­
natremia in the critically ill patient is usu­
ally associated with cardiac, hepatic or 
renal disease. These patients may not
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tolerate more than two bottles of nutri­tional solution a day and when hypo­
natremia occurs, it usually responds to water restriction. Reducing the rate of nutritional fluids to 40 ml./hr. will often 
raise the serum sodium. For more serious 
deviations of electrolyte values, the nutri­
tional solutions should be withdrawn 
temporarily and 10% glucose substituted.
Occasionally, hyponatremia may be due 
to an absolute sodium deficit. This usually 
occurs in seriously ill patients who are sus­
taining large urinary and intestinal losses 
and have received inadequate ancT/or in­
appropriate replacement. Since the urinary 
excretion of sodium is diurinal, the last 
urine collection of any 24-hour period may 
not be a representative aliquot for electro­
lyte determinations. Therefore, the entire 
24-hour collection must be saved and ade­
quately mixed and measured before send­
ing a sample to the laboratory.
Hypernatremia.—Hypernatremia is usu­
ally secondary to the prerenal azotemia 
that follows an excessive water diuresis. Blood urea nitrogen is also raised but the 
creatinine is normal. If hypernatremia is 
accompanied by lethargy, hyperventilation 
or coma, the syndrome of hyperosmotic 
non-ketotic diabetic acidosis should be considered and verified by appropriate 
tests.31 Hypertonic solutions are thought 
to shift fluid from the intracellular to the 
extracellular space and thereby dilute 
serum bicarbonate.32' 33 Accordingly, a 
lowered carbon dioxide combining power 
may be the first sign of an impending 
hypertonic acidosis. Such acidosis occurs 
more commonly in infants, and when seen 
in adults is usually associated with exces­
sive infusion rates. If the intravenous tub­
ing is inadvertently unclamped the patient 
may receive 1100 ml. of hypertonic fluid 
(1300 mOsm/kg.). Therefore, unless a 
constant infusion pump is being used, 
intravenous tubings (pedatrols) contain­
ing a 100-ml. calibrated chamber* are used, thereby limiting the size of an inadvertently 
administered bolus of fluid to the amount 
contained in the chamber. Sixty drops from the chamber equal 1 ml. Two clamps are
#Soluset-100. Abbott Laboratories, North Chicago, 111. 60064.
placed between the pedatrols and the 
bottle, and released every hour to permit 
the appropriate amount of fluid to enter the pedatrols.
Chloride
Theoretically, hyperchloremia could oc­
cur when both sodium and potassium are 
administered as the chloride salts. In prac­
tice, this is seldom a problem. If it should 
occur, sodium may be given as the bi­
carbonate salt or potassium may be given 
as the phosphate salt.
Allergic Reactions
These are uncommon and usually abate 
when the infusion is discontinued, 10% 
glucose is substituted and antihistamines 
are administered.31 If a reaction occurs 
a second time, a different hydrolysate must be tried.
Fever
Whenever a patient has an undiagnosed 
fever, the following steps should be taken:
(1) blood cultures should be drawn from 
a peripheral vein and from the subclavian 
catheter for bacteriology and mycology;
(2) the solution should be discontinued 
and 10% glucose substituted. Ten milli­
litres of the original solution should also 
be sent to bacteriology and mycology; (3) 
if the cause of the fever is not established 
after 24 hours, the catheter should be re­
moved and similarly cultured, even though 
previous blood cultures have been nega­tive.
As mentioned previously, Candida septi­
cemia may be asymptomatic in its early 
stages.24 Therefore, routine urine and blood 
cultures for mycology should be done once 
a week and more frequently if the patient 
has an unremitting low-grade temperature, 
which continues after hyperalimentation has been discontinued.
Conversion to Oral I ntake
If the usual criteria for oral intake are 
met, patients on nutritional alimentation may eat at any time. Because of their high 
glucose concentrations, the solutions may
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decrease appetite. Accordingly, the infusion 
rate is gradually decreased while oral in­
take is increased—as measured by accurate 
calorie counts. The catheter must not be 
removed at the onset of oral intake, be­
cause many chronically ill patients will 
eat no more than 900 cal./day for several 
days or even weeks and may require 
intravenous supplementation. If the pa­
tient is able to consume 1500 cal./day 
while receiving one bottle of nutritional 
solution, the catheter may be removed after 
four to six hours of a 10% glucose in­
fusion.
Marginal oral intakes may be satis­
factorily supplemented with high-caloric 
high-protein milkshakes. The high caloric 
value of these drinks (1 cal./ml.) invokes 
an unavoidably high osmolarity and fat 
content accounting, in part, for the diarrhea 
which sometimes accompanies early feed­
ings. Mucosal atrophy and loss of the ab­
sorptive function of the gastrointestinal 
tract occur with chronic starvation,34'38 and 
diarrhea may be partially circumvented by 
administering frequent small feedings 
during the first days of oral intake. The 
use of a chemically defined diet* is theo­
retically appealing, but our limited ex­
perience with this product does not permit 
comment.
I ntraveno us F eeding  for  the
C r itic a lly  I I I  P a tien t
Heart failure.—Heart failure seriously 
restricts the volume of fluids that can be 
administered each day. Two bottles of 
nutritional solution ( about 2200 ml.) pro­
vide adequate maintenance but less will 
not. These patients may not be able to 
tolerate this much fluid, but substitution 
of albumin infusions for plasma may raise 
the serum protein enough so that the pa­
tient can eliminate the excess water. If not, 
pare) item] diuretics are administered until 
the patient can tolerate the required two 
bottles a da;
Renal failure.—Protein is not given 
parenterally to patients with renal failure 
because this might further elevate the
“Vivonex. Vivonex Corporation, 876 West Dana 
St., Mountain View, Calif.
BUN. Their chronic negative nitrogen 
balance is further accentuated by repeated 
dialysis, anorexia, the necessity for fluid 
restriction and a urinary nitrogen loss of 
at least 4 g./day. Administration of 50% 
glucose provides a maximal number of 
calories (about 2000 cal./day) in a mini­
mal quantity of fluid to a patient consum­
ing little or nothing by mouth but fails to 
provide nitrogen.37 It has been shown, 
however, that an adult requires a minimum 
of 2 g. of essential 1-amino acids per day.38 
When these amino acids are given along 
with an adequate number of calories, nega­
tive nitrogen balance will be avoided (al­
though no weight gain will take place). 
Further experiments performed with 
variants of this diet led to an important 
observation, viz. if any other source of 
nitrogen was given in addition to the 2 g. 
of essential amino acids and carbohydrate 
calories, the patient went into positive 
nitrogen balance and gained weight.39 The 
extra sources of nitrogen include am­
monium chloride, glycine, glutamic acid 
and urea.
Contrary to popular opinion, urea is a 
valuable endogenous source of protein.40 
This has been repeatedly confirmed by the 
presence of radioactive nitrogen in body 
protein after the administration of 15N- 
labelled urea. Since non-uremic subjects 
require 2 g. of essential amino acids, 
calories and any other source of nitrogen 
for weight gain and positive nitrogen 
balance, patients with renal failure can 
utilize their own BUN in attaining positive 
nitrogen balance, when given only 2 g. of 
essential amino acids and a source of ade­
quate calories. Utilization of the BUN also 
reduces the frequency of dialysis and the 
severity of nausea, vomiting, pruritus and 
other such uremic symptoms. As the BUN 
approaches normal levels,* the nitrogen 
balance will again become negative unless 
the physician administers an exogenous 
source of nitrogen.
This essential-amino-acid ( Giovannetti) 
diet has been used extensively on medical
°If the serum creatinine does not remain stable, 
the falling BUN could be equally attributable 
to the diet or to an improvement in the renal 
pathology.
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wards where many of the patients are able 
to consume food by mouth. Trauma, ileus, 
uremic enteritis and small bowel fistulas 
frequently preclude oral feeding in surgical 
patients with renal failure, especially when 
the renal failure is acute. Dudrick postu­
lated that such a patient could receive 
these amino acids intravenously. He pre­
pared a sterile essential-l-amino-acid solu­
tion using standard millipore techniques 
for sterilization.12 This solution was mixed 
with hypertonic glucose (50% ) and the 
final mixture was infused at a constant rate 
through a subclavian catheter. Following 
Dudrick’s techniques, we have also pro­
duced a sterile amino-acid hypertonic- 
glucose solution which has proved safe in 
dogs and is now receiving a clinical trial.
In summary, azotemic patients are in 
severe protein and caloric depletion. Like 
non-azotemic patients they require a mini­
mum of 2 g. of essential amino acids, an 
adequate number of calories and any other 
exogenous or endogenous source of nitro­
gen. In uremia, the patient’s own BUN 
provides such a source. When given by 
mouth, this diet is effective. Reports on the 
efficacy of intravenous essential amino 
acids are encouraging, although no definite 
conclusions can be drawn from the few 
reported cases.
If the physician cannot produce his own 
essential-amino-acid mixtures, he should 
give 50% glucose in the usual manner and 
follow renal function daily. When the BUN 
has stabilized, small quantities of protein 
hydrolysates (50 to 100 ml.) are added 
daily and further treatment is based on 
the response observed. Even if the patient 
has severe oliguria, he must receive at 
least 20 to 30 mEq. of potassium each day.
Liver failure— Glucose reportedly stimu­
lates the combination of ammonia with 
glutamic acid and lowers the blood am­
monia.41 It is known that patients with 
liver disease given adequate calories 
orally will maintain nitrogen equilibrium 
or a slight positive nitrogen balance on 
50 g. of dietary protein daily.42 Although 
Schiff, in his monograph, states that intra­
venous glucose and protein hydrolysates 
can be given to patients with severe liver 
disease, he does not state how many grams 
of protein can be given.43 We have had a
limited experience with four patients suffer­
ing from advanced liver disease, two of 
whom were comatose. Of the 24-hour fluid 
requirement, 90% is given as hypertonic 
(40% ) glucose and the remainder as pro­
tein hydrolysate. If no changes in the BUN, 
urea, blood ammonia or neurologic status 
occur, more protein hydrolysate is sub­
stituted for glucose until the conventional 
750-350 mixture is attained.
There is a sound physiologic explana­
tion for the somewhat surprising success 
of this treatment. Ammonia is formed by 
the breakdown of dietary nitrogenous sub­
stances in the gut. It is transported via the 
portal vein to the liver. Here ammonia is 
converted to urea by the ornithine-citrul- 
line-arginine ( Krebs’-Henselect) cycle.44 A 
hepatectomy or an Eck’s fistula will raise 
the blood ammonia in dogs. Feeding the 
animals protein will produce rapid hepatic 
coma. In the presence of protein or blood 
in the gut, similar elevations of blood 
ammonia occur in human cirrhotics pro­
vided bacteria are present to form am­
monia. We postulate that the administra­
tion of intravenous protein is tolerated be­
cause the gut is bypassed. The precipita­
tion of hepatic coma after the parenteral 
administration of ammonium chloride does 
not support this postulate.
The frequency of glycosuria does not 
appear to be increased when liver patients 
are treated with hypertonic glucose. Theo­
retically, fructose is a better sugar than 
glucose. However, the most highly con­
centrated fructose solution that is com­
mercially available is only 10%, so that 
one would have to give huge volumes of 
fluid to administer sufficient calories.
H y p e r a l im e n t a t io n  C ontrol and
O rdering  S y s t e m
Ideally, one physician should supervise 
all subclavian venipunctures, write the 
initial routine orders, see the patients daily 
and continuously educate nurses and phy­
sicians in this potentially dangerous tech­
nique.
Co-operation from the hospital pharmacy 
is essential and the physician in charge of 
the program must teach the pharmacists 
the proper technique for mixing.
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Fig. 1.—A nutritional intravenous order for 
three bottles of hyperalimentation fluid for a 
single patient for a single day. This form is 
filled out and delivered to the pharmacy by 10 
a.m. The mixed solutions are placed in the ward 
refrigerator by 4 p.m. and are given to the pa­
tient beginning at 8 a.m. the next morning.
After being guided in the ordering of 
nutritional solutions for the first day or 
two, the doctor in charge of the patient 
orders the solutions directly from the 
pharmacy. A sample of a typical order form 
is shown in Fig. 1. Because house staff 
rotate, new interns may make errors in 
ordering. The physician in charge should 
routinely check the order sheets and ask 
the pharmacy to report gross irregularities 
in prescriptions for nutritional solutions.
I m pr o v em en ts in  Pr e se n t  T ech n iq ues
Millipore Filters
Each drop of fluid that leaves an intra­
venous bottle must be replaced by an 
equal volume of room air. Both room air 
and accidental contamination during mix­
ing may introduce bacteria into the solu­
tion. To prevent this, we now place a 
millipore filter, a thin porous sheet of pure, 
cellulose esters,* inside a plastic Swinnex 
filter holder, which has male and female 
adapters to connect to any intravenous line
“Millipore of Canada, Ltd., 55 Montpellier Rlvd., 
Montreal, Que.
and its corresponding catheter. A .45 /x 
filter will prevent the passage of all bac­
teria (except for some strains of pleo­
morphic Pseudomonas). The gravitational 
pressure from a simple intravenous fluid 
bottle will force flow through a .45 /x filter. 
A .22 /x filter will provide absolute 
sterility, but flow must be forced by a 
constant infusion pump.®
Constant Infusion Pumps
Although a large number of infusion 
pumps are commercially available, we have 
had experience with only three. The Har­
vard peristaltic pump employed by Dud- 
rick in his animal experiments is excellent 
but expensive. The Holter infusion pumpf 
is inexpensive, reliable over months of con­
tinuous use, portable, can carry a charge 
so that it can be transported with the pa­
tient and can serve two patients at the 
same time. The makers have proposed 
several important modifications to this 
pump and the new model will soon be re­
leased. The Baxter stroke volume pump 
has been tested here, but is still in the 
design stage. The intravenous tubing that 
accompanies this pump will contain a con­
venient bacterial and air filter.
Non-Reactive Catheters
Silastic is practically non-reactive when 
implanted into the subcutaneous tissues. 
Hence Silastic catheters are associated 
with less infection than polyvinylchloride 
catheters.45’ 46 At this time Silastic is ex­
pensive and is not supplied in a radio­
opaque form. If the tip of one of these 
should break off and be carried as an em­
bolus, it would be extremely difficult to 
locate. Teflon catheters are not only well 
tolerated by tissues, but are supplied in a 
radio-opaque form. Preliminary studies dur­
ing routine intravenous treatment on pa­
tients in our surgical wards suggest that 
phlebitis is less frequent with Teflon than 
polyvinylchloride catheters.
“Our more recent studies indicate that these 
filters may predispose to bacteremia.
fModel RDO 74. Brent Surgical, Toronto, and 
Extracorporeal Medical Specialists, Mt. Laurel 
Township, N.J.
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Intravenous H yperalim entation :
E lectrolyte M etabolism  and
M ixing T echniques
N itrogen Balance
Nitrogen balance, a concept introduced 
in early studies on nutrition, refers to the 
difference between total nitrogen intake 
and total nitrogen excretion.47 A positive 
balance generally reflects growth or reple­
tion; a negative balance decay or deple­
tion. A simple correlation exists between 
average daily weight gain and nitrogen 
retention, provided the nitrogen is being 
used—as evidenced by a stable BUN, serum 
creatinine and uric acid, and that the 
weight gain is not due to water retention— 
as evidenced by a zero water and sodium 
balance. In the absence of adequate 
calories, tissue nitrogen is mobilized and 
used in gluconeogenesis, releasing nitrogen 
which is then excreted. This internal 
mobilization occurs even if exogenous 
nitrogen is given, unless this nitrogen is 
accompanied by sufficient calories to ren­
der gluconeogenesis unnecessary. While 
several classical studies have invoked an 
obligatory nitrogen deficit after stress or 
trauma,48, 48 we now know that nitrogen 
deficits can be reduced or even eliminated 
if nutritional intake is maintained during 
the post-traumatic period.7'11
One pound of lean body tissue contains 
15 g. of nitrogen.50 Simple operations or 
starvation will produce a loss of 10 to 15 g. 
of nitrogen per day in the absence of exo­
genous calories or nitrogen.51 The provision 
of 750 cal./day reduces daily nitrogen 
losses to 8 g./day, but further caloric incre­
ments have no effect on nitrogen balance.52 
However, if both calories and nitrogen are 
supplied, the calories are used solely for 
energy while the nitrogen is used to pro­
duce new protein for intracellular syn­
thesis. The minimum ratio of non-protein 
calories to nitrogen, in grams, is 150:1 
(Fig. 2).
A 70-kg. man has approximately 500 g. 
as carbohydrate stores, a quantity insuffi­
cient to meet even a single day of fasting. 
Such a patient will use labile fat and pro­
tein over the first few days of fasting if 
during this time he receives only 600 
cal./day in the form of 5%  glucose. Since
Fig. 2.—The nutritional benefits of glucose, 
Aminosol with 5%  glucose, and Aminosol with 
50% glucose are shown in the white blocks; the 
average daily losses they must replace are shown 
in the shaded blocks.
he needs approximately 2000 cal./day for 
maintenance, he will break down tissue 
protein to provide additional energy. Al­
though patients seem to tolerate inadequate 
nutritional intake for three to five days, it 
is difficult to accept that even this short 
period of starvation is without detriment. 
If complications ensue, the patient will be 
less resistant to infection and stress be­
cause of this deficit.53
Protein  H ydrolysates as a  Source
of  Intravenous N itrogen
The body acquires amino acids either by 
intestinal digestion of proteins or by intra­
cellular transamination. An alpha-keto acid 
is converted to its corresponding amino 
acid by the transfer of an NH2 group from 
the amino-acid pool. Any amino acid 
needed for protein synthesis can be manu­
factured if the body has the necessary 
transaminase enzyme and the appropriate 
alpha-keto acid, but in eight (essential) 
amino acids the body cannot synthesize 
the alpha-keto acid counterpart. Hence, 
these amino acids must be supplied in the
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diet. Essential and non-essential amino acids have equally important roles in body metabolism.
Polypeptides, tripeptides and dipeptides 
are normally broken down by pancreatic enzymes located in the small bowel. Before 
they are given intravenously, proteins must 
be artificially hydrolyzed into amino acids 
and these amino acids must be in the levo- 
rotatory (1) form.® Amigen is a partial 
pancreatic enzymatic hydrolysate of casein; 
Aminosol is a hydrochloric acid hydrolysate 
of fibrin. Complete acid or enzymatic 
hydrolysis will destroy tryptophane and 
occasionally cystine,54 both of which 
are essential amino acids which the body 
cannot manufacture.
Monopeptides are the only nitrogenous 
products that the body can use when 
given intravenously. Therefore, the dipep­
tides contained in partial hydrolysates are 
excreted in the urine. If mixtures of essen­
tial 1-amino acids are administered, this 
peptide loss would be avoided.55 In addi­
tion, there is evidence that the presence of 
non-essential amino acids in parenteral 
feedings inhibits the utilization of the 
essential amino acids.56 The use of an 
essential 1-amino-acid mixture, which con­
tains no peptides, would eliminate the 
problem of urinary nitrogen loss. Crystal­
line amino-acid solutions have been safely 
administered by Wilmore and Dudrick12 
and are currently being investigated by a 
large North American pharmaceutical 
manufacturer.57
Sources of C alories
Carbohydrates
Attempts to find a substitute for glucose 
have centred mainly around fructose, used 
alone or mixed with an equal amount of 
glucose (invert sugar), and there is con­
siderable evidence that fructose or invert 
sugar may be metabolically superior to 
glucose alone.58'60 Fructose is phosphoryl- ated to fructose 6-phosphate by fructo-
*The nitrogen radical of each of the body’s 21 principal amino acids has the same spatial rela­tionship to its alpha-carbon (the carbon atom directly adjacent to the carboxyl group) as 1-alanine—the simplest amino acid. Hence the term “alpha 1-amino acid”.
kinase and then enters the Krebs’ cycle. Fructokinase is less dependent on normal liver function than glucokinase, the ana­
logous phosphorylating enzyme for glucose, 
which may account for the superior meta­
bolism of fructose in the presence of post­
operative stress, diabetes or liver disease.61 
Unfortunately fructose is available com­
mercially only as a 10% solution and hence 
the volumes required to maintain caloric 
balance by intravenous alimentation would 
be enormous; i.e. 1 1. would contain 100 g. 
of fructose or 400 calories.
Glycerol is tolerated intravenously but 
has shown no superiority to glucose.62 Like 
fructose metabolism, citrate metabolism is 
not altered in the postoperative state and, 
for this reason, citrate has been suggested 
as a glucose substitute.63 Alcohol not only 
provides 7 cal./g., but also produces seda­
tion, analgesia, and, in contrast to other 
analgesics, respiratory stimulation. (The 
potential hepatotoxic effects of intravenous 
alcohol given over long periods have not 
been evaluated.)
Fat is made soluble for intravenous use 
by the addition of an emulsifying agent to 
a triglyceride oil. Glucose is added to pro­
duce the required tonicity. This prepara­
tion provides 9 cal./g. but such side-effects as fever, hypotension, coagulation dis­
orders, lipemia and a fat embolism-like 
syndrome have halted the use of such 
preparations as are available on this con­
tinent.64'68 However, a soy-bean oil emul­
sion0 that has been used extensively in 
Scotland18,67 and Sweden68 is currently 
being investigated here and in the United 
States.69 (Much of the earlier work on 
intravenous fats has been extensively re­
viewed elsewhere.70)
In summary, several compounds are 
potentially capable of supplying the needed 
calories, but glucose is the safest agent 
now used for intravenous alimentation.
Basic Formula
To prevent catabolism, both nitrogen and calories must be provided. Since the 
maintenance of protein stores requires a
'’Intralipid. Pharmacia (Canada) Limited, Mont­real 351, Que.
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minimum of 1 g./kg., a 70-kg. man needs 
70 g. of protein or 12 g. of nitrogen (16%  
of 70) per day.71 One litre of 5%  Amino- 
sol in 5%  glucose contains 50 g. of protein 
(6 g. of nitrogen*) plus 50 g. of glucose, 
and 750 ml. of this solution will provide 
37.5 g. of protein or 4.5 g. of utilizable 
nitrogen plus 37.5 g. of glucose. To prevent 
gluconeogenesis, this 4.5 g. of nitrogen 
must be accompanied by 675 calories (4.5 
x 150). The solution already provides 37.5 
g. of glucose (140 calories) and the addi­
tion of another 350 ml. of 50% glucose 
will complete the 175 g. of glucose (700 
calories), giving a nitrogen:calorie ratio of 
1:190.
This mixture—750 ml. of hydrolysate plus 
350 ml. of 50% glucose—contains 1100 ml. 
of water, 37.5 g. of protein, 4.5 g. of alpha- 
amino nitrogen, 212.5 g. of glucose (850 
calories), 17 mEq. of sodium, 7 mEq. of 
chlorine and 13 mEq. of potassium.
Mixing Techniques
Whether the mixing system is open or 
closed, contamination may occur at any 
time. Filtered, non-turbulent air from a 
laminar air-flow hood provides a larger 
margin of safety72 and allows the pharma­
cist to work with several bottles at the 
same time (Fig. 3 ). Although closed 
systems without laminar air have been 
used successfully, we believe that the initial 
cost and minimal operating expenses make 
the purchase of such a hood well worth 
while. Whether or not a hood is used, care 
must be exercised to assure that mixing is 
done in a room which is completely free 
of an turbulence, away from windows and 
working personnel.84
Casein hydrolysates are supplied in 
vacuum bottles. Solutions that are trans­
ferred by intravenous tubing run very 
slowly and therefore we have employed a 
2000-ml. plastic bag.) The inlet tube of 
the bag is placed into a bottle of Amigen
"The 50 g. of protein in a litre of Aminosol theo­
retically contains 8 g. of nitrogen. However, 2 g. 
of these 8 g. of nitrogen are in the form of non­
utilizable dipeptides and tripeptides. Hence, the 
statement that a litre of Aminosol contains 6 g. not 
8 g. of nitrogen.
fTA-20 Fenwal Transfer Pack, Code No. 4R2041.
Fig. 3.—Aminosol and 50%  glucose are being 
mixed in a laminar air-flow hood by a pharmacist 
observing sterile technique.
inside the hood and 1500 ml. of the solu­
tions is transferred. Meanwhile, all of the 
additives are placed into a 500-ml. bottle 
of 50% glucose which is then similarly 
transferred. An additional 200 ml. of 50% 
glucose is added and the inlet tubing of 
the bag is tied with three knots. The com­
pleted mixture contains 1500 ml. of Ami­
gen, 750 ml. of 50% glucose and about 
100 ml. of additives, as electrolytes and 
vitamins.
Fibrin hydrolysates are supplied in 
screw-cap non-vacuum bottles. Using a 
large laminar air-flow hood, 250 ml. of 
Aminosol is poured from a 1000-ml. bottle 
into a second sterile empty bottle. This 
250 ml. is replaced with 350 ml. of 50% 
glucose. The use of a sterile funnel permits 
rapid pouring. Recently, a solution mixing 
set* has been manufactured which forms 
a sterile junction between a 1000-ml. bottle 
of Aminosol and a 500-ml. bottle of 50% 
glucose.73 Complete mixing of the two 
bottles is attained with five inversions and 
the 1500-ml. mixture contains a nitrogen: 
calorie ratio identical to that attained with 
the 750:350 mixture. With the exception 
of the time during which the bottle cap 
is removed and replaced with the mixing 
set, the mixing is done in a completely 
closed system. However, this still does not
“No. 8100. Abbott Laboratories, North Chicago,
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solve the problem of placement of the 
additives.
The bag system is preferable for the 
preparation of small quantities of solution 
because it is a closed system and, if proper 
precautions are taken, the solutions can be 
mixed without a laminar flow hood. In 
addition, no air enters the bag, which col­
lapses under atmospheric pressure as it 
empties, whereas air must enter a bottle 
if flow is to continue. When large 
quantities of solutions must be prepared, 
the time saved with open-bottle mixing 
more than offsets this theoretical objection.
Additives
Additives are prescribed just as they are 
for routine intravenous therapy. The pa­
tient’s losses are calculated, based on serum 
values, insensible, urinary and other fluid 
losses. The total electrolyte requirements 
are distributed equally among the bottles 
for the day, this being particularly im­
portant with potassium.
Sodium Chloride
The use of a concentrated sodium chlor­
ide solution® not only reduces mixing time, 
but is more accurate. Twenty to 40 mEq. 
of sodium chloride is added to each 
bottle for maintenance and more is added 
to compensate for other losses.
Potassium
Muscle contains 75% of the total body 
potassium and in the fasting state the 
potassium-.nitrogen ratio in muscle is identi­
cal to the urinary potassium:nitrogen ratio. 
This observation implies that when cellu­
lar protein is broken down for gluconeo- 
genesis, potassium is shifted to the extra­
cellular compartment and then excreted. 
Therefore, potassium and protein deficits 
often coexist. When the physician begins 
to administer intravenous protein, he must 
supply potassium in the ratio of 5 mEq. 
for each gram of nitrogen, and in severe 
malnutrition this ratio may often reach
15:1.74 When given to potassium-depleted 
rats, protein hydrolysates will not promote 
growth, and the addition of potassium re­
sults in growth with improved nitrogen 
balance; there is evidence of a similar rela­
tionship in man.75 Accordingly, potassium 
requirements will range from a minimum 
of 80 mEq. to a maximum of 160 mEq./ 
day. Even patients with oliguria require 
30 mEq./day.
Calcium and Phosphorus
Calcium is lost in both the urine and 
feces. Patients on intravenous therapy lose 
nothing through the intestine unless they 
have a coexisting fistula, but immobiliza­
tion increases urinary losses. Most patients 
remain in balance if they ingest 1 g ./ 
day by mouth,76 and our preliminary 
calcium balance studies indicate that this 
will be sufficient during intravenous feed­
ing as well. Ten millilitres of a 10% cal­
cium gluconate solution contains one gram 
(4.74 mEq.) of calcium.
Phosphorus not only is important in bone 
metabolism, but also plays a central role 
in the transformation and production of 
high-energy compounds. We have very 
little data on phosphorus requirements be­
cause phosphate deficiency is rare, but the 
recommended dose is 1 V2 times the cal­
cium dose76—roughly 15 mEq./day. This 
element is supplied by Travenol® as the 
monobasic potassium salt.
Magnesium
The body requires magnesium to activate 
a great many enzyme systems, particularly 
those concerned with oxidative phosphoryl­
ation. It is primarily an intracellular ion 
and there are no conclusive data on normal 
requirements. Based upon balance studies, 
250 mg. of magnesium per day appears 
adequate for adults.71 Since magnesium 
deficiency is most common in prolonged 
starvation or intravenous feeding, we have 
given 500 to 1000 mg./day. Two millilitres 
of a 50% magnesium sulfate solution con­
tain 1000 mg. of magnesium (8.1 mEq.).
523.4% sodium chloride containing 4 mEq./ml. 
Cutter Laboratories, Calgary, Alta.
“Baxter Laboratories of Canada Limited, Malton, 
Ont.
May 1971 INTRAVENOUS HYPERALIMENTATION 191
Iron
Parenteral iron gives rise to many un­
desirable side effects and should be ad­
ministered only if serum iron levels are re­
duced. To avoid iron overload, do not give 
it routinely. Small daily maintenance doses 
can be given intravenously in dogs, but 
the deep intramuscular route is used in 
patients. Information on the most suitable 
preparations, doses and methods of injec­
tion is readily available.78
Trace Elements
This term applies to the remaining ele­
ments which function in all biologic 
systems and includes aluminum, cobalt, 
copper, manganese, zinc and at least 20 
others. Because the measurement of these 
elements is still not routine, very little is 
known concerning the significance of alter­
ations in their serum levels.
Zinc
Zinc is important in wound healing.79-81 
Zinc deficiencies arise because we con­
stantly excrete 0.4 mg./day regardless of 
intake or urinary volume. Most students of 
long-term parenteral nutrition believe that 
one unit of plasma given twice a week 
will provide all the trace elements and the 
essential fatty acids. Proof of this assump­
tion awaits further investigations.
Vitamins
The majority of commercially available 
parenteral preparations do not contain the 
fat-soluble vitamins. Although most vita­
min-deficiency states are due to the lack 
of water-soluble vitamins, single vitamin- 
deficiency states seldom occur.82 It is also 
possible that relative deficiencies may 
exist without clinical manifestation; this is 
especially true for vitamin A, which is im­
portant in wound healing.83
The contents of one 10-ml. vial of 
M.V.I.° will provide two to 10 times the 
National Research Council’s recommended 
daily dose of each vitamin. This vial is
“ Multiple Vitamin Infusion. Arlington Labora­
tories, USV Pharmaceuticals of Canada, Mont­
real 379, Que.
distributed between the total number of 
bottles for the day.
A number of accessory vitamins such as 
choline, biotin and para-aminobenzoic 
acid are not yet available for intravenous 
use. However, folic acid, vitamin K and 
vitamin B12 are available in separate vials 
and should be administered when total 
parenteral nutrition continues for one week 
or more. There is, to date, no way of know­
ing whether these vitamins should be 
divided and given in small daily doses or 
given once weekly. W e give 10 mg. of 
vitamin K and folic acid in the solutions 
every Monday. Although the body stores 
enough vitamin B12 to last for two to three 
years, 100 //.g. are given in the solutions on 
the first day of treatment and once a 
month, to ensure that the weekly admin­
istration of folic acid does not mask a 
previously unrecognized pernicious anemia.
Su m m a r y  and Conclusions
Intravenous hyperalimentation, a new 
form of therapy, is especially useful in pa­
tients who have gastrointestinal complica­
tions, notably fistulas and chronic periton­
itis, and in preparing debilitated patients 
for definitive surgery. Recent experience 
at the Royal Victoria Hospital, Montreal, 
suggests that many lives can be saved with 
this technique, but it requires meticulous 
attention to detail if serious complications 
are to be avoided. This review outlines in 
detail the steps necessary to avoid com ­
plications and obtain adequate results. 
There is no value in giving less than a full 
regimen or in feeding the patient in an 
uncontrolled fashion. In the future this 
form of hyperalimentation, which requires 
a central catheter for long periods, will be 
supplanted in patients with a high risk of 
sepsis by feedings with intravenous fat and 
protein hydrolysates which can be ad­
ministered into a peripheral vein.
Several workers have asserted that many 
patients would benefit if all periods of 
negative nitrogen balance were eliminated 
even after routine operation. This awaits 
further study, but it appears that many 
patients who have “uncomplicated” opera­
tions frequently have periods of prolonged 
recovery. Measurements of efficiency such
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as postoperative oxygen consumption and 
the ability to exercise might provide the 
quantitative data needed to support this 
impression. It is now clearly documented 
that recovery from operation is associated 
with the ability to do more work with less 
cardiac output and less energy expenditure. 
It would be interesting to determine if this 
recovery process could be altered by the 
avoidance of a negative nitrogen balance.
The authors wish to thank Misses B. Jacob­
son and B. Robertson for their assistance in typ­
ing the manuscript; and the Department of 
Pharmacy, Royal Victoria Hospital for preparing 
solutions.
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R e su m e
Les auteurs, se basant sur leur experience 
personnelle chez 60 malades tres gravement at- 
teints qui etaient hospitalises a l’Hopital Royal 
Victoria, exposent en detail les aspects theoriques 
et pratiques de l’alimentation par voie intra- 
veineuse. Ils ont surveille personnellement tous 
leurs malades et ont suivi plusieurs d’entre eux 
grace au controle de leur equilibre metabolique. 
Ils ont explique en detail les raisons d’etre 
physiologiques qui president a I’emploi, aujourd’hui 
classique, du melange du solute glucose hyper- 
tonique et d’hydrolysat de proteine. Les auteurs 
insistent sur les precautions minutieuses qu’il faut 
prendre pour eviter les complications et passent 
en revue le diagnostic et le traitement de ces 
complications, qui surviennent inevitablement
quand on a affaire a des malades tres vulnerables. 
Dans une section speciale, on trouve les modifica­
tions ou’il faut faire subir a la fomiule de base 
pour l’adapter aux besoins des hepatiques, des
cardiaques et des nephropathes. Ils consacrent 
beaucoup de temps a exposer les details delicats 
qui concourent a la securite du melange et le 
controle pharmaceutique des solutions nutritives. 
Cet article detail! e devrait permettre a n’importe 
quel medecin d’instaurer une suralimentation
intraveineuse dans son hopital, quelle que soit 
l’importance de ce dernier et independamment
de son encombrement en malades.
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MEDIASTINAL MALIGNANT 
LYMPHOMAS
A clinical analysis of 97 patients with medi­
astinal malignant lymphomas is reported. The 
ratio of female to male patients was 1.3:1, 
with an average age of 36.1 years for the 55 
women and 37.2 years for the 42 men. Speci­
fically, in mediastinal Hodgkin’s disease, the 
female to male ratio was 2.4:1, while in pa­
tients with lymphoblastic lymphoma the re­
verse was true, with a ratio of 1:2. The 
presenting symptoms in order of frequency 
were: cough in 30 patients, chest pain in 27, 
fever in 13, dyspnea in 12, weight loss in 12, 
palpable nodes in 18, and easy fatigability in 
six patients. Twenty-six other patients were 
asymptomatic.
Roentgenograms of the chest were the single 
most important diagnostic method. Rouleaux 
formation was found in 38.2% of the peri­
pheral blood smears. Angiograms, thoracic 
arteriograms, and lymphangiograms may be 
used in the differential diagnosis.
Staging, based on the Peters and Middle- 
miss method, placed 15 lesions in Stage I, 31 
in Stage II (substage 1), and 51 in Stage II
(substage 2). Hodgkin’s disease composed 
58.7% of the mediastinal lymphomas. In 35 
patients, the structure of the diseased tissues 
was characteristic of nodular sclerosis and, in 
19 patients, showed a diffuse mixed cellularity.
Thirty-five patients had exploratory thorac­
otomy with biopsy, 16 patients had thorac­
otomy with curative resection and 38 had 
supraclavicular node biopsy. The overall five- 
year survival rate for the entire group was 
39.1%, while the 10-year survival rate was 
17.1% and consisted only of Hodgkin’s disease 
survivors. The survival rate for female pa­
tients was 49.1% and for men was 31.7%. Of 
the patients with lymphoblastic lymphomas, 
only two survived for two years. Surgical ex­
cision of the mediastinal lesion with subse­
quent radiation therapy seemed to yield the 
most striking results, as evidenced by the fact 
that 13 of the 16 patients in this group sur­
vived for five years. In contrast, among 80 
patients who did not undergo operation, there 
were only 32 survivors. A more aggressive 
surgical attitude seems to be indicated espe­
cially in combination with radical radiother­
apy.—Van Heerden JA, Harrison EG, Bematz 
PE, et al: Mediastinal malignant lymphoma. 
Chest 57: 518, 1970
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INVAGINATION FOR CONTROL OF REFLUX AFTER 
ESOPHAGOGASTRIC ANASTOMOSIS0
R. D. HENDERSON, M.B., F.R.C.S.[C],+ J. F. LIND, M.D., F.R.C.S.fC], F.A.C.S.* and
B. FEAVER, M.D.,§ Toronto, Ont.
R e f l u x  esophagitis and stricture frequently 
follow esophagogastrectomy. This opera­
tion, which resects the gastroesophageal 
sphincter and creates a hiatus hernia, re­
moves the major antireflux mechanisms1'3 
and exposes the esophagus to free reflux of 
gastric contents. Belsey4 reported that 27% 
of his patients developed esophageal stric­
ture within six months of esophagogastrec­
tomy. Because of this complication, many 
surgeons have attempted to construct a 
barrier to reflux, but their success is in 
doubt because these studies lack adequate 
follow-up in either experimental animals 
or humans.
Surgeons have attempted to control re­
flux: by running the esophageal remnant 
through a submucosal gastric tunnel,5 by 
creating a lower esophageal flap valve,8 by 
invagination of the esophagus into the 
stomach and covering it with gastric 
mucosa,7 by wrap-around invagination of 
the esophagus into the stomach,8 and by 
creating a new esophagogastric-sphincter 
zone with innervated diaphragmatic 
muscle.9
Clinically, there is some evidence that 
a 4- to 6-cm. invagination of the esophagus 
into the stomach decreases reflux and 
slightly lowers the incidence of postopera­
tive strictures.10 This clinical finding was 
investigated to determine experimentally 
the authenticity of an invagination anas­
tomosis and to establish the length of 
anastomosis necessary to prevent reflux.
M ethod
Eighteen healthy 20-kg. dogs were 
studied preoperatively and postoperatively.
“Supported by Medical Research Council of 
Canada Grant MA-1846 and Ontario Cancer 
Treatment and Research Foundation Grant 235.
fDepartment of Surgery, University of Toronto; 
Room 118, University Wing, Toronto General 
Hospital, Toronto, Ont.
^Professor and Chairman, Department of Surgery, 
University of Manitoba, Winnipeg, Man.
^Department of Radiology, University of Mani­
toba, Winnipeg.
Preoperative studies included three eso­
phageal motility records, and a cine barium 
swallow followed by esophagoscopy and 
biopsy of the esophagus. Manometric 
studies were carried out using three Pe 240 
polyethylene tubes with side openings and 
constant water infusion at 3.6 c.c./min./ 
tube. Changes in the intraluminal pressure 
were measured by P23De Statham strain 
gauges and recorded by a Honeywell 1508 
visicorder. The tubes were passed into the 
stomach of conscious trained dogs and 
continuous readings made during the 
period of 1-cm., staged, tube withdrawal.
In each dog the preoperative findings 
were considered to be within normal limits. 
Manometric studies in the normal dog 
demonstrated the high pressure zone 
(HPZ) at the gastroesophageal junction. 
The' HPZ contained the point of respiratory 
reversal where inspiratory positive ab­
dominal waves changed to inspiratory 
negative thoracic waves. The response of 
the HPZ to deglutition was one of relaxa­
tion followed by contraction. In the body 
of the esophagus, peristaltic waves followed 
each deglutition and no significant dis­
order of peristaltic waves was found in 
these dogs.
Following complete preoperative study, 
an esophagogastrectomy was performed in 
each dog. A left thoracotomy was made, 
excising the eighth rib. The stomach was 
mobilized through the esophageal hiatus. 
A 3-cm. cuff of esophagus and a 2-cm. cuff 
of stomach were excised and a vagotomy 
and pyloromyotomy performed.
Three types of esophagogastric anas­
tomosis were constructed in these dogs 
(Fig. 1). In Group I, six dogs had an end- 
to-end esophagogastric anastomosis. In 
Group II, five dogs had an end-to-end 
esophagogastric anastomosis; then the eso­
phagus was invaginated into the stomach 
for a distance of 2 to 4 cm. In Group 
III, seven dogs had the same operation 
but the invaginations were 4 to 5%  cm. in 
length.
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GROUP 1-6 DOGS GROUP II-5 DOGS GROUP IH -7  DOGS
END-TO-END MINOR INVAGINATION MAJOR INVAGINATION
Fig. 1.—Esophagogastrectomy with three types 
of anastomoses: (1) end-to-end, (2) minor invagina­
tion, (3) major invagination. All dogs had a 
vagotomy and pyloroplasty as part of the opera­
tion.
The dogs were allowed a minimum of 
10 days to recover from the operation 
before postoperative studies were done. 
The investigations done before operation 
were now repeated in each dog.
At least three postoperative motility 
studies were done, with additional studies 
in “long-term” dogs. Each dog had one 
or more cine barium swallow studies, 
and reflux was tested by placing the dog 
in the Trendelenburg position and apply­
ing abdominal compression. Esophagoscopy 
and biopsy were done immediately before 
sacrifice and autopsy.
TABLE I .— A v e r a g e  G astro esoph a ge al  
P r e ssu r e  G r a d ie n t
Dogs
Resting 
pressure 
gradient 
(cm. H20)
Abdominal 
compression 
pressure 
gradient 
(cm. H-iO)
Before operation 12 17
Group I : end-to-end 
anastomosis 1.6 0.5
Group I I : 2- to 4-cm. 
invagination 8 9
Group I I I : 4- to 5Ej-cm. 
invagination 10 15
Group /.—In the dogs with end-to-end 
anastomoses (Fig. 2) there was no effec­
tive pressure barrier between the stomach 
and the esophagus. There was a gradual 
fall in pressure as the tubes were pulled 
up the esophagus and the lower and mid- 
esophageal pressures were elevated. When 
abdominal compression was applied, there 
was no elevation of esophageal pressure 
(Table I). In this table, results of pre­
operative esophageal motility studies show 
that a gastroesophageal pressure gradient 
has been maintained. Dogs with end-to-end 
esophagogastrectomy do not have this 
gradient. The dogs with 4- to 5%-cm. in­
vagination anastomosis could maintain a
Dn
Postoperative R esults
Esophageal Motility Tests
i___ i___ i___ i___ i
0 20 40 Secs.
Fig. 2.—End-to-end esophagogastric anastomo­
sis. The upper two traces are from separate eso­
phageal tubes 5 cm. apart, the upper tube being 
more proximal. The lower tracing is a recording 
of respiration. Vertical lines mark each 1-cm. 
move as the tubes are withdrawn proximally in 
the esophagus. The esophagogastric anastomosis 
is marked by the presence of peristaltic waves. 
There is no effective pressure barrier between 
stomach and esophagus and no fall in pressure 
at the point of anastomosis.
Fig. 3.—Diagram of esophagogastric anastomosis 
and invagination to show the relationship of the 
esophageal pressure changes to the invagination. 
In Fig. 4 an actual pressure pattern is illustrated 
in dogs with 5%  cm. of invagination. The lower 
esophagus is maintained at gastric pressure by the 
invaginating stomach. The fall in pressure to 
esophageal levels occurs at the upper margin of 
the invagination.
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normal pressure gradient between stomach 
and esophagus, even when abdominal pres­
sure was applied.
Group II  — In these dogs with invagina­
tions of less than 4 cm., the results were 
variable. In some, there was evidence of a 
small pressure drop at the upper end of the 
invagination but this was less than in the 
4- to 5% -cm. invagination dogs (Fig. 3 ). 
Elevation of abdominal pressure caused a 
rise in esophageal pressure indicating that 
there was no effective barrier to reflux.
Group I I I .—Seven dogs in this group all 
showed a well-defined pressure drop at 
the upper end of the invagination ( Fig. 4).
0 20 40 Secs.
Fig. 4 .—Invagination esophagogastrectomy pres­
sure tracing. The pressure traces are the same as 
in Fig. 2. In this case, the esophagogastric anas­
tomosis is marked by the presence of esophageal 
peristaltic waves. The invaginated distal esopha­
gus is maintained at gastric pressure by the in- 
vaginating stomach and the pressure fall takes 
place at the upper end of the invagination 
(Fig. 3).
This pressure barrier, unlike those in the 
studies in Groups I and II, was com­
pletely maintained during abdominal com­
pression and, in addition, there was no rise 
in esophageal pressure.
The esophagogastric anastomosis was 
recognized in all dogs by the presence of 
esophageal peristaltic waves. In the in­
vaginated esophagus, the short segment of 
invaginated esophagus was maintained at 
gastric pressure, and the pressure fall oc­
curred at the upper end of the invagina­
tion (Fig. 3).
Radiographic Studies
Group 7.—These six dogs with end-to-end 
anastomosis had free reflux up to the 
pharyngoesophageal junction ( 3 - f ). These
Fig. 5.—End-to-end esophagogastric anastomosis 
with free reflux to the pharyngoesophageal junc­
tion. Free reflux occurred with or without ab­
dominal compression.
dogs refluxed while lying prone without 
abdominal pressure or Trendelenburg posi­
tioning (Fig. 5 ).
Group I I .—All of these five dogs had 
reflux to a varying degree. One had only 
a trace ( 1 + ) -  The remaining four had 
moderate ( 2 + )  to severe (3-|-) reflux 
(Fig. 6).
Group 777.—Of the seven dogs with in­
vaginations of 4 to 5V2 cm., one with a 
4-cm. invagination had 1 +  reflux. The re­
maining six had no reflux despite the use 
of the Trendelenburg position and ab­
dominal compression (Fig. 7 ).
Pathology
In all dogs, esophageal biopsy taken be­
fore operation showed a normal macro­
scopic appearance. At the end of the study, 
the dogs were killed and their esophagi 
studied grossly and microscopically.
Group 7.—The dogs with end-to-end 
anastomoses were killed at one month ( two 
dogs), two months (two dogs), and three 
months (two dogs). One dog killed at two
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Fig. 6.—Small invagination esophagogastric
anastomosis with moderate reflux. The short in- 
vaginated segment can be seen surrounded by 
gastric fundus. Free reflux was present with or 
without abdominal compression.
months and one at three months showed 
only a trace of esophagitis. Both of these 
dogs had free reflux and no effective 
barrier on motility studies. The remaining 
four had severe esophagitis with active and 
healed ulceration extending to a maximum 
of 10 cm. above the esophagogastric anas­
tomosis.
Group I I — In this group, four dogs were 
killed at one month. Two had severe eso­
phagitis comparable to the Group I dogs; 
the other two dogs had localized esophag­
itis with small healed ulcers. One dog was 
killed at three months and had slight eso­
phagitis with localized inflammation and a 
small ulcer.
Group I I I —In this group, four dogs were 
killed at one month and three at two 
months. One dog killed at one month had 
a small ulcer at the esophagogastric anas­
tomosis. This dog had a trace of reflux on 
cine barium swallow. The remaining three 
had no evidence of esophagitis grossly or 
microscopically.
D isc u ssio n
This study showed that reflux was pre­
vented by a 4- to 5¥2-cm. invagination of
*
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Fig. 7.—Large (5% -cm.) invagination esophagogastric anastomosis with no reflux. The invagin- 
ated esophagus can be seen surrounded by air-filled stomach. Application of abdominal pressure emp­
tied the barium from the invaginated esophagus, illustrating the flap-valve method of maintaining 
closure of this segment.
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esophagus into the stomach. The effective­
ness of this antireflux mechanism was 
studied by radiology, manometry, eso- 
phagoscopy and by the autopsy pathology. 
Radiologically, free reflux was seen in all 
dogs with simple end-to-end anastomoses, 
and with anastomoses less than 4 cm. in 
length. Many of these dogs developed eso­
phagitis. Dogs with invaginations of more 
than 4 cm. showed no evidence of reflux.
The mechanism that prevents reflux can 
be identified by studying the esophageal 
motility records in the dogs with a 4- to 
5 ¥2-cm. invagination. The invaginated eso­
phagus was maintained at gastric pressure 
by transmission of gastric pressure within 
the invagination. At the upper end of the 
invagination, the pressure fell to normal 
esophageal levels, indicating that an effec­
tive pressure barrier existed which pre­
vented transmission of gastric pressure to 
the remaining esophagus. In this way, the 
stomach is used as a means of transmitting 
gastric pressure to the invaginated intra- 
thoracic esophagus and maintaining closure 
of the invaginated esophageal segment. By 
closing this segment, an effective flap-valve 
antireflux mechanism is created. We ob­
tained further confirmation of the authen­
ticity of invagination by studying 11 pa­
tients with established invagination eso- 
phagogastrectomies.11 In these subjects, we 
found no motor, pH or radiologic evidence 
of reflux and, in all, gastric pressure fell at 
the proximal margin of the invagination.
In three patients with high esophago­
gastric anastomoses, slight reflux could be 
demonstrated. In these patients because of 
the considerable length of stomach within 
the thoracic cavity, effective gastric pres­
sure was not maintained up to the point 
of anastomosis. Because of the lowered 
intragastric pressure, a less effective flap- 
valve mechanism was constructed. These 
data are made more difficult to interpret 
because, with high invagination anasto­
moses, ample stomach is not always avail­
able for full invagination. Nevertheless, 
this observation suggests that the most 
effective anastomosis is created in the 
lower two-thirds of the chest because, in 
this position, gastric pressure is well main­
tained and the flap-valve mechanism is 
most effective.
C onclusions
After esophagogastrectomy, an invagina­
tion esophagogastric anastomosis produces 
a “competent sphincter” at the gastroeso­
phageal junction. Intra-abdominal positive 
pressure acting upon the junction maintains 
an effective pressure barrier. In this study, 
we demonstrated that, to control reflux in 
dogs, at least 4 cm. of esophagus has to be 
invaginated.
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Resu m e
L ’oesophago-gastrostomie realisee par anasto­
mose termino-terminale s’accompagne souvent de 
regurgitation, d’oesophagite et de retrecissement. 
Plusieurs chercheurs avaient deja signale que 
l’invagination de l’cesophage a 1’interieur de 
l’estomac est une technique operatoire qui con- 
stitue en soi un mecanisme efficace contre la re­
gurgitation. Le present article a pour objet 
d’etudier le bien-fonde de cette technique et de 
preciser sa fonction au point de vue mecanique.
Nous avons observe trois groupes de chiens, 
avant et apres oesophago-gastrostomie et avons 
notamment mesure la motilite de l’oesophage, 
examine par cineradiographie la progression du 
baryum durant la deglutition. Acres avoir sacrifie 
les animaux, nous avons procede a la necropsie
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et a l’examen pathologique. Dans le groupe I, la 
technique utilisee etait une anastomose temiino- 
terminale. Ces animaux presentaient des regurgita­
tions constantes et la plupart souffraient d’oeso- 
phagite. Dans le groupe II, la technique avait 
consiste en une invagination de 2 a 4 cm de pro- 
fondeur. Les resultats ont ete variables, mais tous 
les animaux presentaient des regurgitations epi- 
sodiques. Dans le groupe III, on pratiqua une 
invagination avec anastomose. Chez aucun des
animaux du groupe, on ne notait ni regurgitation, 
ni cesophagite.
Au moyen d’un manometre intra-oesophagien, 
nous avons pu demontrer que l’cesophage invagine 
agissait a la maniere d ’une valve a clapet main- 
tenue fermee par la pression gastricjue regnant 
dans la portion d’estomac entourant lanastomose. 
Nous avons conclu que l’invagination de l’ceso- 
phage au sein de l’estomac empeche reellement 
la regurgitation.
INTRAVASCULAR COAGULATION
Disseminated intravascular coagulation has 
been defined as acute transient coagulation 
occurring in the blood flowing throughout the 
microcirculation. The authors determined the 
coagulation abnormalities associated with the 
shock state in humans and correlated the find­
ings with the pathologic studies of patients 
in a shock state who died. Two hundred and 
ninety-four patients in a state of shock were 
studied. A patient was considered to be in 
shock when the arterial pressure was below 
90 mm. Hg with a central venous pressure 
variable depending on the specific type of 
shock, with or without low cardiac output, 
with acid-base imbalance, and with impaired 
renal function.
The frequent association of shock in dis­
seminated intravascular coagulation has been 
demonstrated in the experimental animal, and 
considered as a cause of irreversibility. The 
authors cite a number o f studies that they 
believe clearly support the concept that a 
shock state in humans is not responsible for 
histologically detectable, widespread dissemin­
ated intravascular thrombosis, as occurs in ex­
perimental animals. There were 146 deaths in 
the reported series with 78 autopsies. There 
was little evidence of intravascular fibrin de­
position in the liver, lungs, or kidneys. The 
most consistent change noted was found in 
the liver (dilatation and congestion of the 
sinusoids and hepatic veins).
The authors found, in those who died, a 
significant depletion of clotting factors V, VII, 
IX, X  and XI. The authors explained the 
significant coagulation abnormalities by two 
possible hypotheses. Disseminated intravascular 
coagulation does exist because normally fibrin 
is constantly being formed intravascularly, and 
degraded by the fibrinolytic system. The com­
pensatory mechanisms of fibrinolysis and clear­
ance of fibrin deposition occur and evidence
for disseminated intravascular coagulation will 
be lacking after death, although significant co­
agulation abnormalities were present in vivo. 
The second possibility is that the coagulation 
and fibrinolytic changes observed in shock 
are secondary to the parenchymatous changes 
seen in the hypoxic liver. Since the liver is 
the site of production of almost all clotting 
factors, its involvement can explain the co­
agulation abnormalities observed in the shock 
state. Hepatic changes do occur in shock and 
are thought to be related to the duration of 
the state of shock; that is, if it exists for more 
than 24 hours, hepatic necrosis is almost con­
stant. If it lasts less than 10 hours, it is un­
usual. The decrease in blood flow through the 
portal vein, as well as the hepatic artery dur­
ing a state o f shock, will reduce the oxygen 
tension in the centrizonal cells, causing 
greater anoxic changes than in the peripheral 
cells and lead to necrosis. The activation of 
the fibrinolytic system occurs through tissue 
hypoxia and increased catecholamines, a de­
crease in fibrinolytic inhibitor, and failure of 
hepatic clearance of plasminogen activator. It 
accounts for the decrease in fibrinogen and 
other clotting factors.
In summary, the authors conclude that sig­
nificant alterations in the coagulation and 
fibrinolytic systems were demonstrated in 294 
patients in a state of shock. These changes 
could be interpreted as resulting from dis­
seminated intravascular coagulation. However, 
in 52 bodies examined carefully at autopsy, 
there was no evidence of fibrin deposition. 
The most consistent pathologic changes were 
seen in the liver and ranged from sinusoidal 
dilatation to extensive hepatic necrosis. It was 
concluded by the authors that disseminated 
intravascular coagulation may not play a major 
role in the irreversible stages of shock in 
humans.—Attar S, Hanashiro P, Mansberger A, 
et al: Intravascular coagulation; reality or 
myth? Surgery 68 : 27, 1970
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RENAL ANGIOMYOLIPOMA: DIAGNOSIS AND SURGICAL 
MANAGEMENT*
M. N. W EISLER, B.A., M.D.f and W. H. LAKEY, M.D., F.R.C.S.[C],t Edmonton, Alta.
In this paper we propose to present diag­
nostic criteria for renal angiomyolipoma, 
review current surgical management, and 
describe the authors’ concept of surgical 
management of this lesion, with particular 
reference to the solitary lesion in a patient 
in the hypernephroma age group who has 
minimal or no clinical findings of the 
tuberous sclerosis complex. In addition, a 
typical case will be reported.
Pathologic Background
In 1862 von Recklinghausen first de­
scribed patchy sclerosis of the cerebral 
cortex in a patient who also had multiple 
myomas of the heart. Bourneville later 
applied the name “tuberous sclerosis” to 
the cerebral changes. The term “epiloia” 
was introduced by Sherlock, in 1911, to 
indicate the commonly encountered triad 
of adenoma sebaceum, epilepsy and mental 
deficiency. In 1942 Moolten1 suggested the 
name “tuberous sclerosis complex”, because 
the term “tuberous sclerosis” applied only 
to one feature in this disorder of multiple 
abnormalities.
In the fully developed tuberous sclerosis 
complex, the individual may have numer­
ous and diverse hamartomas in the brain, 
kidneys, bones, skin, heart and lungs. The 
cerebral lesions consist of collections of 
dense glial tissue in patchy distribution. 
In the retina these are known as pha- 
coihas. Of the skin lesions the most com­
mon, adenoma sebaceum, consists of groups 
of nodules which occur most often near 
the nose. Histologically these show in­
creased dermal collagen and hair follicles, 
and a proliferation of sebaceous glands. 
Less common skin lesions are thickened 
patches near the sacrum, shagreen patches,
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and hyperpigmented cafe-au-lait spots. 
Ungual fibromas also occur. Other lesions 
sometimes found in this complex are 
cardiac rhabdomyomas, hepatic hamar­
tomas and cystic pulmonary lesions. Bone 
changes include patchy localized densities 
in the skull, vertebral column and pelvis 
which may simulate osteoblastic metas- 
tases.
The renal lesion, which occurs in 50% 
to 80% of tuberous sclerosis patients, has 
been named “renal angiomyolipoma”. Ap­
proximately 50% of such lesions reported 
to date have been found in patients who 
do not have other evidence of the tuber­
ous sclerosis complex.
The renal lesions are composed of un­
encapsulated adipose tissue, smooth muscle, 
and blood vessels, in varying proportions. 
Several authors2'* have reported that in 
the absence of a demonstrable tuberous 
sclerosis complex, renal angiomyolipomas 
usually present as a single lesion in only 
one kidney. Such isolated lesions are more 
common in females.5- 6 Patients afflicted 
with the tuberous sclerosis complex gener­
ally have multiple angiomyolipomas in 
both kidneys. These patients may be of 
either sex but are younger than those with 
only an isolated kidney lesion.
The leading cause of death attributable 
to the renal angiomyolipoma itself is ex­
sanguinating hemorrhage. Although it is 
often stated that renal angiomyolipomas 
frequently lead to renal failure, only one 
such report was found in the literature.7
The incidence of tuberous sclerosis has 
been variously reported as one in 250 in 
psychiatric populations to one in 300,000 
in the general population. Although it was 
widely held that 75% of tuberous sclerosis 
patients die before reaching 25 years of 
age, several authors have observed other­
wise.8 Patients with tuberous sclerosis com­
plex most commonly die of cerebral hemor­
rhage or in status epilepticus.
The high mortality rate would apply 
only to those patients who have a fully de­
veloped clinical picture of tuberous selero-
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sis complex. It has now become apparent 
that formes frustes of this disease exist 
which include patients with normal intel­
ligence. In analyzing pedigrees of tuberous 
sclerosis, Marshall, Saul and Sachs9 con­
cluded it is due to a rare autosomal domin­
ant gene. Since the trait is known to skip 
a generation, they believe that the expres­
sion of the basic gene is alfected by an 
independent pair of modifying genes. Thus 
mild forms of the complex can occur where 
only a single somatic system is affected or 
severe cases in which two or more systems 
are affected. Also, normal individuals can 
carry the gene.
H istogenesis and Pathology
Although we know little about the 
etiology of renal angiomyolipomas, these 
tumours appear to be benign hamartomas 
on the basis of histologic appearance and 
clinical behaviour.
Inglis10 in 1954 proposed that the renal 
tumours, like the cerebral nodules in tuber­
ous sclerosis, were of neural origin. In 
1960, after further study, he recognized 
that his original interpretation was wrong.11 
Inglis now regards these tumours as a 
distinct type, whether or not they are single 
or multiple or associated with tuberous 
sclerosis. His reasons are: (1) In all of 
these lesions the arteries have no internal 
elastic lamina in the walls. (2) The 
smooth-muscle-like cells of these tumours 
resemble myoid cells of the cutaneous 
glomus. He believes that a common histo- 
genetic factor underlies glomus tumour, 
angioleiomyoma and the renal tumour of 
the tuberous sclerosis complex. (3) He does 
not believe that the smooth-muscle ele­
ments in angiomyolipoma are ordinary 
smooth muscle, but has not decided 
whether the smooth muscle in the walls of 
the blood vessels contributes to the forma­
tion of these tumours.
Most of the controversy regarding the 
etiology of renal angiomyolipoma centres 
around the smooth-muscle cells. Allen and 
Risk12 noted that the smooth muscle is 
usually the wildest element of the tumour, 
sometimes showing cellular pleomorphism 
and mitoses characteristic of malignancy. 
Lucke and Schlumberger13 concur but
point out that any of the elements may 
show pleomorphism.
Moolten1 considers the renal lesion to be 
a hamartoma. In his view the three tissues 
that comprise the lesion arise from nests 
of embryonal cells which remain in a state 
of permanent embryonicity because of a 
failure of induction. According to Moolten 
only three patients with renal angiomyo­
lipomas and tuberous sclerosis have had 
small metastatic deposits in other organs 
that were unmistakably malignant.
When patients with supposedly malig­
nant variants of this renal tumour have 
been irradiated after nephrectomy, they 
did well and survived with no evidence of 
local recurrence or distant metastasesA 12 
Allen and Risk12 found no report of deaths 
from metastatic angiomyolipoma in the 
literature. Perou and Gray0 believe that 
even though isolated angiomyolipomas may 
contain immature cells and be invasive, 
they are not true malignant tumours. 
Because of its benign clinical course, most 
authors have been reluctant to call angio­
myolipoma malignant regardless of its 
gross or microscopic appearance.
Case Report
A 13-year-old white girl with tuberous 
sclerosis was readmitted to the University of 
Alberta Hospital, Edmonton, on December 
24, 1967. In 1964 she had been admitted be­
cause of reddish maculopapular lesions cover­
ing both cheeks in a butterfly pattern. These 
had been diagnosed clinically as adenoma 
sebaceum (Fig. 1). At that time and on three 
subsequent occasions, the skin lesions had 
been abraded for cosmetic reasons. The other 
stigmas of tuberous sclerosis which she ex­
hibited included: (1 ) phacomas of the retinas, 
(2) small fibroadenoma of the scalp, (3 ) 
shagreen patch on the back and (4) a history 
of convulsive episodes beginning at 6 months 
of age and disappearing at the age of 2 years. 
She had failed to pass Grade 3 in school and 
had subsequently progressed with low grades. 
Her mother said she had developed normally, 
sat up at 5 months of age and walked at 11 
months. There was no family history of con­
vulsions, facial acne or mental retardation.
In April 1966 an effort was made to deter­
mine the presence or absence of other lesions 
of the tuberous sclerosis complex. On intra­
venous pyelograms the calyces of the left kid-
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Fig. 3.—Gross specimen of the left kidney 
showing distortion of reniform configuration by 
nodular masses.
In October 1967 while playing she had a 
sharp pain in her left side that was not asso­
ciated with external trauma. Gross hematuria 
occurred a few hours later and she was re­
admitted to the hospital for observation. 
Within the next five days the hematuria sub­
sided.
On December 24, 1967 she again experi­
enced spontaneous left flank pain followed by 
profuse gross hematuria and, on admission to 
the hospital, was treated for hypovolemic 
shock. Profuse gross hematuria persisted and 
she was taken to the operating room for an 
emergency left nephrectomy. At operation the 
left kidney was found to be IV2 times the 
normal size and the perirenal fascia was ad-
Fig. 2.—Intravenous pyelogram showing tumour 
deformity of the left kidney calyces and possible 
early distortion of the upper-pole calyces and in­
fundibulum of the right kidney.
Fig. 4.—Gross specimen of the bivalved left 
kidney showing replacement of normal paren­
chyma and fresh clot in the renal pelvis.
Fig. 1.—Appearance of adenoma sebaceum be­
fore dermabrasion.
ney were distended, blunted and markedly 
distorted, giving the impression that they were 
deformed by a tumour. The upper-pole 
calyces of the right kidney were widened, sug­
gesting possible early distortion (Fig. 2 ) .
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Fig. 5.—High-power photomicrograph demon­
strating a typical area of parenchymal replace­
ment by non-encapsulated fat (H & E, original 
magnification X 125).
herent and edematous. The cortex of the kid­
ney contained scattered yellowish nodules, 
and the upper pole contained an irregular 
mass the size of an orange. The patient’s re­
covery was uneventful.
The kidney weighed 385 g. and measured 
14 x 7 cm. The renal parenchyma was re­
placed by yellow, somewhat trabeculated, 
tumour tissue. Only a small segment of the 
lower pole was recognizable as kidney tissue. 
The cortical surface was studded with yellow 
nodules measuring 0.2 to 0.5 cm. in diameter. 
The renal pelvis and calyces were filled with 
blood (Figs. 3 and 4).
Histologically the tumour was typical of 
angiomyolipoma. There were areas of non- 
encapsulated fat, smooth-muscle cells and 
atypical blood vessels with no inner elastic 
lamina. There was no malignant transformation 
(Figs. 5 and 6).
Follow-up intravenous pyelogram 34 
months later revealed no progression of the 
suspected right upper-pole lesion.
D if f e r e n t ia l  D iagnosis of
R ena l  A n g io m y o lipo m a
Although renal tumours generally pro­
duce few symptoms until late in the
Fig. 6.—High-power photomicrograph demon­
strating many atypical arteries with absent in­
ternal elastic laminas and continuity of the arterial 
walls with the bundles of smooth-muscle-like cells 
in the interstitium (H & E, original magnification 
X 125).
course of the tuberous sclerosis complex, 
sharp pain in the kidney area and syncope 
indicating internal hemorrhage should 
focus attention on a possible angiomyo- 
lipoma.1’ An intravenous pyelogram will 
reveal a space-occupying lesion which 
distorts the calyces and even the renal 
pelvis. Areas of increased radiolucency 
within the kidneys are often seen during 
urographic studies. These are attributed to 
hemorrhage, infarction or collections of 
fat within a tumour. This finding can also 
suggest multiple cystic areas, and thus 
polycystic disease must be considered.
A tumour deformity on intravenous 
pyelogram in a patient with cutaneous 
lesions and radiographic evidence of tuber­
ous sclerosis in bones or brain should sug­
gest renal angiomyolipoma regardless of 
the age of the patient. If the renal lesions 
are bilateral, the diagnosis even more 
strongly favours angiomyolipoma.
The surgeon’s diagnostic abilities and 
criteria are most severely tested in the pa­
tient with some or no clinical findings of
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the tuberous sclerosis complex and a uni­
lateral renal lesion seen on intravenous 
urography. In this situation he may be 
helped by the arteriographic findings re­
ported by Viamonte et al.14 in a typical 
case of renal angiomyolipoma in a patient 
with tuberous sclerosis. On performing 
selective renal arteriography, they found 
changes which they interpreted as charac­
teristic of angiomyolipoma and by which 
they could differentiate this lesion from 
hypernephroma or polycystic disease. In 
the arterial phase there was hypervascu­
larity and abnormal distribution of vessels. 
There was loss of normal tapering and also 
tortuosity of the arteries as in hyper­
nephroma. However, small regular out- 
pouchings from the interlobar and inter­
lobular arteries were seen. These resembled 
“berry” aneurysms and the appearance of 
the artery at its termination suggested a 
cluster of grapes. Puddling of contrast 
material was also observed as in hyper­
nephroma. The venous phase developed 
normally in contrast to the early appear­
ance often associated with hypernephroma. 
No arteriovenous fistulas were seen. Poly­
cystic renal disease could be ruled out 
easily because it has a relatively avascular 
angiographic pattern. These findings sug­
gested the true diagnosis to Viamonte et 
al. before other stigmas were sought.
Surgical M an ag em en t  o f  Renal
A ngio m yo lipo m a
Surgical exploration is often performed 
in order to establish the diagnosis of renal 
angiomyolipoma in suspected cases. Ac­
cording to Van Heerden et al.,15 all such 
patients should be explored, except those 
with bilateral multiple lesions. They 
believe there is no indication for com­
plete or partial nephrectomy when the 
lesions are bilateral. If the lesion is uni­
lateral and partial nephrectomy is possible, 
it should be performed.
McQueeney, Dahlen and Gebhart16 
argue that the needless sacrifice of a kid­
ney for a benign tumour may often be 
avoided by biopsy and examination of a 
frozen section. They acknowledge the risk 
of disseminating the tumour if it is malig­
nant by taking the biopsy. They believe
that once the diagnosis has been made, 
conservative local excision is adequate 
treatment. Straffon17 explores all patients 
with suspected renal angiomyolipoma to 
rule out a necrotic hypernephroma.
Allen and Risk12 warn that there is no 
plane of cleavage between the angiomyo­
lipoma and normal kidney. Morphologic­
ally the large masses of fat in these 
tumours are not encapsulated. There is a 
potential risk of brisk hemorrhage on at­
tempting partial nephrectomy. Further­
more these lesions possess a growth po­
tential and may recur if incompletely ex­
cised.
Our concept of the surgical management 
of renal angiomyolipomas is based on the 
following considerations: This lesion,
whether it is associated with tuberous 
sclerosis or not, is a hamartoma and 
benign in behaviour. The main cause of 
death attributable to renal angiomyo­
lipoma is exsanguinating hemorrhage. 
Many angiomyolipomas are small and are 
totally asymptomatic. Of patients afflicted 
with the tuberous sclerosis complex, renal 
angiomyolipomas generally occur in both 
kidneys. Patients with mild forms of the 
tuberous sclerosis complex live to an older 
age and therefore renal angiomyolipomas 
may appear in those in the hypernephroma 
age group. There may be specific arterio­
graphic signs of renal angiomyolipoma. If 
substantiated, these will enable a more 
definitive preoperative diagnosis. There is 
a poor plane of cleavage between normal 
kidney and the angiomyolipoma. There­
fore in attempted partial nephrectomy 
there is the risk of possible hemorrhage 
which may necessitate total nephrectomy. 
Renal angiomyolipomas may recur if in­
completely excised.
Our current approach to the diagnosis 
and surgical management of renal angio­
myolipomas is as follows: we do a personal 
and family history, and a careful physical 
examination seeking stigmas of the tuber­
ous sclerosis complex. Each patient has an 
intravenous pyelogram, nephrotomogram 
and renal arteriogram, and chest, skull and 
skeletal radiographs.
The patient who has the stigmas of both 
tuberous sclerosis and bilateral renal lesions
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should have no operation, except that 
necessary to control life-threatening hemor­
rhage. If there are large bilateral lesions 
and massive hemorrhage from one kidney, 
we would attempt partial nephrectomy 
after first gaining access to the renal artery 
so that it may be quickly clamped should 
uncontrollable hemorrhage persist. In pa­
tients who have the tuberous sclerosis 
complex and a unilateral angiomyolipoma, 
and are less than 40 years of age, neph­
rectomy is performed only for uncon­
trollable hemorrhage. If a patient with 
these lesions is not bleeding but is in the 
hypernephroma age group, nephrectomy is 
performed. Although most of these lesions 
are likely to be angiomyolipomas, present 
diagnostic procedures do not provide a 
definitive preoperative diagnosis and we 
believe that biopsy of renal tumours can­
not be justified. Furthermore, the risk to 
life is greater from an overlooked adeno­
carcinoma than from the subsequent de­
velopment of an angiomyolipoma in the 
other kidney.
Patients who have a unilateral tumour 
deformity on urographic examination but 
have none of the stigmas of tuberous 
sclerosis should have a nephrectomy. 
Rarely, histologic examination will show 
that the lesion is an angiomyolipoma. If so, 
the surgeon need have no concern over the 
subsequent development of a similar lesion 
in the remaining kidney because bilateral 
angiomyolipomas do not develop except in 
patients with the tuberous sclerosis com­
plex.
Su m m a ry
Renal angiomyolipoma may occur in the 
absence of tuberous sclerosis. Whether or 
not it is associated with the tuberous 
sclerosis complex, it behaves as a benign 
lesion. Because the tuberous sclerosis com­
plex is incompletely expressed in some pa­
tients, these individuals live to an older 
age than was earlier realized. Because the 
angiomyolipoma appears as a tumour- 
deformity on intravenous pyelography, it 
must be differentiated from hyperneph­
roma, particularly in those patients 40 years 
or older, and because unilateral renal 
angiomyolipomas usually occur in the ab­
sence of the tuberous sclerosis complex. 
Recently certain arteriographic signs have 
been reported as specific for renal angio­
myolipoma. If substantiated, these may en­
able a more definite preoperative diagnosis.
The surgical management proposed is 
more conservative than has heretofore been 
advocated. Patients with stigmas of tuber­
ous sclerosis and who have the renal lesion 
should be treated by nephrectomy only to 
control life-threatening hemorrhage. Partial 
nephrectomy is not recommended. Those 
patients with unilateral angiomyolipomas 
who are in the hypernephroma age group 
should have a nephrectomy regardless of 
the presence or absence of the tuberous 
sclerosis complex.
In addition, the literature on the subject 
is briefly reviewed and a typical case is 
reported.
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Resume
L ’angiomyolipome renal, qui est une dysem- 
bryoplasie benigne, peut survenir en l’absence de 
sclerose tubereuse. Les malades qui souffrent du 
complexe de sclerose tubereuse ont generalement 
des angiomyolipomes dans les deux reins, tandis 
que ceux qui ne sont pas affectes de sclerose
tubereuse, ont couramment des tumeurs unilate- 
rales. Les malades qui presentent des formes be- 
nignes de ce complexe vivent jusqu’a un age 
avance et, par consequent, les masses renales 
unilaterales doivent etre differenciees d’un hyper- 
nephrome. On a signale avoir trouve des signes 
arteriographiques specifiques d’angiomyolipome 
de sorts que, si on les decouvre, on pourra poser 
un diagnostic plus precis. Les auteurs exposent un 
mode operatoire plus conservateur des angiomyoli­
pomes renaux. La cause principale du deces at- 
tribuable a l’angiomyolipome est l’exsanguination 
par hemorragie. Chez les malades souffrant du 
complexe de sclerose tubereuse, la nephrectomie 
n’est recommandable que dans ce type de situa­
tion tragique. Les malades qui n’ont de tumeurs 
renales que d’un cote et qui ont plus de 40 ans 
devraient etre sounds a la nephrectomie, inde- 
pendamment de la presence ou de 1’absence du 
complexe de sclerose tubereuse. Les auteurs pre­
sentent un cas typique et passent brievement en 
revue la litterature pertinente.
SPLENIC ABSCESS
The most common cause of splenic abscess 
is a focus of infection elsewhere in the body. 
A splenic abscess almost always occurs in an 
abnormal spleen. Although the mortality rate 
is high, the combination of well-timed surgical 
procedures and antibiotic therapy can be cura­
tive.
The study presents three patient reports 
representing three varieties of splenic abscess- 
arterial spread, trauma, and intra-abdominal 
suppuration. The first patient showed a back­
ground of cerebral embolism suggesting bac­
terial endocarditis. A history of pain in the 
left lower portion of the chest and in the 
upper portion of the abdomen suggested the 
possibility of splenic abscess. The roentgeno­
grams showed the hemidiaphragm to be 
elevated. Needle aspiration yielded purulent 
material. The spleen was removed and con­
tained splenic abscesses. The patient apparently 
had a splenic infarct on the basis of her sickle 
cell disease or bacterial endocarditis, and then 
the infarct subsequently became infected.
The second patient was a 16-year-old boy 
who had trauma to his left side, and subse­
quently had a pustule develop on his elbow. 
His course suggested hematogenous spread of 
bacteria from the pustule to an intrascapular 
splenic hematoma resulting from the previous 
trauma. The preoperative diagnosis of splenic 
abscess was made, the spleen was removed, 
and the abscess drained. Subsequently, the 
patient’s course was complicated lay apparent
subphrenic abscess, bleeding in the upper 
portion of the gastrointestinal tract, and finally 
cholecystitis which necessitated cholecystos- 
tomy.
The third patient, a 58-year-old man, had 
a laparotomy in 1962 because of peritonitis 
secondary to perforated diverticulum. At that 
time, a colostomy was done. Subsequently he 
had numerous episodes of fever. In 1967 he 
had right upper quadrant pain and he had a 
cholecystectomy. Postoperatively, he did poorly 
and liver and spleen scans disclosed a large 
defect in the spleen; the diagnosis of splenic 
abscess was made. A splenectomy was per­
formed and the wound drained. Confluent 
abscesses were found in the spleen. Antibiotic 
therapy in this patient was chloramphenicol 
15 g. daily for seven days postoperatively and 
erythromycin 2 g. daily for three months. The 
outstanding characteristic of the third patient 
was the probable presence of an infected 
spleen for five years after perforation of the 
colonic diverticulum.
The high mortality rate associated with 
splenic abscess can be lowered by increased 
awareness, use of all diagnostic means, and 
prompt operation with appropriate antibiotic 
therapy. Laboratory data are not much help 
in diagnosis; however, the clinical course, 
roentgenograms showing elevated hemidia­
phragm, and the use of splenic scanning were 
helpful.— Pickleman JR, Paloyan E, Block 
GE: Surgical significance of splenic abscess. 
Surgery 68 : 287, 1970
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OSTEOCHONDRITIS DISSECANS AND ANOMALOUS CENTRES OF 
OSSIFICATION: A REVIEW  OF 80 LESIONS IN 61 PATIENTS
F. LANCER, M.D., F.R.C.S.JC] and E. C. PERCY, M.D., F.R.C.S.[C],» Montreal, Que.
T his paper presents a clinical review of 
osteochondritis dissecans, a condition in 
which an osteochondral fragment gradually 
separates from an articular surface. This 
study, which was limited to the knee—the 
most common site of this lesion, is based 
on 80 joints in 61 patients. We propose 
that the osteochondritis dissecans in many 
of these patients developed on the basis of 
a pre-existing anomalous centre of ossifica­
tion. We have not demonstrated the 
anomalous centre in any of these patients 
by radiographs but will present evidence 
of this hypothesis below. These patients do 
not seek medical advice until they develop 
symptoms; by that time, in our view, the 
centre has already separated. In this group, 
30 patients were treated conservatively and 
11 by surgical excision of the fragment. 
The fragment was extracted in 14 patients 
and pegged in situ in another eight cases.
E tiology and Pathogenesis
Many explanations have been offered 
for osteochondritis dissecans of the knee; 
most of them fall into two categories: 
those based on ischemia and those on 
trauma. According to Fairbank,1 osteo­
chondritis dissecans results from the acute 
impingement of the tibial spine on the 
medial femoral condyle. Although many 
have supported this concept, and radi­
ologists often report a “prominent” tibial 
spine, arthrotomy has provided little 
support for this theory. Moreover, the 
prominent spine does not explain osteo­
chondritis dissecans in other joints and the 
occasional finding of more than one lesion 
in a single joint. The ischemic hypothesis 
assumes that the lesion follows infarction 
of the subchondral bone after end-artery 
occlusion. This occlusion has been at­
tributed to fat emboli,2 tubercle bacilli,3 
and erythrocyte aggregates.4 This hypo­
thesis does not explain the constant site of
“Suite 410, 3550 Cote des Neiges Road, Montreal 
109, Que.
the lesions in contrast to the random 
distribution that characterized emboliza­
tion.
We propose that the theories of ischemia 
and trauma are not necessarily mutually 
exclusive; both might operate when the 
lesion develops on the basis of an anomal­
ous centre of ossification. These centres are 
common in the knee especially in the 
medial femoral condylar articular surface. 
In studying this condition, Ribbing5 radio­
graphed 291 children; Smillie0 also de­
scribed this condition in his text. Both 
authors concluded that there is a definite 
relationship between anomalies of ossifica­
tion and trauma, and the subsequent de­
velopment of osteochondritis dissecans. 
These anomalous centres of ossification 
appear to heal spontaneously, usually by 
the time the distal femoral epiphysis has 
closed. The condition “juvenile osteo­
chondritis dissecans” probably represents 
asymptomatic anomalous centres that often 
heal spontaneously. The blood supply to 
these centres, which is via the bony 
nucleus of the distal femoral epiphysis, is 
presumably tenuous and susceptible to 
shearing forces.
Fig. 1 shows the forces that act at the 
articular surface of the knee. As the knee 
passes from flexion to extension, the femur 
rotates internally on the tibia—the “screw- 
home” effect. This rotation, which is asso­
ciated with twisting of the anterior cruci­
ate ligament around the posterior cruciate 
ligament and relative shortening of these 
structures, not only apposes the articular 
surfaces at the end of extension but pro­
duces a twisting force which is dissipated 
horizontally at the articular surface. We 
propose that this “torsional impaction”,7 a 
phenomenon of normal knees, twists 
the anomalous centre, and, by creating a 
horizontal plane of cleavage, ruptures its 
fragile nutrient vessels as they pass from 
the bony nucleus of the femoral epiphysis. 
Avascular necrosis of the centre follows. 
Repetition of torsional impaction with
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Fig. 1.—Forces acting at the articular surface of 
the right knee, femur rotating medially and tibia 
laterally, seen from in front. As the knee passes 
from flexion to extension the femur rotates inter­
nally on the tibia—the “screw-home” effect. In 
extension, this twists the anterior cruciate liga­
ment about the posterior and shortens these liga­
ments, bringing tibia and femur together. This 
motion not only apposes the articular surfaces but 
transfers the horizontal twisting to the articular 
surface. The entire process is referred to as “tor­
sional impaction”. (Reproduced by permission 
from H e l f e t  AJ: Management o f Internal D e­
rangements of Knee, Philadelphia, Lippincott, 
1963, p 12.)
walking dissects the centre from the main 
epiphysis and fractures the articular cartil­
age, and eventually a loose body forms. We 
believe that in the majority of patients 
osteochondritis dissecans develops on a pre­
existing anomalous centre of ossification, 
and that the torsional impaction associ­
ated with walking leads to avascularity 
and subsequent separation.
In our experience, knees with osteo­
chondritis dissecans frequently have asso­
ciated congenital anomalies, such as genu 
recurvatum, loose patellas, and lax col­
lateral ligaments. These knees tend to be 
unstable and exaggerate the normal forces 
acting at the knee and increase the chance 
of injuring the anomalous centre and 
forming an osteochondral fragment.
M ethod  o f Study
In this study, we assessed 80 knees in 
61 patients with osteochondritis dissecans. 
The cases were obtained through the 
record departments of the Montreal Gen­
eral Hospital and Montreal Children’s Hos­
pital and from the records of members of 
the attending staff at these institutions. 
Twenty patients were interviewed and ex­
amined by the authors; the remainder had 
been examined by members of the attend­
ing staff at the respective hospitals. We 
excluded transchondral fractures from the 
study because they result from acute 
trauma which provokes violent twisting of 
the knee and subluxation or dislocation of 
the patella.
R esu lt s
These 80 knees were divided into four 
separate groups according to their manage­
ment. For each patient, the individual sur­
geon selected the treatment.
Conservative Treatment (.30 Patients)
This group, 18 males and 12 females, 
contained 47 knees (Table I) . In 17 pa­
tients between 7 and 18 years of age both 
knees were involved. In them, the average 
duration of treatment was four months— 
a range of two months to one year. The 
symptomatic knee was placed in a long- 
leg cylinder with the knee flexed to vary­
ing degrees. Usually weight bearing was 
allowed but the results of treatment were 
the same when the patient bore his full 
weight, partial weight, or no weight at all. 
In 28 patients, the lesion was over the 
medial femoral condyle, in 15, both knees 
were involved. In two patients, there was 
a lesion over the lateral femoral condyle in 
both knees. Twenty-eight patients had no 
symptoms at follow-up—four months to 10 
years after conservative treatment. Two 
lesions separated after treatment in a long- 
leg cylinder (Cases 2 and 14). In Case 2, 
the fragment was extracted and 14 months 
later the patient had no symptoms, al­
though the medial femoral condyle ap­
peared to be flattened on the radiograph. 
In the other patient (Case 14), the frag­
ment was fixed back into its bed; the pa­
tient had no symptoms three years later 
and his films appeared normal.
Excision (11 Patients)
These patients were between 12 and 25 
years of age. In this procedure we removed
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TABLE I.—C o n se r v a t iv e  T r e a t m e n t . R esuets  in  30 P a tie n ts
Vol. 14
Age Duration of
Results RadiographNo. Name Sex (years) Location* Follow-up treatment
1 M.L. M 13 MFC (bilat.) 1 yr. 4 mos. Asymptomatic Normal
2 J.F. F 9 MFC 1 yr. 4 mos. Detached Flattening
3 S.L. F 16 MFC 18 mos. 6 wks. Asymptomatic N ormal
4 K.M. M 17 MFC 1 yr. 4 mos.
5 F.U. M 7 LFC (bilat.) 
MFC “
3 yrs. 2 mos.
6 J.N. F 13 2 yrs. 6 mos.
7 P.I. F 12 MFC 6 yrs. 4 mos.
8 L.J. F 10 MFC (bilat.) 
MFC “
4 yrs. 4 mos.
9 T.N. M 15 3 yrs. 6 mos.
10 J.D. M 12 MFC “ 2 yrs. 4 mos.
11 D.R. M 13 MFC “ 2 yrs. 2 mos.
12 D.G. M 12 MFC “ 3 yrs. 2 mos.
13 S.R. M 13 MFC “ 10 mos. 2 mos.
14 F.K. M 18 MFC “ 3 yrs. 5 mos. Detached
15 L.A. M 16 MFC “ 5 yrs. 4 mos. Asymptomatic
16 B.J. M 15 MFC “ 10 yrs. 1 yr. il
17 M.C. F 12 MFC 3 yrs. 6 mos.
18 M.F. F 16 MFC (bilat.) 2 yrs. 4 mos.
19 C.R. M 11 MFC 2 yrs. 4 mos.
20 D.C. F 10 MFC 3 yrs. 3 mos.
21 0 .0 . F 12 LFC (bilat.) 4 yrs. 3 mos.
22 c .o . M 13 MFC “ 3 yrs. 3 mos.
23 D.C. M 15 MFC “ 4 yrs. 4 mos.
24 Y .O . F 10 MFC 1 yr. 3 mos.
25 L.D. F 12 MFC 6 mos. 4 mos. u u
26 o.c. M 11 MFC (bilat.) 8 mos. 2 mos.
27 L.P. M 12 MFC 2 yrs. 6 wks.
28 A.C. M 13 MFC 1 yr. 3 mos.
29 S.L. F 9 MFC 4 mos. 3 mos.
30 B.J. M 8 MFC 1 yr. 4 mos.
Average Average Average 28 29
18 M 12.5 28 MFC 2.5 yrs. 4 mos. asymptomatic normal
12 F 2 LFC
*MFC = medial femoral condyle; LFC = lateral femoral condyle.
th e  o s teo ch o n d ra l frag m en t from  its b e d  on N o p a tie n t h a d  any  lim ita tio n  of genera l
th e  a r tic u la r su rfa c e  of th e  m ed ia l fem oral activ ity . T h e  rad io g rap h s  of tw o  of th e
condy le  in seven m ales a n d  fo u r fem ales th re e  sy m p to m atic p a tien ts  show ed  early
(T a b le  I I ) . A t fo llow -up five m onths to d e g e n e ra tiv e  o s teo arth ritis  o f th e  m ed ia l
six years la te r, e ig h t p a tie n ts  h a d  no sym p- fem ora l c o m p artm en t. O ne of th e  p a tien ts
tom s. T h ree h a d som e sym ptom s in  the w ith o u t sym ptom s h ad  a sim ilar resu lt
k n ee  w ith  occasional m ild p a in  a n d  swell- ( C ase  3 8 ) . T h e  rad io g rap h s of an  asym pto-
ing a fte r  exercise (C ases 35, 36  an d  41 ). m atic  p a tie n t a re  show n  in F ig . 2.
TABLE II.—E x c isio n . R esults  in 11 P a tie n ts
No. Name
Age
(years) Sex Location* Follow-up Results Radiograph
31 M.T. 14 M MFC 1 yr. Asymptomatic Normal
32 J.N. 13 F MFC 8 mos.
33 K.S. 12 F MFC 1 yr.
34 G .K . 25 M MFC 6 yrs.
35 R.G. 20 F MFC 1 yr. Pain
36 R.B. 19 M MFC 1 yr. Irregularity
37 D.D. 18 F MFC 6 mos. Asymptomatic Normal
38 L.A. 16 M MFC 5 mos. Irregularity
39 D.C. 18 M MFC 1 vr. Normal
40 E.R. 14 M MFC 2 vrs.
41 M.D. 14 M MFC 2 yrs. Pain Irregularity
Average 17.5 7 M 11 MFC Average 2 yrs. 8 asymptomatic 8 normal 
4 F
*MFC = medial femoral condyle.
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Fig. 2a Fig. 2b
Fig. 2.—Excision, Case 37. A 16-year-old youth had a one-year history of pain and occasional 
swelling. The osteochondral fragment was excised, (a) Anteroposterior view before operation shows 
the lesion on the medial femoral condyle; (b) anteroposterior view five years after operation.
Extraction (14 Patients)
These patients were treated by removing 
the osteochondral fragment as it lies loose 
in the joint cavity. Nine were males and 
five females (Table III). They were be­
tween 9 and 30 years of age. The medial 
femoral condyle was involved in 12, the
lateral condyle in two. At follow-up, two 
months to five years later, 11 patients had 
no symptoms and had clinically normal 
knees. Three knees produced symptoms; 
two gave pain occasionally during vigorous 
activity or long standing (Cases 42 and 
51). The knees appeared normal clinically. 
The third patient had occasional pain and
TABLE III.—E xtraction. R esults in 14 Patients
No. Name
Age
(years) Sex Location* Follow-up Clinical result Radiograph
2 J.F. 9 F MFC 14 mos. Asymptomatic Some flattening
42 G.M. 14 M M FC 3 yrs. Occasional discomfort Slight roughening
43 P.S. 14 F MFC 2 vrs. Asymptomatic Normal
44 R.M. 15 F LFC 2 vrs. ( t l l
45 L.A. 30 M MFC 5 yrs. ( l Some flattening
40 R.H. 20 M MFC 4 yrs. (( Normal
47 G.L. 25 M MFC 8 mos. i t
48 M.C. 17 F MFC 1 yr. Crepitus and “
occasional pain
49 D.B. 17 M MFC 3 yrs. Asymptomatic l l
50 J.A. 23 M M FC 2 mos. a
51 R.O. 19 M MFC 5 vrs. Occasional pain “
52 S.Q. 18 M MFC 2 vrs. Asymptomatic i t
53 G.S. 23 M LFC 1 vr. l l l l
54 R.P. 29 F MFC 5 yrs. 11 Early osteoarthritis
Average 19.5 9 M 12 MFC Average 2.4 vrs. 11 asvmptomatic 10 normal
5 F 2 LFC
*MFC = medial femoral condyle; LFC = lateral femoral condyle.
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Fig. 3a Fig. 3b
Fig. 3c
some limitation of activity; on examina­
tion, the knee had palpable crepitus and 
slight effusion (Case 48). In two patients 
with no symptoms, the knee showed some 
flattening of the medial femoral condyle; 
a third asymptomatic knee had a slight 
irregularity at the site of the lesion (Cases 
2, 45 and 54). The knee of Case 45, 
asymptomatic at five-year follow-up, is 
shown in Fig. 3.
Fixation (8 Patients)
In this procedure the osteochondral frag­
ment is fixed to its bed using small bone 
pegs.8 If the osteochondral fragment lies 
in its bed, the fragment is drilled with a 
7 /64-inch drill bit and the fragment fixed 
to the subchondral bone with the small 
bone pegs (usually two per fragment). If 
the fragment is loose and can be fitted into
Fig. 3.—Extraction, Case 45. A 30-year-old man 
had a six-month history of a loose fragment, 
which was later extracted; (a) anteroposterior view 
before operation, (b) lateral view before opera­
tion and (c) anteroposterior view five years after 
operation. Note the irregularity of the medial 
femoral condyle.
T
N
\
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Fig. 4a Fig. 4b
Fig. 4c Fig. 4d
Fig. 4.—Fixation, Case 60. This 20-year-old man had a three-month history of pain. The 
fragment was fixed in situ with autogenous bone pegs; (a) tunnel view before operation, (b) tunnel 
view three years after operation, (c) lateral view before operation, and (d) lateral view three years 
after operation.
its bed without producing a prominence, 
bone pegs are inserted; if not, the frag­
ment is extracted. The pegs, cortical bone 
of matchstick thickness about 2 cm. long, 
are obtained from the subcutaneous border 
of the medial aspect of the proximal tibial 
metaphyses; banked homologous bone can 
also be used. Eight patients had this pro­
cedure (Table IV). These patients—five 
men and three women—had an average age 
of 20 years (range 17 to 23). In all, the 
medial femoral condyle was involved. In 
two, the fragment was loose and was re­
duced and fixed with the bone peg; in the 
other six, the fragment was pegged in situ. 
After a follow-up of from eight months to 
three years, all patients were asymptomatic 
and radiographs were normal. The radio­
graphs of a typical knee are shown in 
Fig. 4.
Associated L esions
In these 61 patients (80 joints), 33 joints 
had an arthrotomy. Associated lesions con­
sisted of six torn medial menisci, one torn 
lateral meniscus, and five subluxating
214 THE CANADIAN JOURNAL OF SURGERY Vol. 14
TABLE IV.— F ix a t io n . R esults  in  E ig h t  P a tie n ts
No. Name
Age
(years) Sex Location* Follow-up Clinical result Radiograph
14 F.K. 18 U MFC 3 yrs. Asymptomatic N ormal
55 R.G. 22 M MFC 8 mos. U a
56 R.C. 19 F MFC 2 yrs. “ u
57 R.K. 20 M MFC 3 vrs. i t it
58 T.Il. 21 F MFC 1 yr. a “
59 R.S. 23 M MFC 2 yrs. a ti
60 L.D. 20 F MFC 3 yrs. n i t
61 E.C. 17 M MFC 1 yr. 1 i t
Average 20 5 M 8 MFC Average 1.9 yrs. 8 asymptomatic 8 normal
3 F
patellas with early chondromalacia of the 
patella. The osteochondral lesions probably 
represent the result of ligamentous insta­
bility which increases the normal torsional 
forces on the knee. Probably more of these 
patients (than the five noted) had sub­
luxating patellas because it was not looked 
for in all. As noted above, we did not 
demonstrate anomalous centres in any of 
these patients.
D iscussion
Osteochondritis dissecans in the adoles­
cent is managed differently from that in 
the adult. If this lesion arises in an 
anomalous centre of ossification in the 
femoral epiphyseal centre, its natural 
history, usually one of spontaneous healing, 
becomes easier to understand. A long-leg 
cylinder, recommended by Green and
Fig. 5.—Arthrogram of a knee with osteochon­
dritis dissecans of the medial femoral condyle. The 
contrast medium has penetrated between the 
osteochondral fragment and its base. This lesion 
would probably not heal spontaneously.
Banks,9 will protect the knee from torsional 
stress. In most of our patients (28 of 30 
patients or 45 of 47 knees), the lesion 
healed with complete recovery. Occa­
sionally healing is delayed, probably be­
cause the anomalous centre separates com­
pletely from its subchondral bed before 
treatment begins.
Recently we have begun to assess pa­
tients with osteochondritis dissecans by 
arthrography, a technique described by 
Almgard and Wikstad in 1964.10 Fig. 5 
shows that the contrast medium penetrates 
between the osteochondral fragment and 
its bed, suggesting that this lesion would 
not heal spontaneously. The arthrogram 
may be valuable in predicting prognosis 
before one chooses conservative therapy. 
As long as the fragment remains in its bed, 
however, and the distal femoral epiphyseal 
line has not closed, conservative therapy is 
usually successful.
When the femoral epiphyseal line has 
closed, spontaneous healing is much less 
likely. The lesion is less common at this 
age, but, from our results, we believe that 
drilling and pegging the fragment (fixa­
tion) is justified. This procedure, unlike 
insertion of the Smillie nail, does not re­
quire subsequent arthrotomy for removal.® 
So far such pegging has been successful 
in all eight patients in this group although 
our follow-up is short. The alternative, ex­
cision, has in our series been associated 
with subsequent degenerative changes in 
three of 11 patients (two symptomatic).
The management of the loose fragment 
is less clear. Usually, the fragment changes 
its shape considerably after breaking off 
from the articular surface. The cartilage 
component, which is nourished by synovial 
fluid, increases in size and when replaced
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in its bed creates a prominence. In these 
patients, the fragment should probably be extracted. Drilling the defect on the 
femoral articular surface is reported to help by accelerating replacement of the defect 
by fibrocartilage.11 Degenerative osteo­
arthritis commonly follows this form of 
treatment. Occasionally, however, if the 
fragment is trimmed, it can be replaced in 
its bed and the articular contour restored. 
We have not done such trimming and re­
placement often enough to draw any 
definitive conclusions.
Su m m a r y
In the knee, an anomalous centre of 
ossification may predispose to osteochond­
ritis dissecans. In the adolescent, this lesion 
seems to heal spontaneously.
The forces in the normal knee, especially 
when intensified by a ligamentous laxity, 
may induce horizontal cleavage, dissection 
of an osteochondral fragment, avascular 
necrosis, and subsequent loose-body forma­
tion. In this process, torsional impaction is 
probably the primary force.
An arthrogram often detects patients 
with osteochondritis dissecans in whom 
there is horizontal cleavage of the articular 
cartilage.
Before the distal femoral epiphysis has 
closed and especially before horizontal 
cleavage appears, immobilization in a long- 
leg cylinder induces healing.
Where possible the osteochondral frag­
ment should be fixed with bone pegs rather 
than by metallic fixation; this treatment is 
better than either excision or extraction.
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R e su m e
Dans le genou, un centre anormal d’ossification peut predisposer a l’osteochondrite dissequante. Chez l’adolescent, cette lesion semble evoluer vers la guerison spontanee.Les forces mecaniques qui agissent sur le genou normal, surtout quand elles sont intensifiees par une certaine laxite des ligaments, peuvent pro- voquer un clivage horizontal, la dissection d’un fragment d’osteo-cartilage, une necrose avasculaire et subsequemment la formation d’un corps etran- ger. Dans ce processus, l’impact de torsion est probablement la force primaire en cause.Un arthogramme permet souvent de decouvrir des malades souffrant d’osteochondrite dissequan­te, chez lesquels existe un clivage horizontal du cartilage articulaire.Avant la fermeture de l’epiphyse femorale dis­tale et surtout avant l’apparition du clivage hori­zontal, Timmobilisation dans un cylindre de la longueur de la jambe favorise la guerison.Quand la chose est possible, on devra fixer le fragment osteocartilagineux par des chevilles osseuses plutot que par des protheses metalliques. Ce traitement est preferable a l’excision ou a l’ex- traction.
CHANGE OF ADDRESS
Subscribers should notify The Canadian Journal of Surgery of their change of 
address two months before the date on which it becomes effective, in order that 
they may receive the Journal without interruption. (Write to: Subscription Depart­
ment, The Canadian Journal of Surgery, C.M.A. House, 1867 Alta Vista Drive, 
Ottawa 8, Ontario.)
216 THE CANADIAN JOURNAL OF SURGERY Vol. 14
DIVERTICULITIS OF THE VERMIFORM APPENDIX
D. A. AUBREY, M.B., M.S., F.R.C.S.,0 Cardiff, Wales
T his report describes a patien t w ith ap­
pendicular diverticulitis and briefly reviews 
the relevant literature.
C ase Report
A previously healthy 22-year-old man com­plained of pain of 18 hours’ duration in the 
right iliac fossa. He had no other symptoms. Since there was tenderness and local muscular rigidity in that area, emergency appendec­
tomy was done and an acutely inflamed ap­pendix removed. Postoperative recovery was uneventful.
In its distal one-half, the musculature of the appendicular wall was thickened and, extend­
ing through its whole thickness, there was a narrow “false” diverticulum (Fig. 1). The lat­ter was lined by granulation tissue and there 
was an acute inflammatory reaction in the surrounding muscularis and serosa, although elsewhere the appendix was normal. The 
pathological diagnosis was acute appendicular diverticulitis.
D iscussion
The incidence of appendiceal diverticula 
is about 0.5%1-4 (0.08%5 to 2.8%«), the 
condition being commonest in the fourth 
decade.5 A solitary diverticulum is com­
moner than multiple ones4 and the mesen­
teric aspect of the distal part of the ap­
pendix is most frequently affected.5' 7 The 
uncomplicated condition is sometimes 
recognized radiologically,7*9 but this in­
vestigation often fails to demonstrate it 
when the appendix is obstructed at its cecal 
end.1, 3 Most patients present either with 
acute appendicitis,3, 7 or with a mass in the 
right iliac fossa;1,7 usually they have ex­
perienced vague symptoms for many 
years.3 ,10
Although “true” and “false” diverticula 
may be distinguished histologically,1,3' 7 
this distinction is rarely possible at opera-
*Senior Surgical Registrar, The University De­partment of Surgery, United Cardiff Hospitals and Welsh National School of Medicine, Cardiff, Wales.
Present address: Department of Surgery, Edward T. Meyer Memorial Hospital, 462 Grider Street, Buffalo, N.Y. 14215, U.S.A.
Fig. 1.—Section of the vermiform appendix showing the collapsed false diverticulum pene­trating through the hypertrophied muscle coats (original magnification X 10).
tion.5 The condition predisposes to acute 
appendicitis with early perforation2,5— 
which is not surprising because most 
diverticula are merely mucosal herniations 
—and the advanced inflammatory changes 
often make even simple identification of 
the diverticulum difficult or impossible.5 
Thus, the appendix may simply disappear 
into an inflammatory mass,7 or be sur­
rounded by a granuloma after diverticular 
perforation into the mesoappendix.2 These 
“hidden” diverticula can simulate carci­
noma, and right hemicolectomy has been 
done unnecessarily for the condition.7 
Clearly this should be avoided if possible. 
If, therefore, at operation, there is a mass 
of dubious etiology in the right iliac fossa, 
and an infective lesion such as a hidden 
appendiceal diverticulum is a possibility, 
the surgeon may simply drain the area, 
administer antibiotics and re-explore after 
a short interval, when the condition might 
be more obviously benign and append­
ectomy safely performed.
Because appendicular diverticula pre­
dispose to perforative appendicitis,2, 5 ap­
pendectomy should be advised if the un­
complicated condition is found incidentally, 
i.e. radiologically. Furthermore, because 
chronic and “healed” perforative appendi­
citis are potent factors in the pathogenesis
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of the condition,1- 0111-13 appendectomy 
should be performed expeditiously in these 6 
conditions, so as to forestall diverticular 
formation.
7.
Su m m a r y
Because “hidden” appendicular diver- 8. 
ticulitis can mimic carcinoma, it is im­
portant to be aware of this uncommon 
condition. If the lesion is suspected as the 
cause of a mass in the right iliac fossa, a 
conservative surgical approach seems pref­
erable to emergency right hemicolectomy. 
Appendectomy is indicated for the un­
complicated condition to prevent acute 
perforative appendicitis. Diverticulum 
formation may follow chronic and “healed” 
appendicitis, hence prompt appendectomy 
is advisable in these conditions.
The author wishes to thank Mr. H. G. Roberts, 
Consultant Surgeon, St. Woolos Hospital, for per­
mission to publish the case; Dr. G. S. Andrews, 
Consultant Pathologist, Royal Gwent Hospital, 
for advice on pathology; and Mr. Nigel Pearce 
for the photographs.
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R e s u m e
Dans 1’examen histologique de l’appendice chez 
un jeune homme de 22 ans une diverticulite ap- 
pendiculaire a ete diagnostique. La litterature 
relative a cette pathologie peu frequente indique 
qu’une diverticulite appendiculaire “latente” peut 
creer une masse dans la fosse iliaque droite et 
simuler une tumeur neoplastique. Si le chirurgien 
soup^onne cette pathologie, il devra envisager un 
traitement chirurgicale conservateur plutot que de 
recourir d’emblee a une hemicolectomie droite 
d’urgence. Pour prevenir une appendicite perforee, 
l’appendicectomie est indiquee dans les cas sans 
complication. Comme la formation du diverticule 
peut etre la consequence d’une appendicite chroni- 
que “refroidie”, l’appendicectomie d’urgence est 
alors indiquee.
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HYDROLYSIS OF STILBESTROL DIPHOSPHATE BY THE ACID 
PHOSPHATASE OF THE BLADDER MUCOSA0
C. PROMISLOW, M.Sc. and J. G. CONNOLLY, M.D., F.R.C.S.[Eng. & C], F.A.C.S.,
Kingston, Ont.
I n addition to the acid phosphatase found 
in the prostate gland, the bladder mucosa 
also contains measurable amounts of this 
enzyme, the function of which has not been 
determined. Some bladder carcinogens are 
detoxified in the liver by conjugation to 
the phosphate or glucuronide, and ex­
creted into the enterohepatic circulation 
and urine. Since urinary stasis is found in 
some patients with bladder carcinoma, it 
is of interest to determine if hydrolysis 
(deconjugation) occurs in vivo. During a 
recent investigation, we noted that after 
an intravenous injection of stilbestrol di­
phosphate, some hydrolysis of this com­
pound occurred in the bladder wall. We 
therefore elected to study the fate of a 
solution containing tritiated stilbestrol di­
phosphate instilled into the isolated urinary 
bladder of rabbits.
Because stilbestrol is ether soluble and 
stilbestrol diphosphate is water soluble, its 
radioactivity, and therefore the extent of 
its hydrolysis, can be determined in each 
fraction. In this experiment hydrolysis was 
measured in the instilled solution, in homo­
genates of the bladder wall, and in the 
venous blood from the bladder.
\
M a te r ia l  and  Methods
Twenty adult male rabbits, weighing an 
average of 4 kg., were anesthetized with 
intravenous pentobarbital ( Nembutal) sup­
plemented by open ether. The bladder was 
exposed through a midline abdominal in­
cision, and the lower ureters were isolated 
and ligated at their entrance into the 
bladder. The bladder was catheterized, 
emptied by manual expression; and washed 
three times with 10 ml. of acetate buffer 
(pH 5.0 at 38° C .). The test solution, con­
taining approximately 0.057 mg. of tritium-
*From the Department of Urology, Queen’s Uni­
versity, Kingston, Ont.
Supported by Ontario Cancer Treatment and Re­
search Foundation Grant 154.
labelled diethylstilbestrol diphosphate sod­
ium (4 /re. in 20 ml. acetate buffer), was 
instilled through a No. 20 needle inserted 
into the mid-point of the urethra and 
guided into the bladder. The urethra was 
then ligated above the point of injection, 
the bladder was tested for leakage, re­
turned to the peritoneal cavity and the skin 
incision closed. The urethra was ligated at 
the bladder neck. The anatomy of the 
rabbit differs from that of the human or 
dog, and we are certain that no prostatic 
secretions entered the bladder during the 
experiment. While acid phosphatase can 
be demonstrated in the bladder mucosa, 
the whole purpose of this study was to 
demonstrate that the acid phosphatase in 
the bladder mucosa could hydrolyze a 
suitable substrate.
To determine the rate of absorption of 
the instilled solution, four rabbits were 
sacrificed at 15 and 30 minutes, and at 
one, two and four hours. Immediately be­
fore death, we obtained a sample of blood 
from the vesical veins by ligating all the 
tributaries of the iliac vein, except those 
draining the bladder, and aspirating blood 
from the iliac vein. Simultaneously a 
sample of blood was obtained by cardiac 
puncture. The rabbit was killed by air 
embolism, the bladder excised and the 
volume of the recovered solution measured 
—invariably this was ±  0.5 ml. of the 
instilled volume. The bladder was then 
washed five times with 5-ml. portions of 
acetate buffer and prepared for analysis. 
Representative samples from the recovered 
solution, including bladder washing, blad­
der wall and serum, were prepared for 
liquid scintillation counting.
We used two methods to prepare the 
tissues for counting: (1 ) the hyamine-
hydroxide toluene method measures the 
total radioactivity (water-soluble plus 
ether-soluble components), and (2) the 
ether extraction-toluene phosphor method 
measures the ether-soluble radioactive 
components ( diethylstilbestrol) 4
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We used established techniques1 to 
measure the activity in the various solu­
tions. However, in measuring the ether- 
soluble components in the recovered 
bladder solutions, we made one modifica­
tion: the solutions were immediately added 
to 5 ml. of cold ether (5° C .) in centrifuge 
tubes, shaken to inhibit further enzyme 
action and centrifuged. Further ether ex­
traction continued as described elsewhere.1
The rate of absorption from the bladder 
was determined by measuring the radio­
activity that remained in the bladder solu­
tion. These measurements were made at 
intervals which allowed for partial dis­
appearance (e.g. 20% to 70%) of the 
radioactive material. The results were ex­
pressed as a percentage of the total in­
stilled compound that had been absorbed 
in that time.
R e s u l t s
After instilling 4 /ic. of :!H stilbestrol di­
phosphate in 20 ml. of acetate buffer into 
the isolated rabbit bladder, there is a 
rapid loss of radioactivity with time (Fig. 
1), which is not accounted for by loss of 
volume because ±  0.5 ml. of the initial 
solution was recovered. At 30 minutes, only 
70% of the initial radioactivity can be re­
covered from the bladder solution (Fig. 
1). At this time, extensive hydrolysis of the 
stilbestrol diphosphate had occurred, be­
cause 45% of the initial radioactivity was 
now ether soluble, leaving 25% in the 
water-soluble phase (stilbestrol diphos­
phate). Absorption accounted for the re­
maining 30% of the radioactivity.
During the first two hours, loss of radio­
activity proceeds rapidly because at the 
end of this time only 30% of the initial 
activity remained in the bladder solution. 
After two hours, absorption (loss of radio­
activity) markedly decreases, and between 
two and four hours only an additional 10% 
is absorbed.
When the log. of total radioactivity (3H 
stilbestrol diphosphate plus 3H stilbestrol) 
remaining in the bladder solution over the 
first two hours is plotted against time, a 
straight line is obtained. During the period 
of maximal stilbestrol transfer, the absorp­
tion of the compound follows first-order 
kinetics ( the absorption of a compound per
TIME (HRS.)
AVERAGE STANDARD DEVIATION OF TH E  MEAN V  (X )* 2 .3 5  (n = 4 , df»30>
Fig. 1.—Percentage of instilled radioactivity re­
covered from the bladder solution over a four- 
hour period.
unit of time is directly proportional to its 
concentration) ,2
To confirm that the radioactivity in the 
ether-soluble fraction was free stilbestrol, 
the recovered solutions were tested by the 
Dryer method3 of colourimetric chemical 
analysis—a method applicable only to 
samples that contain large quantities of 
stilbestrol (0.125 to 0.005 mg.). Aliquots 
of bladder solution taken at 15 and 30 
minutes, and one and two hours, contained 
.024, .020, .012 and .005 mg. of stilbestrol 
respectively. Bladder-wall and blood 
samples contained quantities too small for 
analysis. W e found that the samples of 
bladder wall that had been exposed to the 
radioactive solution for the shortest periods 
(15 and 30 minutes) contained the great­
est quantity of radioactivity (Fig. 2 ). In
AVERAGE STANDARD DEVIATION OF TH E  MEAN ? l 7 l = 0 . 6  ( n < 4 . d f > 3 0 )
Fig. 2.—Percentage of instilled radioactivity 
recovered from the bladder wall over a four- 
hour period.
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addition, all the radioactivity in the 
bladder-wall samples taken at that time 
was ether soluble ( stilbestrol). The re­
covered activity at this peak period was 
5% to 6% of that initially instilled. The 
ether-soluble fraction in the bladder wall 
dropped sharply during the first hour, and 
a more gradual decrease occurred until, 
at four hours, only 0.4% of the activity 
initially instilled was recovered from the 
bladder. After reaching a peak at 15 
minutes, both the water-soluble and ether- 
soluble radioactivity dropped with time. 
Therefore apparently no stilbestrol diphos­
phate or stilbestrol was deposited intra- 
murally.
To determine the absorption of stil­
bestrol or stilbestrol diphosphate, we sub­
tracted the amount of radioactivity in the 
cardiac samples from that in the vesical 
serum. The maximal radioactivity in the 
vesical veins occurred 30 minutes after the 
experiment began (Fig. 3 ). Most of the
TIME (HRS.)
Fig. 3.—Radioactivity in venous-arterial serum 
after instillation of 3H stilbestrol diphosphate in 
rabbit bladder.
activity leaving the bladder was found in 
the ether-soluble fraction, which suggests 
that the lipid-soluble 3H stilbestrol is pref­
erentially absorbed, or, less likely, that it 
is converted outside the bladder.
The product of the integrated area under 
the curve (Fig. 3) is the overall difference 
of radioactivity in the venous and arterial 
systems. By calculating this area and 
multiplying it by the approximate flow 
rate (13 ml./min.) in the cannulated in­
ternal iliac vein, we determined that the
total amount of radioactivity absorbed 
into the vesical veins was 1.10 x 10fi cpm 
(counts per minute) over the four-hour 
period. Initially 1.65 x 1 O'1 cpm was in­
stilled into the bladder as 3H stilbestrol di­
phosphate. Therefore 67% of the radio­
activity was transported from the bladder 
by the vesical veins. At four hours only 
20% of the radioactivity remained in the 
bladder solution (Fig. 1) and 1.6% in the 
bladder tissue (Fig. 2). Thus we could 
account for 89% of the initial instilled 
radioactivity. The results obtained were 
consistently reproducible. The spread of 
data as measured by the average standard 
deviation of the mean (Figs. 1 and 2) was 
low compared with the trends established.
Fig. 4.—Hydrolysis of 3H stilbestrol diphosphate 
by the enzyme in the acetate buffer which had 
been instilled into the isolated bladder for one 
hour.
To determine if the acid phosphatase 
hydrolyzed the stilbestrol diphosphate in 
the bladder mucosa or in the instilled 
solution, 20 ml. of the acetate buffer was 
instilled into the isolated rabbit bladder. 
At the end of one hour the solution 
was removed and placed in a beaker 
in a water bath at 37° C. To this was 
added 4 /re. of 3FI stilbestrol diphos­
phate in 0.1 ml. of acetate buffer. Samples 
of this solution were taken at various 
times to determine the extent of 3H stil­
bestrol diphosphate hydrolysis. The total 
concentration of radioactivity (water- plus 
ether-soluble components) remained con­
stant, but the composition of the solution 
changed. The stilbestrol diphosphate was 
rapidly hydrolyzed (Fig. 4), indicating 
that large quantities of the enzyme mi­
grated or were leached out into the 
buffered solution. Hydrolysis was mark­
edly inhibited after one hour.
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D iscussion
Our results show that tritiated stilbestrol diphosphate instilled into the isolated rabbit bladder was rapidly hydrolyzed to 
free stilbestrol, which was then absorbed. The rate of absorption was rapid but of 
short duration. In the first half-hour the 
ether-soluble radioactivity (free stilbestrol) in the bladder solution, bladder wall, and 
venous blood reached a maximum (Figs. 1-3). At the end of one hour, only 54% 
of the radioactivity that had been instilled 
into the bladder could be recovered (Fig. 
1). It appeared that a barrier must be 
overcome before absorption occurs, and 
that a similar barrier operates once the 
concentration of the compound falls below a certain level.
If the concentration of 41 stilbestrol in 
the bladder solution were kept constant, 
the absorption from the bladder would 
probably remain constant. However, in 
this experiment the radioactivity in the bladder solution decreased with time. The 
rate at which :iH stilbestrol diphosphate 
was converted to ;iH stilbestrol by enzyme 
hydrolysis probably also decreased with time. In an in vivo experiment (Fig. 4) we 
showed that such a decrease occurred and 
is probably caused by some inhibitory mechanism.
During the period of maximal absorp­
tion (15 to 30 minutes) most of the 
activity in the bladder tissue and the 
venous blood was ether soluble (Figs. 2 
and 3). There appeared to be no deposi­
tion of 3H stilbestrol in the bladder wall 
because the radioactivity decreased with 
time. Only 0.4% of the instilled activity 
was found in the bladder wall at four 
hours as free 3H stilbestrol.
Since the lipid-soluble metabolite was 
preferentially absorbed, the enzyme, acid 
phosphatase, played a vital but indirect role in absorption of stilbestrol. However, 
the pH and temperature must be con­
trolled before enzyme activity can begin. In three instances where the bladder con­
taining the instilled solution was allowed to cool for two hours, there was negligible 
hydrolysis. The pH of the solution, in addi­
tion to affecting enzyme activity, also 
affects the permeability of the bladder wall
to certain ions.2-4 The optimal pH for 
enzyme activity in man does not neces­sarily coincide with the pH necessary for 
maximal absorption of the product of the 
enzyme action. The lipid solubility of the 
product is an important factor in absorp­tion. Numerous reports on the mechanism 
of drug absorption and secretion across cell 
membranes indicate that the capacity of 
chemicals to traverse the membranes is to 
a great degree a function of their lipid 
solubility. Thus products of enzyme action 
that are soluble in lipids at the correct pH are absorbed.
Summary
Experiments were designed to determine the extent of hydrolysis of 41 stilbestrol 
diphosphate instilled into the isolated rabbit bladder.
Animals were sacrificed at 15 and 30 
minutes, one, two and four hours after 
instillation of the solution (4 /xc. in 20 ml. 
of acetate buffer). The radioactivity in 
recovered solutions, bladder tissue and 
serum samples was counted using liquid 
scintillation techniques. At 30 minutes, only 
70% of the initial radioactivity can be re­
covered from the bladder and 45% hydro­
lysis had occurred. This loss of radio­
activity which represented absorption 
(since there was no loss in volume) con­
tinued rapidly for the first two hours. The 
radioactivity in the bladder wall, and the 
venous blood draining the bladder, reached 
a peak within the first 30 minutes, and 
was all in the hydrolyzed form (free stil­
bestrol). We found that approximately 
67% of the radioactivity initially instilled 
was transported from the bladder by the 
vesical veins. At four hours, only 20% of 
the radioactivity remained in the bladder solution, and 1.6% in the bladder tissue.
a u v r  jia u ^jn u i i s
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2. Bo r zellec a  JF, L o w e n t h a l  W: Kineticanalysis of drug movement from isolated urinary bladder of rabbit. Arch Int Pharmacodyn 166: 26, 19673. D ry er  RL: Chemical assay of diethylstil-bestrol. Clin Chem 2: 25, 19564. B oyland  E: Biochemistry of Bladder CancerSpringfield, 111, Thomas, 1963, p 44
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R esu m e
Etant donne que des malades atteints de cancer 
vesical souffrent de stase urinaire, nous avons 
decide d’etablir le point de savoir si le diphos­
phate de stilboestrol marque au tritium est de- 
conjugue in vivo. Nous avons done instille ce 
compose dans la vessie isolee de lapin, a raison 
de 4 Me de 8H diphosphate de stilboestrol dans 
20 ml d’un tampon a l acetate. Nous avons alors 
mesure la radio-activite dans les solutions re- 
cuperees, dans le tissue vesical et dans des 
echantillons de serum, utilisant a cette fin la 
technique de scintillation en milieu liquide. Nous
avons constate que 30 minutes apres instillation 
du compose marque, on ne recuperait que 70% 
de la radio-activite initiale dans les solutions 
instillees et que l’hydrolyse s’etait produite a 
concurrence de 45%. Dans la paroi de la vessie 
et la veine vesicale, la radio-activite atteignait un 
sommet a 30 minutes, periode a laquelle le 
produit etait completement hydrolyse.
Nous concluons que le diphosphate de stil­
boestrol marque au tritium subit l’hydrolyse ou la 
dephosphorylation sous Faction de la phosphatase 
acide de la vessie et que la muqueuse absorbe 
de preference le stilboestrol liposoluble libre.
CARCINOMA OF URETER
Ureteral carcinoma accounts for 1% of all 
carcinoma of the upper urinary tract. The 
prognosis of carcinoma of the ureter has been 
evaluated generally as poor, possibly because 
of the thinness of the ureteral wall and its rich 
lymphatic drainage system, which allows local 
invasion and metastatic spread to occur at a 
relatively early stage. The difficulty in diag­
nosis and the consequently advanced stage 
of the disease at the time of treatment could 
also be implicated in the poor prognosis. The 
authors’ study was undertaken to correlate the 
clinical, radiologic, and pathologic findings in 
100 new cases of carcinoma of the ureter in 
an attempt to evaluate the factors which might 
provide an earlier diagnosis.
Patients were gathered from 13 different 
hospitals. All pertinent data were transferred 
to a prepared questionnaire and coded having 
all the tumours graded by pathologists. All 
instances of ureteral tumours associated with 
carcinoma of the kidney, the ureteral stump 
after nephrectomy, or of primary carcinoma of 
the bladder extending into the ureter were 
excluded. It was found that ureteral tumours 
occur three times more frequently in male 
than in female patients. The clinical findings 
in 102 patients were gross hematuria in 76%, 
frequency and dysuria 52%, colic in 50%, and 
other symptoms with lesser frequency. It is 
also of interest to note that albuminuria was 
found in 45% and anemia was present in 13% 
of the patients; pyuria was seen in 23%. Uro­
grams were intravenously administered and 
63% of the patients in whom the kidney did 
not visualize were associated with invasive 
tumour, while only 37% were non-invasive. 
The more anaplastic tumours had a greater 
percentile of decreased visualization. Retro­
grade pyelograms demonstrated the tumour in 
80% of the patients. The ureteral catheter 
could not be passed by the tumour in approxi­
mately 50% of the patients.
In most carcinomas, there appears to be a 
close correlation between the degree of cellu­
lar anaplasia and the invasion of the tumour. 
The survival rates of patients with total 
nephroureterectomy with or without radiation, 
simple nephrectomy, and partial ureterectomy, 
or some form of kidney-conserving procedure 
are discussed. Overall, the five-year survival 
rate for 54 patients operated upon before 
1963 was 42.6%.
In their discussion, the authors indicate that 
carcinoma of the ureter does not tend to be 
more malignant than a tumour of the bladder 
urothelium, and that its prognosis, in general, 
is not as poor as has been suggested previ­
ously. They also found that complete nephro­
ureterectomy with excision of a periureteral 
cuff of the bladder is the most widely prac­
tised treatment for primary tumours of the 
ureter. The authors state that the method of 
surgical treatment is of secondary importance 
in influencing the ultimate outcome of this dis­
ease. They emphasize that the 15% of re­
current tumours in the bladder indicates the 
need for careful follow-up examinations even 
in patients who have undergone a radical 
operation.
This is an interesting article with much of 
significance to those who would treat patients 
with ureteral tumours. The importance of the 
anaplasia of the carcinoma and the degree of 
invasion is stressed. The importance of follow­
up examinations cannot be overstressed.— 
Bloom NA, Vindone RA, Lytton B: Primary 
carcinoma of ureter; report of 102 new cases. 
]  Urol 103: 590, 1970
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BENIGN CYSTADENOMA O F TH E PANCREAS: A CASE REPO RT"
I. SANDERSON, M.B., B.S., G. Y. HIRAKI, M.D., F.R.C.S.fC] and 
M. I. DAVIS, M.D., F.R.C.S.fC], Toronto, Ont.
Benign cystadenoma of the pancreas is 
rare, making up from 2%  to 10% o f all 
pancreatic cystic lesions. At the Charity 
Hospital, New Orleans, only seven such 
tumours were seen among 2,182,427 ad­
missions over a 27-year period.1 At the 
Presbyterian Hospital, New York, three 
multilocular and seven papillary cyst- 
adenomas were found in 23,551 surgical 
specimens.
Benign cystadenoma, an encapsulated 
cystic epithelial neoplasm usually derived 
from duct epithelium, is of two types: 
papillary and multilocular. The latter is 
less common than the former.2 It can 
affect any part of the pancreas but more 
commonly the tail and/or the body than 
the head.
The tumour occurs more often in women 
(9 :1  in some series) and in the fifth and 
sixth decades. Symptoms are non-specific 
or may be absent; when present, they are 
usually the result of pressure of the slowly 
enlarging tumour on contiguous structures. 
The usual presenting symptoms are a mass, 
dyspepsia, abdominal pain and weight loss. 
The patients may have associated biliary 
tract disease (1 2 % ), diabetes mellitus 
(8 %  to 13% ) and, less commonly, obesity, 
sterility, hypertension and thyroid dys­
function. Jaundice is an uncommon pre­
senting symptom.3
This paper will describe a woman with 
benign cystadenoma of the head of the 
pancreas who had interesting and unusual 
symptoms and who was treated success­
fully by pancreaticoduodenectomy.
Case R eport
Mrs. R.C., a 60-year-old white woman, was 
first seen in the Women’s College Hospital, 
Toronto, on March 31, 1969, with a seven- 
week history of general ill-health, anorexia, 
nausea and vomiting, abdominal cramps and
"From the Department of Surgery, Women’s Col­
lege Hospital, Toronto, Ont.
Reprint address: Dr. G. Y. Hiraki, Department of 
Surgery, Women’s College Hospital, Toronto, Ont.
some diarrhea. Two and one-half weeks before 
admission she noticed generalized itching and 
that her urine was becoming darker and her 
stools lighter. She became frankly jaundiced 
four days before admission.
On physical examination, her liver was 
palpable 3 cm. below the right costal margin, 
and a globular mass was felt at the lower 
margin of the liver. She was afebrile and 
neither the liver nor the mass was tender. A 
preliminary diagnosis of infectious hepatitis 
was made.
The laboratory findings were those of chol­
estatic jaundice: serum bilirubin 3.0 mg./lOO 
ml.—conjugated 2.0 mg./lOO ml. and free 1.0 
mg./lOO ml.—serum cholesterol 456 mg./lOO 
ml., alkaline phosphatase 8.8 Sigma units, 
isocitric dehydrogenase 11.0 units/ml., serum 
glutamic oxaloacetic transaminase 183 units/ 
ml., serum glutamic pyruvic transaminase over 
125 units/ml., total serum proteins 7.4 g./lOO 
ml. and electrophoresis showing slight eleva­
tion of the beta globulins. All other labora­
tory investigations including blood sugars and 
hematology were within normal limits.
With no specific treatment except bed rest 
and low-fat diet, the patient improved. A 
single-dose oral cholecystogram on April 16 
did not visualize either the gallbladder or 
biliary tree. The double-dose oral cholecysto­
gram performed the following day showed 
grossly impaired dye concentration insufficient 
for diagnostic purposes. Her serum bilirubin 
level at this time was 1.8 mg./lOO ml. total 
with 1.2 mg./lOO ml. conjugated and 0.6 
mg./lOO ml. free.
Tests for hepatobiliary function improved 
and her jaundice disappeared. She was dis­
charged from hospital on April 26 with a 
diagnosis of “infectious hepatitis of the chol­
estatic type, or cholelithiasis” . She had been 
taking Premarin (conjugated estrogenic sub­
stances) and Librium (chlordiazepoxide HC1) 
at the time of admission and was advised to 
discontinue them.
Weekly liver function tests were performed 
on an outpatient basis and continued to show 
gradual improvement. She remained some­
what tired. On June 9, a repeat double-dose 
oral cholecystogram outlined the gallbladder 
and showed adenomyomatosis of this organ. 
On June 19, an intravenous cholangiogram 
revealed obstruction of the lower end of the 
common bile duct. The common duct was
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Fig. 1.—Intravenous cholangiogram. The com­
mon bile duct, cystic duct and gallbladder are 
grossly dilated. Note the calcification at the site 
of obstruction.
grossly dilated and there was a small area of 
calcification at the site of obstruction. The 
appearance of the cut-off (Fig. 1) suggested 
the possibility of an infiltrating neoplasm at 
the lower end of the common bile duct.
W hen readmitted on July 8, she had felt 
quite well for two weeks and her stools and 
urine were both normal. On physical examina­
tion, her gallbladder was palpable and she 
had a questionably palpable common bile 
duct. Serum cholesterol was 373 mg./lOO ml. 
and alkaline phosphatase was 3.1 Sigma units. 
All other investigations were within normal 
limits. An upper gastrointestinal series re­
vealed no distortion of the stomach or duo­
denum by the pancreas, although there was 
some indentation of the first part of the duo­
denum superiorly, suggesting enlargement of 
the common bile duct. Our preoperative diag­
nosis was “stone in the common bile duct 
causing partial obstruction, or carcinoma of 
the pancreatic head”.
At laparotomy on July 11, the common 
bile duct was grossly dilated to approximately 
2 cm. diameter. The gallbladder, which was 
dilated and full, did not contain any stones. 
A hard mass, approximately 6 cm. in diameter, 
involved the head of the pancreas, and this 
mass was surrounded by numerous thin-walled
cysts measuring 1 to 1M cm. in diameter (Fig. 
2 ). There were several large soft lymph nodes 
in the surrounding area. The body and tail 
of the pancreas appeared normal and there 
was no evidence of metastases. The duodenum 
and head of the pancreas with the tumour 
were mobilized and the tumour was freed 
easily from the underlying superior mesen­
teric artery. The lesion, at this point thought 
to be malignant, was considered operable and 
pancreaticoduodenectomy was performed.
Fig. 2.—Posterior aspect of the resected speci­
men showing the cystic tumour within the head 
of the pancreas, and the dilated common bile duct 
entering the mass.
On microscopic examination, the tumour 
was a multiloculated cyst in which most of 
the spaces were lined by flattened cells, with 
a few still showing some columnar epithelium 
(Figs. 3 and 4 ) . There was old hemorrhage 
and organization with fibrosis in the walls of 
the cysts and collections of lymphocytes, hut 
no tumour showed at the resected margin of 
the pancreas. The lymph nodes were negative 
for metastases. The lesion was consistent with 
benign (multiloculated) cystadenoma of the 
pancreas, showing focal areas of degeneration.
After the operation she made a good re­
covery. On the fourteenth postoperative day
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Fig. 3.—Low-power view showing multiple 
cysts and some normal pancreatic tissue (bottom 
right) (H & E X 40).
her T-tube was removed, and she was dis­
charged from hospital two days later on a 
full diet. Before discharge, her fasting blood 
sugar was 88 mg./lOO ml. and a two-hour 
post cibum blood sugar was 134 mg./lOO ml., 
serum amylase 50 Somogyi units/100 ml., 
serum cholesterol 214 mg./lOO ml., alkaline 
phosphatase 4.1 Sigma units and serum 
glutamic pyruvic transaminase 25 units/ml.
She continues well and has no dietary 
problems.
D iscussion
Jaundice, and especially an episode of 
jaundice which subsequently subsides, is 
an uncommon presenting symptom in pa­
tients with cystadenoma of the pancreas. 
The tumour affects the head of the pan­
creas in about 35%  of patients, and in­
volves the head alone in about 18.5%; 
in spite of this, jaundice was seen in only 
three of 81 patients in one series.1 In
Fig. 4.—A higher-power view of the tumour. 
The flattened cells of the cyst tend towards 
columnar epithelium (H & E X 250).
another series3 only two of 30 patients 
had jaundice. Presumably, in our patient, 
the presenting symptoms and the jaundice 
were precipitated by inflammation and 
edema associated with hemorrhage into a 
cyst, or local pancreatitis due to local pres­
sure blocking off one of the smaller pan­
creatic ducts. The calcification seen on the 
radiograph in the region of the common 
duct obstruction and the histologic pic­
ture suggest that the patient had either 
local hemorrhage or pancreatitis. As the 
local edema and inflammation subsided, 
the obstruction was partially relieved. 
Clinically our patient never had a palpable 
pancreatic mass, but we felt the enlarged 
and dilated gallbladder and, probably, the 
common duct. She did not have diabetes 
mellitus and presumably this develops only 
when all the pancreas, or the entire tail 
and body, is involved. Our patient had no 
primary biliary tract disease and none of 
the other associated conditions described 
above.
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Routine radiographs would probably not 
show a tumour of this size. Angiographic 
studies might have shown some large vessel 
displacement, increased vascularity in the 
region of the tumour and areas of de­
creased vascularity suggestive of cyst 
formation.4 However, it seems unlikely 
that a definitive diagnosis could have been 
made by this means, especially in so small 
a tumour.
The operative management of these 
tumours depends upon their size, site and 
the degree of involvement of contiguous 
structures. If feasible, total excision is per­
formed; if not, marsupialization or simple 
biopsy, with or without some form of by­
pass procedure is done.
The surgeon should attempt total ex­
cision, firstly, because cystic change in the 
pancreas commonly conceals a carcinoma. 
Grossly, such cystic change may look 
benign, and biopsy specimens for frozen 
section may not include the malignant 
area. At the time of operation, therefore, 
it is a wise precaution to treat a suspected 
benign cystadenoma as a resectable carci­
noma.
Secondly, malignant pancreatic cyst- 
adenomas are thought to arise from pre­
existing benign cystadenoma, especially if 
the lining epithelium is of tall columnar 
cells resembling pancreatic duct epithelium 
or intestinal epithelium.2 Thus, anything 
less than total excision will leave behind 
potentially malignant tissue.
Finally, benign cystadenomas of the 
pancreas have reportedly reached con­
siderable size—25 cm. or so in diameter.3 
Unless the surgeon attempts total excision, 
relentless growth of the remaining tumour 
may eventually cause further symptoms 
due to pressure on adjacent structures.
In our patient, the size and position of 
the tumour made pancreaticoduodenectomy 
the procedure of choice. This rather radi­
cal procedure for a benign lesion is justi­
fied by the three reasons listed above. At 
operation we were mainly concerned that 
the cystic change was secondary to a 
carcinoma.
The operation was technically simple, 
the adjacent tissues were in good condi­
tion and the patient was not debilitated 
by her tumour. This appears to be in con­
trast with patients with a pancreatic carci­
noma in a similar site. Hence, one can 
anticipate a good postoperative course and 
a good overall result in patients with 
benign cystadenoma of the pancreas, 
especially if the tumour is small.
Summary
Benign cystadenoma, a rare tumour of 
the pancreas, gives rise to non-specific 
symptoms associated with pressure of the 
enlarging tumour on contiguous structures. 
Because most of these tumours affect the 
body and/or tail of the pancreas, jaundice 
is an uncommon presenting symptom.
The tumour should be totally excised for 
three reasons: (1) it is grossly indistin­
guishable from cystic change associated 
with a carcinoma, (2) it may be potentially 
malignant and (3) the tumour may grow 
to a considerable size and further impinge 
on adjacent structures.
A 60-year-old woman with a benign 
multiloculated cystadenoma of the head of 
the pancreas presented initially with ob­
structive jaundice which later resolved. 
She was subsequently shown to have 
partial obstruction of the lower end of the 
common bile duct. Total excision of her 
tumour was successfully achieved by pan­
creaticoduodenectomy.
The authors wish to thank Dr. D. E. Ryder, 
Department of Pathology, and Miss Ann Murray, 
Department of Photography, for their kind assist­
ance.
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Resume:
L’adenome kystique benin du pancreas, tumeur 
rare, s’observe plus frequemment chez la femme 
et au cours des cinquieme et sixieme decennies 
de la vie. La forme papillaire est plus frequente 
que la forme multiloculaire. Ses symptomes ne 
sont pas specifiques et correspondent a la pression
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exercee par la tumeur en voie de developpement 
sur les structures anatomiques contigues. Etant 
donne que la majorite de ces tumeurs siegent 
dans le corps et la queue du pancreas (ou l’une 
des deux regions), l’ictere est un symptome peu 
frequent.; Elies ne sont "eneralement diagnosti- 
quees qu’au moment de r operation, surtout si la 
tumeur est de petite taille.
II importe de pratiquer une excision radicale 
et ce pour trois raisons: (1 ) macroscopiquement, 
la tumeur ne peut etre distinguee des modifica­
tions de nature kystique accompagnant un carci- 
nome; (2 ) la degenerescence maligne est possible 
et (3 ) eile peut atteindre des dimensions con­
siderables et comprimer davantage les structures 
adjacentes.
Au Women’s College Hospital de Toronto, On­
tario, nous avons vu pour la premiere fois un 
adenome kystique multiloculaire benin chez une 
femme qui presentait en meme temps une jaunisse 
d’origine cholostatique. L’ictere a disparu sans 
traitement specifique, rnais on a decouvert subse- 
quemment qu’elle avait une occlusion partielle de 
l’extremite inferieure du choledoque. Au moment 
d’operer, on decida d’exciser radicalement la le­
sion kystique au moyen d’une pancreatico-duo- 
denectomie, de crainte qu’elle ne fut associee a 
un carcinome.
RENAL VEIN RENIN ACTIVITY IN 
RENOVASCULAR HYPERTENSION
Surgical correction of hypertension secon­
dary to renal artery disease depends on 
arteriographic determinations of renal artery 
disease and specific functional diagnostic 
methods. The intravenous pyelogram provides 
a useful screening test, and the divided kidney 
function tests provide useful functional in­
formation related to unilateral or asymmetric 
renal ischemia, but neither test provides de­
pendable prognostic value.
A measurement of renin activity might also 
be significant in the evaluation of patients with 
suspected renovascular hypertension. To de­
termine the value of renin activity, 25 patients 
with renovascular hypertension were studied. 
In all instances, rapid-sequence intravenous 
pyelograms were obtained. Complete criteria 
for positive study included a 1.5-cm. or more 
difference in renal size, disparity in early 
nephrogram effect, disparity in pyelocalyceal 
appearance time, and a high concentration of 
contrast media in the suspected kidney. 
Secondly, divided kidney function tests were 
made on 19 of the 25 patients. Collections for 
determination of respective urine flow rates, 
urinary concentrations of para-aminohippuric 
acid, creatinine, and sodium, and separate 
renal clearances of para-aminohippuric acid 
and creatinine were obtained on all patients.
Blood for renin activity assay was drawn 
from the right and left renal veins and from 
the inferior vena cava. Patients were on a 
normal salt intake without premedication and 
were recumbent for three hours before renal 
vein sampling. On two patients, studies were 
done in both recumbent and tilted positions. 
Values were also obtained for renin activity 
from peripheral plasma of six normotensive 
patients.
Seventeen women and eight men between 
16 and 57 years of age who had hypertension 
for an average of 2.5 years were surgically 
treated. Mural dysplasia was found in 20 renal 
vascular lesions, and atherosclerotic lesions in 
four. One patient, treated by nephrectomy, 
had a hypoplastic kidney without specific 
arterial disease. Eighteen patients had arterio­
graphic evidence of renal artery lesion, five 
bilateral. The length of follow-up studies 
ranged from six months to three years, and 
patients were considered cured if the blood 
pressure was 140/90 mm. Hg or less without 
drags six months or longer after operation. 
Improved patients showed a reduction in dia­
stolic pressure of 15 mm. Hg or more or were 
normotensive after treatment that previously 
was ineffective. Both pressure gradients and 
electromagnetic flowmeter studies were per­
formed.
Of the 25 patients, six had nephrectomy, 
one a secondary nephrectomy, and one a part 
of a one-stage bilateral procedure. Twenty 
angioplastic procedures were done in 19 pa­
tients.
Intravenous pyelograms were abnormal in 
89% of the patients with unilateral renal artery 
disease, at least one of the split function tests 
was positive in 10 of 12 patients cured by 
operation and in three of four improved by 
operation. Absolute values of plasma renin 
activity had doubtful diagnostic significance, 
but a ratio of 1:5 indicated functionally 
significant renal artery stenosis irrespective of 
absolute values. The study did not prove that 
assay of renal vein renin activity can totally 
replace divided kidney function tests. Rather, 
the methods apparently complement each 
other.—Kaufman JJ, Lupu AN, Franklin S, et 
al: Diagnostic and predicative value of renal 
vein renin activity in renovascular hyper­
tension. / Urol 103: 702, 1970
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SPINAL CORD COMPRESSION IN POLYOSTOTIC 
FIRROUS DYSPLASIA*
NINIAN T. MATHEW, M.D., D.M.( Neurol. ) ,f  A. BHAKTAVIZIAM, M.D. and 
JACOB ABRAHAM, M.S., M.S.(Neurol.), F.A.C.S., Vellore, S. India
I n  fibrous dysplasia, normal bone which 
undergoes physiologic lysis is replaced by 
abnormal fibrous tissue proliferation.1 
Mono-ostotic and polyostotic varieties have 
been described. The polyostotic type may 
be associated with cutaneous pigmentation 
and sexual precocity in females—a condi­
tion termed Albright’s syndrome.2
Vertebral involvement is rare in poly­
ostotic fibrous dysplasia; Harris, Dudley 
and Barry3 reported an incidence of 14%. 
Spinal cord compression in polyostotic 
fibrous dysplasia affecting the vertebrae is 
even rarer. So far, only nine such cases 
have been reported in the literature.4'7
This paper describes a patient with poly­
ostotic fibrous dysplasia who presented 
with paraplegia.
Fig. 1.—Radiograph of the pelvis showing 
multiple osteolytic areas in the pelvis and upper 
part of the femur. Distortion of the pelvis is also 
evident.
“From the Departments of Neurological Sciences 
and Pathology, Christian Medical College Hospi­
tal, Vellore, S. India.
fPresent address: Department of Neurology, Bay­
lor College of Medicine, Houston, Texas 77025.
Fig. 2.—Femur and leg bones showing “shep­
herd’s crook” deformity of the femur and the 
irregular appearance of the shaft of the fibula.
Case Report
A 20-year-old man was admitted to the 
neurological service of the Christian Medical 
College Hospital, Vellore, on September 4, 
1969, complaining of the sudden onset of 
paralysis of both lower limbs associated with 
moderate pain in the dorsal spine. He also had 
urinary retention with dribbling. From the age 
of 10 years his lower extremities were de­
formed, and the left lower limb was three 
inches shorter than die right. H e walked with 
a limp, but had never consulted a doctor for 
this reason. H e was working as a mechanic in 
a garage. There was no family history of simi­
lar complaints.
On examination, the patient was dwarfed 
and greatly deformed. He had frontal bossing 
of the skull, dorsal kyphosis with slight scolio-
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Fig. 3.—Lumbar spine showing collapse of the logic fracture dislocation between T5 and T6 
L3 vertebra. (arrow).
sis, exaggerated lumbar lordosis, pigeon chest 
deformity, prominent Harrison’s sulcus, “shep­
herd’s crook” deformity of the left thigh and 
bowing of both legs. There was no abnormal 
cutaneous pigmentation and there were no 
endocrine abnormalities. Neurologic examina­
tion revealed paraplegia with a sensory level 
at the T6 dermatome. Motor power was grade 
0 (MRC scale) in the lower limbs. Deep- 
tendon reflexes in the lower limbs were ex­
aggerated. Superficial reflexes were lost, and 
he had bilateral Babinski responses. Upper 
limbs and cranial nerves were normal.
On radiographic examination he had mul­
tiple bony lesions compatible with polyostotic 
fibrous dysplasia (Figs. 1-3). Angulation was 
evident between T5 and T6 in the film of the 
dorsal spine (Fig. 4 ) .  He had a normal leuko­
cyte count and hematocrit. Cerebrospinal fluid 
was clear, with a normal cell count, 260 mg./ 
100 ml. protein and 80 mg./100 ml. glucose. 
Manometry revealed a partial block at T4. 
Serum calcium was 10.5 mg./lOO ml. and 
serum phosphate was 3.4 mg./lOO ml. Urinary 
calcium excretion was 86 mg./24 hrs. and 
urinary phosphorus excretion was 342 mg./24 
hrs. (These are within the normal range in 
our laboratory.) Alkaline phosphatase was 26 
King-Armstrong units. He had a total serum 
protein of 7.9 g./lOO ml., albumin of 5.3 
g./lOO ml. and globulin of 2.6 g./lOO ml. 
Serum electrophoresis showed normal propor­
tions of the various proteins. Lumbar myelo­
graphy confirmed the partial block at the 
T4 level.
At biopsy, bone was obtained from the left 
femur. Histologic sections showed spindle 
cells arranged loosely with many small blood 
vessels, and thin bony trabeculae, forming 
arches or segments of circles in it (Fig. 5 ) .  
Osteoblasts lined these arches of osteoid tra­
beculae and there were occasional osteoclastic 
giant cells in the stroma. Bone from the ad­
jacent areas showed normal structure.
The spinal cord was decompressed by lamin­
ectomy from T3 to T6. It was severely 
stretched over the angulation of the spine. 
There was no abnormal tissue in the extradural 
space which could have compressed the spinal 
cord. After operation the spasticity and motor 
power improved ( the latter to grade 3 ) ,  but 
the reflexes remained unaltered.
D isc u ssio n
Conditions that produce multiple bone 
lesions similar to polyostotic fibrous dys­
plasia are hyperparathyroidism, Hand- 
Schiiller-Christian disease, Paget’s disease 
of bone, and generalized neurofibromatosis. 
The normal biochemical findings in this pa­
tient and the normal pattern of the un­
affected areas of the skeleton rule out 
hyperparathyroidism and Paget’s disease. 
The clinical features and histopathology 
also help to exclude Paget’s disease and 
Hand-Schuller-Christian disease. General­
ized neurofibromatosis is invariably asso­
ciated with cutaneous pigmentation or
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Fig. 5.—Microscopic appearance of the biopsy 
specimen from the femur (H & E X 120).
hypertrophy of the tissues, which this pa­
tient did not have. The histologic findings 
of the loose fibrous stroma and thin trabec­
ulae of bone, with the characteristic 
pattern in the biopsy, confirm the diagnosis 
of polyostotic fibrous dysplasia.
The spinal cord involvement in the 
present case was secondary to a pathologic 
fracture of the vertebrae, unlike the case 
reported by Montoya, Evarts and Dohn.7 
These authors found a large mass of soft 
gritty tissue in the epidural space causing 
compression of the spinal cord; their pa­
tient improved remarkably after the opera­
tion.
Because very few patients with poly­
ostotic fibrous dysplasia and spinal cord 
compression have been treated by opera­
tion it is difficult to decide on the best form 
of surgical management. All those reported 
in the literature were treated by lamin­
ectomy and all were reported to have done 
well as indicated by postoperative neuro­
logic status, as did our patient. Until we 
have more experience and have determined 
the results of other surgical measures, such 
as anterolateral decompression or trans­
thoracic anterior decompression, lamin­
ectomy and spinal cord decompression 
seem to offer the best approach to the 
problem.
Su m m a r y
A 20-year-old man was admitted to hos­
pital because of the sudden onset of para­
paresis. He had multiple bony deformities 
and a gibbus deformity of the dorsal spine. 
Radiographs revealed changes suggestive 
of polyostotic fibrous dysplasia, and bio­
chemical studies and bone biopsy sup­
ported the diagnosis. Paraplegia was due to 
spinal cord compression by collapsed and 
angulated dorsal vertebrae. Laminectomy 
and decompression of the spinal canal re­
sulted in moderate recovery of function 
below the lesion.
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R e s u m e
Un jeune homme de 20 ans a 6te hospitalise au 
Christian Medical College Hospital de Vellore 
(Indes), pour un debut brusque de paraparesie. II 
presentait de nombreuses difformites osseuses et 
une gibbosite de la colonne dorsale. Des radio- 
graphies ont revele des modifications osseuses 
laissant presager une dysplasie fibreuse des os. 
Des analyses biochimiques et une biopsie osseuse 
ont confirme ce diagnostic. La paraplegie relevait 
d’une compression medullaire causee par un af- 
faissement vertebral et une angulation anormale 
des vertebres. Une laminectomie et la decompres­
sion du canal rachidien ont donne une certaine 
amelioration fonctionnelle en dessous de la lesion.
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ANTERIOR TIBIAL COMPARTMENT SYNDROME COMPLICATING 
FEMORAL EMBOLECTOMY
A. O. RANSFORD, M.B., F.R.C.S.0 and J. L . PROVAN, B.Sc., M .S .(Lond .), F .R .C .S .,t
Tc.ionto, Ont.
Git u t z 1 described the anterior tibial com ­
partment syndrome as ischem ic necrosis 
with variable functional impairment of the 
neuromuscular contents of that discrete 
fascial space known as th e anterior tibial 
compartment. Sufficient cases have been 
reported to emphasize that a num ber of 
etiologic factors may be involved. Several 
have been described after arterial em­
bolism,2’ 3 but the syndrome has not previ­
ously been reported as a complication of 
femoral embolectomy. This paper describes 
two patients who suffered this com plica­
tion after an otherwise successful em bol­
ectomy.
C ase Reports
Case 1 — A 60-year-old New Zealand wom­
an was admitted to the University College 
Hospital, London on May 15, 1968, three days 
after the onset of severe pain in the right calf 
and foot. She had a five-year history of atrial 
fibrillation and a two-year history of bilateral 
calf claudication after walking 50 yards. In 
1966 she had a mild attack of congestive 
cardiac failure for which she was treated with 
digitalis, Inderal (propranolol HC1) and di­
uretics. She also had polycythemia which had 
not been treated.
Tins slim plethoric woman had widespread 
rosacea. Her blood pressure was 150/90 mm. 
Hg. Left ventricular hypertrophy was present 
but there were no signs of congestive cardiac 
failure. Both femoral pulses were palpable but 
there was no pulsation distal to these. Below 
the knee both legs were cold and the veins 
empty. There was anesthesia from half-way 
down the right shin, and the skin was dusky 
blue. The left foot was also discoloured but 
there was no sensory loss.
Her hemoglobin was 148% (21.6 g./lOO 
m l.), hematocrit 65%, leukocyte count 11,400/ 
c.mm. with a normal differential count. Plate-
l!University College Hospital Medical School, 
London, England.
tThe Wellesley Hospital, Toronto, Ont.
Reprint address: Dr. J. L . Provan, Room 439, 
Turner Wing, The Wellesley Hospital, 160 
Wellesley Street East, Toronto, Ont.
lets were normal, sedimentation rate was 38 
mm. in one hour (W estergren). The blood 
urea nitrogen was 56 mg./100 ml. Her electro­
cardiogram showed atrial fibrillation with 
ischemic changes.
We made a diagnosis of right superficial 
femoral artery thrombosis secondary to athero­
sclerosis and polycythemia.
An intravenous infusion was set up and 500 
ml. of low molecular weight dextran (Rheo- 
macrodex) was given over four hours. Heparin, 
100 mg. every six hours, was given intraven­
ously by the same route. W e attempted to re­
duce the polycythemia by withdrawing 800 ml. 
of blood and replacing it with reconstituted 
plasma. With this treatment, the condition of 
the left foot improved considerably but be­
cause the right foot had deteriorated, we ex­
plored the right femoral artery.
After the bifurcation of the right femoral 
artery was exposed and a transverse arteri-
Fig. 1.—Case 1. The anterior tibial compart­
ment after application of patch grafts.
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otomy made, we discovered that an embolus 
had lodged at the bifurcation of the femoral 
artery; there was little propagated thrombus 
and the vessels were otherwise normal. Using 
a Fogarty catheter, the superficial and deep 
femoral arteries were cleared of clot. The 
arteriotomy was sutured with 5-0 continuous 
silk.
After operation the right femoral, popliteal 
and posterior tibial pulses had good volume. 
The dorsalis pedis pulse was absent throughout 
the patient’s convalescence. Two days later, 
when she complained of pain in the region 
of the right shin, we found that the skin was 
discoloured over the right anterior tibial com­
partment and that she had developed a foot- 
drop. She had paresthesia in the foot and 
sensory loss in the first toe cleft. The condition 
of the skin over the anterior tibial compartment 
deteriorated over the next two weeks and 
eventually sloughed together with much of the 
underlying muscle. Culture from the slough 
grew Proteus mirabilis and Staphylococcus 
pyogenes. The dead tissue was later excised 
and patch grafts were applied (Fig. 1). She 
was discharged after three months with a 
dorsiflexion caliper for the correction of the 
foot-drop.
Case 2 .—A 54-year-old general practitioner 
was admitted to the University College Hos­
pital, London on June 20, 1968, suffering from 
severe gastroenteritis. He was otherwise well 
although he had recently developed claudica­
tion in the right calf during long walks. On 
admission he required intravenous fluid re­
placement. Two hours after admission he 
suffered a myocardial infarction and two hours 
later developed sudden severe pain in his left 
leg. At this time his blood pressure was 130/ 
80 mm. Hg. He had a bounding left femoral 
pulse but no pulses were palpable distally. The 
left leg was white and cold, the veins were col­
lapsed and there was no sensation over the 
dorsum of the foot and toes. W e made a diag­
nosis of left femoral embolism secondary to a 
cardiac mural thrombus and Heated him with 
100 mg. heparin intravenously, 500 ml. of 
Rheomacrodex and 500 ml. of plasma. Four 
hours elapsed before he was considered fit 
enough for embolectomy.
After the left common femoral artery was 
exposed, the superficial and deep femoral 
arteries were cleared of clot through a trans­
verse arteriotomy using a Fogarty catheter. 
The arteriotomy was closed with continuous 
5-0 silk suture and the patient sent back to the 
ward. The wound continued to ooze blood and 
the patient was returned to the operating room
five hours later for resuture of the arteriotomy. 
The popliteal and posterior tibial pulses were 
present throughout, but the dorsalis pedis 
pulse did not return until the third postopera­
tive day. During this period the patient com­
plained of severe pain in the anterolateral 
aspect of his left lower leg, which was in­
creased by the slightest touch. He had a left 
foot-drop with an area of anesthesia in the 
first toe cleft. The skin over the anterior tibial 
compartment was edematous and bluish. The 
skin did not deteriorate and no grafting or 
other treatment was required. When he was 
discharged from hospital a month later, the 
skin was healthy, but the anterior tibial com­
partment was still tender to palpation. The 
sensory loss was constant with an area of 
hyperesthesia around it. He required a dorsi­
flexion caliper to correct the foot-drop.
D iscussion
The anterior tibial compartment syn­
drome was first described by Sirbu, 
Murphy and W hite in 19444 as a com plica­
tion of the repair of a small muscle hernia 
through the anterior crural fascia. How­
ever, in 1943, Vogt described the syn­
drome in a soldier after prolonged m arch­
ing5 and it has subsequently been observed 
repeatedly in individuals, usually young, 
who have been subjected to unaccustomed 
strenuous exercise.6 It  has also been re­
ported after local trauma, sometimes as 
minor as a twisted ankle, but often after 
more m ajor accidents.7 Carter described 
this misadventure after blood transfusion 
into the vein of a foot in which the blood 
presumably tracked up a synovial sheath. 
It has been reported as a complication of 
atherosclerosis obliterans and diabetes 
mellitus,7 of proximal arterial thrombosis8 
and femoropopliteal bypass.1 The litera­
ture contains two references to this syn­
drome after arterial embolism2- 3 which 
was treated conservatively by various 
methods such as oral Priscoline (tolazoline 
HC1), intra-arterial papaverine sulfate 
and paravertebral lumbar sympathetic 
block. Em bolectom y was not done in these 
two instances.
Anatomy
The anterior tibial compartment is 
bounded anteriorly by the deep fascia,
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medially by the crest and lateral surface 
of the tibia, posteriorly by the interosseous 
membrane and laterally by the fibula and 
anterior intermuscular septum. It contains 
the tibialis anterior, extensor digitorum 
longus, extensor hallucis longus and pero- 
neus tertius muscles. Some workers have 
suggested that this is an inexpansile com­
partment, viz. that the tendons plug the 
inferior aspect of the compartment as 
they pass under the superior extensor 
retinaculum.
The anterior tibial nerve, the main 
branch of the lateral popliteal nerve, is 
given off as that nerve winds round the 
lateral aspect of the neck of the fibula. It 
enters the compartment by piercing the 
anterior intermuscular septum. This nerve 
provides the motor supply to the muscles 
in the compartment and the extensor digi­
torum brevis on the dorsum of the foot. 
Its sensory branch supplies only the area 
of the first toe cleft.
The anterior tibial artery enters the com­
partment through a defect above the inter­
osseous membrane and runs distally to 
leave inferiorly as the dorsalis pedis artery. 
This artery supplies the muscles of the 
compartment but the 12 to 16 branches to 
the tibialis anterior muscle are virtually 
end-arteries.fl The other muscles have an 
alternative anastomotic supply either from 
the peroneal or posterior tibial arteries.
In this syndrome the onset of pain in 
the anterolateral aspect of the leg is 
followed, 12 to 24 hours later, by swollen, 
tense, brawny induration of the skin over 
the anterior tibial compartment. The 
muscles in the compartment are tender to 
palpation and there is usually a weakness 
of dorsiflexion. There may be loss of the 
dorsalis pedis pulse and sensory loss in the 
first toe cleft.1 Putty-like material may be 
discharged and, if the space is explored,10 
this can be seen to originate mostly from 
the necrotic tibialis anterior muscle.
On microscopy the spectrum of changes 
ranges from coagulative necrosis with loss 
of striation and of nuclei, to complete loss 
of architecture with infiltration by inflam­
matory cells. Later the necrotic muscle is 
replaced by fibrous connective tissue which 
may contain scattered islands of muscle.1
Anterior Tibial Nerve and Foot-D rop
Previously the foot-drop was believed 
to be neurologic. Carter, Richards and 
Zachary® disproved this and showed that 
the drop was due chiefly to muscle necro­
sis. They admitted that the nerve was 
affected to a varying extent by local 
ischemia or increased pressure within the 
space but pointed out that the foot-drop 
does not recover when sensation returns. 
The foot-drop may improve somewhat 
when the fibrous scar tissue contracts.
Because muscle necrosis, caused by a 
rise in pressure in the compartment, and 
atrophy of the muscle, caused by nerve 
injury in the absence of muscle necrosis, 
have not always been distinguished in the 
literature we should emphasize here that 
the two clinical methods for testing for 
nerve involvement or regeneration, viz. 
stimulation of the extensor digitorum brevis 
on the dorsum of the foot and sensory test­
ing in the first cleft, are themselves open 
to criticism. In the first method, the 
muscle is also supplied by the dorsalis 
pedis artery and its arterial supply may be 
compromised if this pulse is absent. In the 
second, surgical division of the anterior 
tibial nerve does not always produce 
sensory loss in the first toe cleft; therefore 
the absence of apparent anterior tibial 
nerve involvement does not necessarily 
mean that the foot-drop is produced as a 
result of nerve necrosis.
Pathogenesis
Hughes11 believed that this syndrome 
was primarily vascular and pointed out 
that if increased compartmental tension 
alone was the cause, all the muscles would 
be affected equally. In contrast to the 
other muscles in the compartment, the 
branches of the anterior tibial artery that 
run to the tibialis anterior muscle are 
virtually end-arteries; this may explain this 
muscle’s increased vulnerability.
Muscle swelling in an inexpansile com­
partment probably produces occlusion of 
the local capillaries, venules and lymph­
atics. This occlusion leads to extravasation 
of fluid and raises still further the pressure 
in the anterior tibial compartment, to a 
point where even the arterial supply is
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prejudiced and the dorsalis pedis pulse 
eventually becomes impalpable. All the 
precipitating factors so far described could 
operate on this basis. After thrombosis, 
embolism, surgical or other trauma to the 
femoral or popliteal artery, sufficient blood 
must enter the limb to avoid gangrene of 
the foot. This relative ischemia produces 
swelling of all the distal muscles of the 
limb but only in the inexpansile compart­
ment, which contains the dorsiflexors of 
the foot, does the vicious circle produce 
muscle necrosis. Severe unaccustomed exer­
cise produces generalized muscle swelling 
in the limb but only in the inexpansile 
anterior tibial compartment is this occa­
sionally disastrous.
The remaining etiologic factors—repair 
of muscle hernias through the anterior 
crural fascia, hematoma from muscle rup­
ture after direct trauma such as a twisted 
ankle, and blood tracking up a synovial 
sheath after faulty blood transfusion—can 
be explained on the same principle, that is, 
on increase of volume within an in- 
expansible compartment.
After embolectomy this syndrome can be 
prevented by one of two measures: (1) 
Ensure that the anterior tibial artery is 
cleared of clot or propagated thrombus. If 
there is any doubt, do arteriography to 
make sure. (2 ) Perform an anterior crural 
fasciotomy as a prophylactic measure if 
the dorsalis pedis pulse is not palpable 
after the embolus is removed.
Su m m a r y
Two patients developed the anterior 
tibial compartment syndrome after other­
wise successful embolectomy—a misadven­
ture not previously reported.
This syndrome is probably caused by 
swelling of the tibialis anterior muscle after 
a period of arterial occlusion. Swelling of 
the muscle in the inexpansile anterior 
tibial compartment leads to occlusion of 
veins, lymphatics and finally arteries, pro­
ducing nerve death as well as muscle
necrosis. To prevent this syndrome, sub­
cutaneous crural fasciotomy should be con­
sidered if, after embolectomy, the dorsalis 
pulse cannot be palpated.
The photograph of Case 1 is reproduced by 
the kind permission of Mr. D. N. Matthews.
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R esum e
Apres avoir subi une embolectomie, par ailleurs 
parfaitement reussie, deux operes ont presente le 
syndrome de la loge tibiale anterieure. Cette 
complication n’avait pas ete signalee jusqu’a pre­
sent.
Ce syndrome est probablement caus6 par 
l’enflure du muscle jambier anterieur apres une 
certaine periode d’occlusion arterielle. L’enflure 
du muscle dans la loge du tibia anterieur, qui est 
inexpansible, aboutit a l’occlusion de veines, de 
vaisseaux lymphatiques, puis d’arteres, et finale- 
ment a la mort du nerf et a la necrose musculaire. 
Pour prevenir cet accident, on peut envisage! de 
pratiquer une fasciatomie crurale par voie sous- 
cutan^e si, apres embolectomie, l’artere pedieuse 
ne peut etre palpee.
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FRACTURE DISLOCATION OF THE UPPER HUMERUS INTO THE
THORACIC CAVITY*
P. G. STABLEFORTH, M.B., F.R.C.S.,f P. AYRES, M.B., B.S. and 
GLEN A. TAYLOR, M.D., F.R.C.S.[C],t Toronto, Ont.
T hree patients have been described who 
sustained severe fracture dislocation of the 
upper humerus into the thoracic cavity,1-3 
none of which required thoracotomy. In 
the woman described in this paper, thor­
acotomy was a life-saving procedure, and 
her case presented three interesting 
aspects: first, such fracture dislocation is 
an unusual cause o f severe traumatic herno- 
pneumothorax. Second, the findings at early 
exploration suggested a new mechanism 
of injury that allows the humeral head to 
remain separated and free in the thoracic 
cavity. Third, this potentially lethal injury 
occurred in an elderly woman after mini­
mal trauma.
Case Report
The patient, an obese 73-year-old woman, 
was admitted to the Emergency Department 
of Sunnybrook Hospital, Toronto, apprehen­
sive and uncooperative. Her chief complaint 
was of left shoulder pain. Earlier she had 
fallen down three steps onto her outstretched 
right arm, then a further three steps to the 
ground, landing on her outstretched left arm.
She was in shock and had a pulse rate of 
120/min. and a systolic blood pressure of 80 
mm. Hg. She was not in respiratory distress, 
but had surgical emphysema over the anterior 
left upper chest. There were no palpable rib 
fractures. There was increased resonance to 
percussion over the left upper chest, and the 
breath sounds were diminished. Left arm and 
shoulder movements were painful; clinically, 
we thought the left humeral neck was frac­
tured. There were no abnormal neurologic 
findings in the left upper limb, the extremity 
was warm and the peripheral pulses were 
present. The right wrist had the “dinner-fork” 
deformity of a Colles’ fracture.
Full physical examination was otherwise 
normal and there was no obvious cause for the 
patient’s hypotension. A rapid infusion of 500
“ From the Department of Surgery, Sunnybrook 
Hospital, University o f  Toronto, Toronto, Ont.
fPrincess Margaret Rose Orthopaedic Hospital, 
Edinburgh, Scotland.
XAssociate in Surgery, University of Toronto.
ml. Ringer’s lactate solution restored the 
systolic blood pressure to 140 mm. Hg. Needle 
aspiration revealed a pneumothorax and a 
chest tube was inserted through the second 
interspace in the mid-clavicular line. Under­
water seal drainage produced air and blood. 
At this point, the patient’s condition appeared 
to be stable.
Laboratory investigations produced the 
following results: hemoglobin, 12 g./lOO ml.; 
blood urea nitrogen, 15 mg./lOO ml.; serum 
sodium, 135 mEq./l.; potassium, 3.6 m Eq./l.; 
chloride, 101 mEq./l., carbon dioxide com­
bining power, 20 m Eq./l.; blood sugar, 81 
mg./lOO ml.; and electrocardiogram normal.
A posteroanterior chest film (Fig. 1) demon­
strated a severe fracture of the neck of the
Fig. 1.—Posteroanterior radiograph demon­
strating pleural effusion, fracture of the neck of 
the humerus with the head apparently in the 
thoracic cavity, fractures of the second, third and 
fourth ribs, and a fracture of the glenoid (note 
that the chest tube has become displaced).
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Fig. 2.—Stereoscopic view of the left shoulder joint. The head of the humerus is lying in the thoracic cavity.
humerus, a fracture of the glenoid and a 
“flail” segment of second, third and fourth 
ribs anterolaterally. There was a left pleural 
effusion. Stereoscopic views (Fig. 2) showed 
the humeral head in the left thoracic cavity.
During this examination the patient again 
became hypotensive and did not respond to 
infusions of whole blood. The chest drain had 
become displaced, so a new drain was in­
serted and the patient prepared for emer­
gency thoracotomy.
A standard left thoracotomy was made 
through the bed of the fifth rib. There was a 
massive hemothorax, the source of which was 
not immediately evident, and the patient re­
mained hypotensive. The free humeral head 
was immediately identified and removed from 
the cavity. The apex of the thoracic cavity 
was then packed off to allow resuscitation by 
continued whole-blood replacement.
When the patient’s blood pressure had 
stabilized, removal of the packing revealed an 
8-cm. long laceration in the apical lateral 
aspect of the left upper lobe. There were no 
adhesions of the lung to the chest wall. The 
laceration was 5 cm. deep, was not bleeding, 
but leaked a small amount of air. The adjacent
segment of chest was unstable over an area 
12 cm. long in the region associated with 
double fractures of the second, third and 
fourth ribs. The third intercostal space was 
extensively lacerated at what we presumed to 
be the site of penetration by the upper 
humerus. Bleeding did not resume after the 
packing was removed. The original source of 
the bleeding appeared to be the intercostal 
vessels. The vessels of the second to fifth 
interspaces were ligated with heavy silk, and 
the lung laceration was closed with a running 
chromic catgut suture, after we had inflated 
the lung to be sure that there was no major 
bronchial communication. Two chest drains 
were attached to an Emerson pump and the 
wound was closed.
For the first 24 hours the patient was 
managed with an Emerson volume ventilator 
and an endotracheal tube. Because we could 
not “wean” the patient from the ventilator at 
this time, a tracheostomy was performed, and 
assisted ventilation continued for a further 
five days. The tracheostomy tube was re­
moved on the fifteenth postoperative day.
Because the patient was critically ill at the 
time of operation, the shoulder injury was 
managed conservatively. We did not replace 
the humeral head with a prosthesis during this 
operation.
The patient had no residual chest com­
plaints four months after her injury. She had 
not regained active glenohumeral abduction 
but could carry on limited domestic activity. 
We contemplate no further operation.
D iscussion
This patient’s mode of presentation 
emphasizes that concealed intrathoracic 
hemorrhage may precipitate profound 
hypovolemic shock without signs of severe 
chest injury. W e believe that the major 
source of bleeding was the intercostal 
vessels in the “flail-chest” segment and that 
the lung laceration, a limited injury, con­
tributed little to the patient’s shock.
Severe fracture dislocation of the upper 
humerus with extracapsular displacement 
of the head fragment, a rare lesion, ac­
counts for 1.1% 4 and 1% 5 of reported 
shoulder fractures and dislocations. Most 
fracture dislocations are anterior and occur 
in obese elderly women. Displacement of 
the separated humeral head into the thor­
acic cavity has been described three times 
previously.1-3
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Authors of previous papers, describing 
this injury, believed that the humeral neck 
fractured as it lay between the ribs follow­
ing dislocation. For the following reasons 
we propose that the fracture p reced es  the 
dislocation.
The pattern of fracture is constant 
whether the head comes to lie finally in 
the chest or, more commonly, in the 
axilla.4’ 6 This fracture can be reproduced 
consistently by applying a longitudinal 
force7 such as would be applied during a 
fall onto the outstretched hand with the 
humeral head still within its socket, but not 
by angulatory forces to the humeral neck 
as would occur if dislocation preceded 
fracture.5
If the subject falls on the abducted out­
stretched arm, the dislocated upper humer­
us would then be directed against or, 
rarely, into the chest. Manipulation during 
transportation, muscle recoil, or gravity 
could cause the shaft to return from the 
chest, leaving the head trapped in the 
thorax.
Severe axillary vessel damage is rare in 
fracture dislocation of the humerus be­
cause the sharp upper-humeral shaft is still 
capped by the head when it traverses the 
axilla. The lung laceration in this patient 
could have been caused by sudden blunt 
trauma to a fully inflated lung, although
this damage to the lung may have been in­
flicted by the sharp uncovered proximal 
humeral shaft after displacement of the 
head (Fig. 3).
Su m m a r y
An elderly woman sustained a severe 
fracture dislocation of the left upper 
humerus into the thorax during a fall. The 
free head of the humerus remained in the 
thoracic cavity while the shaft returned to 
its normal anatomic position.
The patient presented in shock, which 
failed to respond to conservative treatment 
and necessitated emergency thoracotomy. 
A deep laceration of the left upper lobe 
was found; however, the massive hemo­
thorax originated from torn intercostal 
vessels of a “flail” segment involving the 
second to fourth ribs. This finding empha­
sizes that occult intrathoracic bleeding may 
cause severe hypovolemic shock after rela­
tively minor trauma.
Previous authors describing this injury 
believed that the humeral head, following 
dislocation, fractured as it lay between the 
ribs. We propose a different mechanism 
of injury, viz. that the fracture precedes 
the dislocation and when the capped 
humerus comes to lie in the thoracic cavity 
the head can separate. The shaft then re­
turns to its anatomic position leaving the 
free head in the thoracic cavity.
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R esu m e
Apres une chute, une femme agee a subi une 
fracture-luxation de l’humerus superieur gauche 
qui a penetre dans la cavite thoracique. La tete 
libre de 1’humerus resta dans la cavite thoracique, 
tandis que la diaphyse de l’humerus revenait a 
sa position anatomique normale.
L’etat de choc de la blessee ne cedant pas au 
traitement conservateur classique, il fallut re- 
courir a la thoracotomie. On trouva une lace­
ration profonde du lobe superieur, mais l’hemo- 
thorax massif provenait de vaisseaux intercostaux 
laceres dans un “volet” thoracique qui affectait les
cotes, de la deuxieme a la quatrierne. Cette con- 
statation confinne qu’une hemorragie intrathoraci- 
que occulte peut provoquer un choc severe par 
hypovolhemie et ce, meme apres un traumatisme 
relativement mineur.
D’autres auteurs en decrivant cette lesion 
estimaient que la tete de l’humerus apres luxation 
s’est fracturee alors qu’elle reposait entre les 
cotes. Personnellement, nous croyons a un me- 
canisme different: la fracture precede la luxation 
et quand l’humerus est emprisonne dans la cavite 
thoracique, la tete peut se separer. La diaphyse 
revient alors a sa position anatomique premiere 
et la tete de l’humerus demeure dans le thorax.
GIANT CELL TUMOUR
A study of giant cell tumours of the bone 
was conducted surveying 195 patients between 
1910 and 1969. A complete follow-up study 
was obtained on all but six of these patients. 
The study revealed that the tumour is more 
common in female patients less than 20 years 
of age. Seventy-five per cent of the patients 
were females. The youngest patient in this 
series was 12 years old.
Approximately 77% of the giant cell tumours 
were located at or near the end of a major 
tubular bone of the extremity. One hundred 
of the tumours occurred at the knee, 51 at 
the distal end of the femur, and 43 at the 
proximal portion of the tibia. In this series, 
the majority of tumours were observed about 
the knee joint. The most common complaint 
of the patient was pain or swelling, or both. 
Approximately half the patients had symp­
toms six months before seeking or receiving 
appropriate medical care.
Grossly, the giant cell tumour is typically 
grey, brown, or has a mottling of these colours. 
The tumour is soft and pliable, and grey and 
white necrotic zones may be present.
In this series, primary treatment consisted 
of at least 15 different types of management. 
These included radiation, curettage or ex­
cision with or without forms of cautery, with 
or without bone grafting, and with or without 
radiation, as well as an en bloc  resection and 
amputation. Since the majority of patients had 
received primary treatment at other institu­
tions before coming to the Mayo Clinic, the 
primary therapy is difficult to assess. In the 
treatment of recurrent disease after primary 
curettage or excision seven patients had
amputation and this proved curative. In 11 
of the patients with recurrent symptoms after 
primary treatment with curettage and ex­
cision, irradiation without biopsy was given. 
Five patients were alive and well after seven 
to 40 years. Five of the remaining six patients 
had a recurrent giant cell tumour, and after 
radiation therapy for recurrent tumour de­
veloped a sarcoma in the affected region.
Seven patients had complete en bloc  resec­
tions before 1967. Six patients were well for 
two to 30 years; four of these had been ob­
served for more than 10 years. The seventh 
patient had a prosthetic replacement of the 
knee after resection of the primary lesion. 
Twenty-one patients underwent amputation 
for benign giant cell tumour in addition to the 
10 who had an amputation as primary treat­
ment at the Mayo Clinic.
In this series of patients 17 had malignant 
giant cell tumours (8.7% of the total). Ten of 
the 17 patients died of these tumours within 
one year and one patient died at 3.2 years. 
One patient survived 55 years after a total re­
section of the tumour and three patients were 
long-term survivors after amputation. The 
authors believe that radiation therapy contrib­
utes to the malignant transformation of giant 
cell tumours.
The shortest interval from radiation to 
recognition of a post-irradiation sarcoma was 
3.7 years. Sarcomas developed in seven of the 
37 irradiated patients or 19%. Sarcoma de­
veloped in only one of the surgically treated 
patients (3%). This is an interesting series be­
cause of the long-term follow-up study in­
volved.—Dahlin DC, Cupps RE, Johnson EW : 
Giant-cell tumor; study of 195 cases. Cancer 
25: 1061, 1970
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All communications concerning this journal 
should be marked “The Canadian Journal of 
Surgery” and addressed to the Editor, C.M.A. 
Publications, 129 Adelaide Street West, Toronto.
The Journal is published bi-monthly. Sub­
scription is $15 per year ($7.50 per year for 
trainees in surgery), and starts with the Janu­
ary issue of each year. Single copies are $2.50 
each, payable in advance. (I t  would be greatly 
appreciated if subscribers would add bank ex­
change to their cheques.)
INSTRUCTIONS TO CONTRIBUTORS  
Manuscripts
Manuscripts in duplicate of original articles, 
case reports, and other contributions should 
be forwarded with a covering letter re­
questing consideration for publication in The 
Canadian Journal o f Surgery. Acceptance 
is subject to the understanding that they 
are submitted solely to this Journal, and 
will not be reprinted without the consent 
of the author and the publishers. Accept­
ance or rejection of contributions will be 
determined by the Editorial Board. As 
space is available, a limited number of 
case reports will be published. Articles 
should be typed on one side only of un­
ruled paper, double-spaced, and with wide 
margins. The author should always retain a 
carbon copy of material submitted. Every 
article should contain a summary of the 
contents. The Concise Oxford Dictionary 
will be followed for spelling. Dorland’s 
Illustrated Medical Dictionary will be fol­
lowed for scientific terminology. The Edi­
torial Board reserves the right to make the 
usual editorial changes in manuscripts, in­
cluding such changes as are necessary to en­
sure correctness of grammar and spelling, 
clarification of obscurities or conformity 
with the style of The Canadian Journal of 
Surgery. In no case will major changes be 
made without prior consultation with the 
author. Authors will receive galley proofs 
of articles before publication, and are asked 
to confine alterations of such proofs to a 
minimum.
Reprints
Reprints may be ordered on a form which 
will be supplied with galley proofs. It is 
important to order these before publication 
of the article, otherwise an extra charge 
for additional type-setting will be made.
R eferences
References should be referred to by numer­
als in the text. They should include in 
order: the author’s name and initials in capi­
tals, title of the article, abbreviated journal 
name, volume number, page number and 
year. The abbreviations of journal names 
should be those used in Index M edicus. 
References to books should include in order: 
author’s name and initials, title of book, 
number of edition (e.g. second ed .), city 
of publication, title of publishing house, 
year of publication, page number if a 
specific reference. For examples, see this 
journal January 1971 issue onwards.
Illustrations
A reasonable number of black-and-white 
illustrations will be reproduced free with 
the articles. Colour work can be published 
only at the author’s expense. Photographs 
should be glossy prints, unmounted and 
untrimmed, preferably not larger than 8" 
x 6". Prints of radiographs are required 
and not the originals. The magnification of 
photomicrographs must always be given. 
Photographs must not be written on or 
typed on. An identifying legend may be 
attached to the back. Patients must not be 
recognizable in illustrations, unless the 
written consent of the subject for publica­
tion has been obtained. Graphs and dia­
grams should be drawn in India ink on 
suitable white paper. Lettering should be 
sufficiently large that after reduction to 
fit the size of the Journal page it can still 
be read. Legends to all illustrations should 
be typed separately from the text and sub­
mitted on a separate sheet of paper. Illustra­
tions should not be rolled or folded.
Language
It should be clearly understood that con­
tributors are at full liberty to submit 
articles in either English or French, as they 
please. Acceptance will be quite independ­
ent of the language of submission. If the 
contributor wishes, he may submit an in­
formative summary of not more than 300 
words in the language other than that in 
which he has submitted the article. For 
example, an article in English must carry 
an English summary and may, if the author 
wishes, carry a more detailed summary in 
French.
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LE JOURNAL CANADIEN DE CHIRURGIE
Toute communication concernant le Journal 
devra porter la mention “Le journal canadien de 
chirurgie” et etre adressee a l’Editeur, Publica­
tions de l’A.M.C., 129 Adelaide Street West, 
Toronto.
Le journal est publie a tous les deux mois. Le 
prix de l’abonnement est de $15. par an ($7.50 
par an pour les medecins qui sont residents en 
chirurgie) et commence avec le numero de 
janvier de chaque annee. Un exemplaire isole 
coute $2.50 et est payable d’avance. (Nous 
serions reconnaissants aux souscripteurs de vou- 
loir bien ajouter a leur cheque le montant des 
frais bancaires eventuels).
INSTRUCTIONS A NOS 
COLLABORATEURS
Manuscrits
Les manuscrits d’articles originaux, de rap­
ports cliniques etc. seront envoyes en deux 
exemplaires, accompagnes d’une lettre deman­
dant qu’on veuille bien considerer leur publica­
tion dans L e  journal canadien de chirurgie. Ils 
ne seront acceptes qu’a la condition qu’ils 
n’aient ete soumis qu’a notre Journal et qu’ils 
ne soient pas reimprimes sans le consentement 
expres de l’editeur et l’auteur. L’acceptation 
ou le refus des articles soumis releve du Con- 
seil de la publication. Si la place est disponible, 
un nombre limite d’histoires cliniques pourront 
etre publies. Les articles seront dactylographies 
sur un seul cote d’un papier non ligne, a double 
espace et avec une large marge. L’auteur devra 
toujours conserver une copie au papier carbone 
du texte soumis. Tout article devra etre ac- 
compagne d’un resume. L ’orthographe sera 
celle adoptee par le dictionnaire Larousse. 
Quant a la terminologie scientifique, elle sera 
basee sur le Dictionnaire des termes techniques 
de medecine ou tout autre ouvrage de refe­
rence serieux. Le Conseil de la publication se 
reserve le droit d’apporter au texte les change- 
ments qu’il jugerait a propos pour assurer la 
correction grammaticale et l’orthographe, pour 
eliminer d’eventuelles obscurites ou pour ren- 
dre la presentation conforme au style du Jour­
nal canadien d e  chirurgie. Aucun changement 
important ne sera apporte au texte sans que 
l’auteur ait ete prealablement consulte. Les 
auteurs recevront avant la publication des 
epreuves d’imprimerie de leur texte, auxquelles 
ils sont pries d’apporter le minimum de correc­
tions.
Tires-d-part
On pourra commander des tires-a-part sur 
une formule qui est envoyee avec les epreuves. 
II est important de les commander avant la 
publication de l’article, sous peine de devoir 
payer un supplement pour une nouvelle com­
position.
Bibliographie
Les references bibliographiques seront indi- 
quees par des numeros dans le corps du texte. 
Elies comprendront dans l’ordre: le nom de 
l’auteur et ses initiales, en majuscules, le titre 
abrege du Journal, le numero du volume, le 
numero de la page et l’annee. Les abreviations 
admises pour les noms de revues sont celles qui 
figurent dans Vlndex Medicus. Les renvois aux 
livres comprendront dans l’ordre: le nom de 
l’auteur, ses initiales, le titre de l’ouvrage, le 
numero de 1’edition (p. ex. deuxieme ed.), la 
ville et le nom de la maison d’edition, et 
l’annee de la publication; enfin, le numero de 
la page s’il s’agit d’un renvoi precis. Pour 
examples, voyez Tissue de janvier 1971 et ceux 
a venir.
Illustrations
Le journal accepte de publier gratuitement 
un nombre raisonnable d’illustrations en noir 
et blanc. Les reproductions de cliches en cou- 
leurs seront publiees aux frais de l’auteur. Les 
photographies seront imprimees sur papier bril- 
lant, ne seront ni montees ni calibrees et d’un 
format maximum de 6" x 8". En ce qui con- 
ceme les radiographies, nous demandons des 
copies et non pas Toriginal. On devra toujours 
foumir un agrandissement de microphoto­
graphies. Il ne faut jamais ecrire ou dactylo- 
graphier un texte quelconque sur les photo­
graphies. Une legende les identifiant pourra 
etre jointe au dos. Dans les illustrations mont- 
rant des malades, ceux-ci ne pourront etre 
reconnus, a moins qu’ils n’en aient donne le 
consentement ecrit prealablement a la publica­
tion. Les graphiques et diagrammes seront des- 
sines a l’encre de Chine sur un bon papier a 
dessin blanc. Le lettrage devra etre ecrit en 
caracteres assez grands pour que, apre reduc­
tion proportionnelle au format du Journal, ils 
soient encore lisibles. Les legendes devant 
accompagner les illustrations seront dactylo­
graphies sur une feuille independante du 
texte. Les illustrations ne seront ni roulees ni 
pliees.
Langue vehiculaire
II doit etre clairement etabli que les colla- 
borateurs ont pleine liberte de soumettre leurs 
articles en frangais ou en anglais, a leur choix. 
L’acceptation de l’article sera entierement inde­
pendante de la langue choisie par l’auteur. Si 
le collaborates le desire, il peut decrire le 
contenu de l’article en un sommaire ne depas- 
sant pas 300 mots et dans une langue differente 
de la langue choisie pour l’article lui-meme. 
Par exemple, un article ecrit en frangais doit 
comporter un resume en frangais et peut, si 
l’auteur le desire, etre accompagne d’un som­
maire plus detaille en anglais.
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Advances in Parenteral Nutrition. Fortschritte 
der Parenteralen Emahrung. Symposium of the 
International Society of Parenteral Nutrition, 
Prague, September 3-4, 1969. Edited by Gerhard 
Berg. 243 pp. Illust. Intercontinental Medical 
Book Corp., New York; Georg Thieme Verlag, 
Stuttgart, Germany, 1970. DM 39,00. $10.85 
(approx.). Paperbound.
Anesthesia for Outpatient Surgery. David D. 
Cohen and John B. Dillon. 67 pp. illust. Charles 
C Thomas, Publisher, Springfield, 111., 1970. 
$5.75.
Cancer of the Urinary Bladder. With Emphasis 
on Treatment by Irradiation. William L. Cald­
well. 116 pp. Illust. Warren H. Green, Inc., St. 
Louis; McAinsh and Company Limited, Toronto, 
1970. $8.80.
Cardiac and Vascular Diseases. 2 vols. Edited 
by Hadley L. Conn, Jr. and Orville Horwitz. 1735 
pp. and index. Illust. Lea & Febiger, Philadelphia; 
The Macmillan Company of Canada Limited. 
Toronto, 1971. $43.50.
Cardiovascular Surgery 1969. Council on 
Cardiovascular Surgery, American Heart Associa­
tion, Scientific Sessions, Dallas, Texas, Novembei 
13-16, 1969. American Heart Association Mono­
graph Number 30. Edited by Earle B. Mahoney. 
178 pp. Illust. The American Heart Association, 
Inc., New York, 1970. $5.00. Paperbound.
Chirurgie du mediastin. P. Razemon and M. 
Ribet. 215 pp. Illust. Masson et Cie, Paris, 1970. 
78 F. $14.25 (approx.). Paperbound.
Complications of Anesthesia. Compiled and 
edited by Lawrence J. Saidman and Frank Moya. 
298 pp. Illust. Charles C Thomas, Publisher, 
Springfield, 111., 1970. $12.75.
The Continuing Education of the Surgeon.
Transactions of the 12th Annual Meeting of The 
Allen O. Whipple Surgical Society. Edited by 
Harold G. Barker. 121 pp. Illust. Charles C 
Thomas, Publisher, Springfield, 111., 1971. $11.75.
Current Problems in Surgery. Edited by Max 
Saegesser. Vol. 14, Surgical Oncology. Edited by 
Frederic Saegesser and Jacques Pettavel. 907 pp. 
Illust. The Williams & Wilkins Company, Balti­
more; Burns & MacEachern Limited, Toronto, 
1970. $66.80.
Meniscus Lesions. Practical Problems of Clini­
cal Diagnosis, Arthrography and Therapy. P. Rick- 
lin, A. Riittimann and M. S. del Buono. American
Translation by Karl H. Mueller. 142 pp. Illust. 
Intercontinental Medical Book Corp., New York; 
Georg Thieme Verlag, Stuttgart, Germany, 1971. 
DM 59,00. $16.35 (approx.).
Ophthalmic Plastic Surgery. 4th ed. Sidney A. 
Fox. 590 pp. Illust. Grune & Stratton, Inc., 
New York; Longmans Canada Limited, Toronto, 
1970. $34.25.
Principles and Practice of Spinal Anesthesia. P.
C. Lund. 875 pp. Illust. Charles C Thomas, 
Publisher, Springfield, 111., 1971. $37.75.
Rh Immunisation and Its Prevention. Series 
Haematologica Volume III, 3, 1970. J. C. W ood- 
row. Edited by Kaj Cert Jensen and Sven-Aage 
Killmann. 151 pp. Munksgaard, Copenhagen, 
1970. Dan. Kr. 78.00. $10.60 (approx.). Paper- 
bound.
Selective Bibliography of Orthopaedic Surgery.
Including a Basic Science Supplement on the 
Musculoskeletal System. 2nd ed. The American 
Academy of Orthopaedic Surgeons. 114 pp. The 
C. V. Mosby Company, St. Louis, 1970. $8.00.
Surgery of the Upper Respiratory System. Vol.
I. William W. Montgomery. 492 pp. Illust. Lea 
& Febiger, Philadelphia; The Macmillan Company 
of Canada Limited, Toronto, 1971. $27.50.
Surgical Anatomy. Vols. 1 and 2. 5th ed. Barry
J. Anson and Chester B. McVay. 1241 pp. and 
index. Illust. W. B. Saunders Company, Phila­
delphia; W. B. Saunders Company Canada 
Limited, Toronto, 1971. $48.60.
Urologische Operationslehre. Number 5. Opera- 
tionen an Leistenkanal, Hoden, Skrotum und 
Samenstrang. Konservative und chirurgische Be- 
handlung der urologischen parasitaren Erkrankun- 
gen. Edited by G. W. Heise and E. Hienzsch. 116 
pp. Illust. VEB Georg Thieme, Leipzig, 1970. 
DM 35,00. $10.20 (approx.). Paperbound.
Urologische Operationslehre. Number 6. Trans- 
urethrale Operationen. Fehler und Gefahren bei 
transurethralen Eingriffen. Edited by G. W. Heise 
and E. Hienzsch. 169 pp. Illust. VEB Georg 
Thieme, Leipzig, 1970. DM 51,00. $14.15 (ap­
prox.). Paperbound.
Urologische Operationslehre. Number 7. Nier- 
entransplantation. Operative Behandlung des 
renalen Hochdrucks. Operationen bei Nieren- 
anomalien. Operative Behandlung der Ren mobilis. 
Edited by G. W. Heise and E. Hienzsch. 120 pp. 
Illust. VEB Georg Thieme, Leipzig, 1970. DM 
35,00. $10.20 (approx.). Paperbound.
Ventriculocisternostomy. Long-Term Experi­
ences. Robert C. Cantu, Jost J. Michelson and 
lames C. White. 138 pp. Illust. Charles C Thomas, 
Publisher, Springfield, 111., 1970. $14.75.
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operative enterocolitis and foreign bodies in 
the abdominal cavity.
The chapter on the surgery of the stomach 
and duodenum by R. Nissen is particularly in­
structive, dealing in detail with atypical closure 
of the duodenal stump and with complica­
tions after gastrectomy. A surgeon facing 
postoperative complications or anticipating 
intraoperative difficulties will profit from a 
perusal of the appropriate section and will be 
fascinated by some of the ingenious solutions j 
tried by others.
SURGERY AND BIOLOGY OF WOUND RE­
PAIR. Erie E. Peacock, Jr. and Walton Van
Winkle, Jr. 630 pp. Illust. W. B. Saunders
Company, Philadelphia; W. B. Saunders Com­
pany Canada Limited, Toronto, 1970. $23.25.
We have long needed a book written, in a 
concise and organized way, with a view to 
better understanding of the mechanism of re­
pair and regeneration of wounds. The authors 
have made a commendable contribution in this 
regard. This is an excellent book, which serves 
to translate the apparently complex scientific 
facts of wound repair to practical application 
in everyday surgery.
The book can actually be divided into two 
sections. The first, consisting of five chapters, 
deals with the basics of repair such as in­
flammation, epithelization, wound contraction, 
synthesis and maturation of collagen. The 
second section of the book deals with specific 
problems and their management. The dis­
cussions are based on the principles, beauti­
fully elucidated in the first half.
The facts are presented in a simple and 
well-organized way, and the style is superb, 
presenting enjoyable reading. An excellent 
selection of references is given at the end of 
each chapter.
In the section dealing with skin wounds, 
the author explains why, even though the 
superficial skin is approximated accurately, a 
scar sometimes results which is as wide as the 
wound had been before closure. Here he deals 
with the desirability of using subcuticular 
sutures and the necessity for using non-absorb- 
able colourless material.
A special section is devoted to lower leg 
ulcers popularly, but inaccurately, referred to 
as “stasis ulcers”. The authors’ views regard­
ing their treatment are definite and clear. 
There is a message that many surgeons will 
find valuable.
The section on burn care and skin grafting 
is well written. The modem trends in the 
management of tendon and nerve injuries and 
their associated problems are given in a logi­
cal and understandable way.
The chapter on visceral injuries is rather 
brief and the section on intestinal anastomoses 
should have been elaborated further.
On the whole, this excellent book is recom­
mended to all students of surgery.
w h e n  la x atives  a re  u n w is e
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Less abrasive than a brush 
... and just as effective'
NOTICE
BRITISH COUNCIL SPECIALIST COURSE
A postgraduate course “Patient Monitoring 
and Intensive Care” will be held in London, 
Glasgow and Edinburgh from October 17 to 
30, 1971. This course is designed to give 
clinicians and clinical research workers a theo­
retical and practical survey of the rapidly 
developing field of patient monitoring and in­
tensive care. The course will be directed by 
Professor J. P. Shillingford of the Medical Re­
search Council Cardiovascular Research Unit, 
Royal Postgraduate Medical School, London. 
The course has been planned to cover instru­
mentation, patient management and nursing 
care as well as the organization of intensive 
care units in coronary, renal, respiratory, 
neurologic and other diseases, and intensive 
postoperative care.
The provisional program is as follows.
London—Royal Postgraduate Medical School 
(J. P. Shillingford and colleagues)—Monitor­
ing in anesthetics; instrumentation and organ­
ization for research into, and treatment of, 
myocardial infarction; the intensive care of 
the acute respiratory emergency; treatment 
and instrumentation used in the management 
of respiratory failure; and renal dialysis. Medi­
cal Research Council Division of Medical 
Engineering (H. Wolff and colleagues)—New 
methods of advanced instrumentation in moni­
toring and patient care. St. Thomas’s Hospital 
(G. Spencer)—General intensive care in a 
teaching hospital.
Glasgow (two days)—Western Infirmary 
and other hospitals (T. D. V. Lawrie and 
colleagues)—Hyperbaric oxygen; renal inten­
sive care; neurosurgical intensive care; gen­
eral postoperative intensive care; intensive 
care of the respiratory patient.
Edinburgh (two days)—Royal Infirmary 
(M. Oliver and colleagues) —Intensive care of 
the coronary patient, including organization, 
monitoring and nursing.
The course is open to senior medical prac­
titioners and medically qualified hospital ad­
ministrators who wish to become further 
acquainted with recent advances in this field. 
There are vacancies for 20 members. The fee 
is approximately $264 which includes the cost 
of lectures, excursions during the course, hotel 
accommodation and two meals in London, and 
full board elsewhere. Applications should be 
made to The British Council, 80 Elgin Street, 
Ottawa, Ontario, and must be received in 
London by July 1, 1971.
w h e n  la x a t iv e s  a re  u n w is e
SU R FA K
Su rfak  is a safe, effective fecal 
softener which prevents the for­
mation of hard, dry stools thus 
reducing pain and discomfort, 
undue straining and irritation. 
Su rfak is not a laxative. . .  it 
acts solely to permit normal bowel 
function by preventing the for­
mation of hard, dry stools. 
Com p o sitio n : Each capsule con­
tains 50 mg. or 240 mg. of dioctyl 
calcium sulfosuccinate. In d ica­
tions: Prevention and treatment 
of constipation, especially in he­
morrhoids, anal fissures, geriatrics, 
pediatrics, immobilized patients, 
pregnancy, following anorectal 
surgery, ulcerative colitis, divert­
iculitis, and to avert straining after 
abdominal surgery, in cardiac 
patients and hypertensive patients. 
Contraindications: None known. 
Precautions: None known. A d ­
verse effects: Mild, transitory
cramping pains may rarely occur. 
Dosage: Usual adult dose is 240 
mg. daily; children and adults with 
minimal needs, 50 to 150 mg. daily. 
S u p p ly : Red, soft gelatin 240 mg. 
capsules in bottles of 100; orange, 
soft gelatin 50 mg. capsules in 
bottles of 100.
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B R ey  Hoecha TM 760/730/H
G3HOECHST
Hoechst Pharmaceuticals, 
Division of Canadian Hoechst Limited, 
Montreal 383
Few antibiotics are so right so often,
for severe Gram-negative hospital infections
Kant rex
KANAMYCIN SULFATE
Kantrex offers a spectrum uniquely suited to hospital 
practice. Few antibiotics provide such broad bactericidal 
coverage against Gram-negative bacteria and hospital 
staphylococci.
The rapid bactericidal action attained with Kantrex permits its use in severe infections be­
fore culture results are known. Its rapid absorption and diffusion facilitate penetration to in­
fection sites throughout the body for prompt therapeutic response—usually in 24-48 hours— 
and remission usually within 5-7 days.
Prompt use of Kantrex in Klebsiella pneumonia may save a lung or a life. Prompt use in 
pyelonephritis may reduce renal destruction so often seen in Proteus infections. Prompt 
use in bacteremia may prevent impending shock and fatality.
New dosage guidelines.assure low risk of toxicity. A simple basic dose of 7.5 mg./ Kg./
I.M. applies to all patients on Kantrex therapy. In patients with normal renal func­
tion, Kantrex injections are given twice a day; when renal impairment is present, 
the dose remains'the same but the time interval between doses is increased ,s 
depending upon the serum creatinine concentrations of the patient.
To calculate the time interval between the first and succeeding doses 
of Kantrex in patients with decreased renal function, simply multiply 
the mg. of creatinine x 9—e.g. if serum creatinine levels are 2 mg./
100 ml., the dosage interval should be 2 x 9 =  i8  hours be­
tween Kantrex doses.
In anuric adults give 7.5 mg./Kg./I.M. as a single loading 
dose. In adults on hemodialysis, 7.5 mg./Kg./I.M. every other 
dialysis.
To avoid ototoxicity, daily Kantrex dosage should not ex­
ceed 1.5 Gm. and total therapy should not exceed 15 Gm. or 
10 days.
When dosage recommendations are followed, therapeutic 
levels of Kantrex are maintained with low risk of toxicity.
Current evaluations of the Kantrex-neomycin-gentamicin 
group of antibiotics cite Kantrex as the safest for parenteral 
administration.Tz
K
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Kantrex*
KANAMYCIN SULFATE
Injection
PRESCRIBING INFORMATION. For complete 
information, consult Package Circular.
Indications: Infections of the urinary, respira­
tory and gastrointestinal tracts and of skin, soft 
tissues, bone periosteum and blood due to sen­
sitive organisms.
Contraindications: A history of hypersensitivity 
to the drug. Prior auditory damage by kana- 
mycin or other agents may be a contraindica­
tion if effective alternative therapy is available.
Warnings: Renal malfunction can cause ab­
normally high serum levels of kanamycin—as­
sess renal function periodically both before and 
during therapy. If renal insufficiency exists, de­
crease the size and frequency of dosages. Dis­
continue kanamycin and check hearing if 
azotemia increases. In older patients and pa­
tients receiving a total dose in excess of 15 
Grams, watch carefully for signs of ototoxicity.
Precautions: If mycotic or bacterial superinfec­
tion occurs, discontinue kanamycin and initiate 
appropriate therapy. Cumulative ototoxic effects 
may be produced by concurrent or consecutive 
use of other ototoxic drugs. High doses may 
cause irritation at infection sites. The drug 
should not be physically mixed with other anti­
microbials.
Adverse Reactions: Severe, irreversible hearing 
loss can occur. Stop therapy if tinnitus or hear­
ing loss occur. Signs of renal irritation may 
occur (casts, cells, proteinuria). If renal func­
tion is normal such irritation is reversible and 
is not necessarily an indication for stopping 
therapy. Skin eruptions have been noted rarely. 
To avoid respiratory depression, postpone intra- 
peritoneal instillation in postoperative patients 
until recovery from anesthesia and muscle re- 
laxants is complete.
Usual Dosage: 15 mg./Kg./day I.M. in divided 
doses preferably at 12-hour intervals. Average 
adult dose is 1 Gram daily. Do not exceed 1.5 
Gram even in the heaviest patients. Reduce size 
and frequency of dosages when renal insuffi­
ciency is present. Patients should be well hy­
drated to minimize renal irritation. Inject deeply 
into the upper wall, outer quadrant of the glu­
teal muscle.
Supplied: Rubber capped vials as a ready-to-use 
sterile aqueous solution in two concentrations: 
0.5 Gm. in 2 ml. 1.0 Gm. in 3 ml. Also Available 
—Pediatric Injection 75 mg. in 2 ml.
Complete prescribing information available 
on request.
References: 1. Finegold, S.M., ef a/.: California 
Med. 111:362 (Nov.) 1969. 2. Riley, H.D., Jr.: 
Pediatrics 1970, New York, Medical World 
News, 1970 pp. 16-18.
BRISTOL
Bristol Laboratories of Canada
Division of BTI Products Ltd. 
Candiac, P.Q.
/
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